A snapshot into the uptake and utilization of potential oligosaccharide prebiotics by probiotic lactobacilli and bifidobacteria as accessed by transcriptomics, functional genomics, and recombinant protein characterization by Andersen, Joakim Mark
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 20, 2017
A snapshot into the uptake and utilization of potential oligosaccharide prebiotics by
probiotic lactobacilli and bifidobacteria as accessed by transcriptomics, functional
genomics, and recombinant protein characterization
Andersen, Joakim Mark; Abou Hachem, Maher ; Svensson, Birte; Barrangou, Rodolphe; Klaenhammer,
Todd
Publication date:
2012
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Andersen, J. M., Abou Hachem, M., Svensson, B., Barrangou, R., & Klaenhammer, T. (2012). A snapshot into
the uptake and utilization of potential oligosaccharide prebiotics by probiotic lactobacilli and bifidobacteria as
accessed by transcriptomics, functional genomics, and recombinant protein characterization. Kgs. Lyngby:
Technical University of Denmark (DTU).
I 
 
 
 
A snapshot into the uptake and utilization of potential oligosaccharide prebiotics by 
probiotic lactobacilli and bifidobacteria as accessed by transcriptomics, functional 
genomics, and recombinant protein characterization   
 
Ph.D. thesis (2012) 
 
 
Joakim Mark Andersen 
Enzyme and Protein Chemistry (EPC), 
Department of Systems Biology, 
Technical University of Denmark (DTU) 
 
 
 
 
 
Supervisors: 
R&D Director Dr. Rodolphe Barrangou, DuPont Nutrition and Health, WI, USA 
Assoc. Prof. Maher Abou Hachem, EPC, Department of Systems Biology, DTU, DK 
Prof. Todd Klaenhammer, Department of Food Science, North Carolina State University, NC, USA 
Prof. Birte Svensson, EPC, Department of Systems Biology, DTU, DK  
  
II 
 
 
III 
 
Preface 
 
The present thesis summarizes the results of my Ph.D. project carried out in the Enzyme and 
Protein Chemistry group (EPC), Department of Systems Biology, Technical University of 
Denmark from February 2009 to May 2012 under supervision of Professor Birte Svensson and 
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Professor Todd Klaenhammer, respectively. The Ph.D. stipend was funded by DTU Systems 
Biology and DuPont (former Danisco A/S) and the project was supported by the Danish Strategic 
Research Council for the project “Gene discovery and molecular interactions in 
prebiotics/probiotics systems. Focus on carbohydrate prebiotics” (project no. 2101-07-0105) and 
the North Carolina Dairy Foundation for the work conducted at NCSU. Collaboration with 
Professor Hanne Frøkiær (Copenhagen University) was initiated to explore the immune-
modulation of L. acidophilus NCFM although not completed the work outline is summarized. 
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of galactooligosaccharide uptake by lacS in Lactobacillus acidophilus. Proc Natl Acad Sci USA. 
108: 17785−17790 
Joakim Mark Andersen, Rodolphe Barrangou, Maher Abou Hachem, Sampo Lahtinen, Yong 
Jun Goh, Birte Svensson, Todd R. Klaenhammer. Transcriptional analysis of prebiotic uptake 
and catabolism by Lactobacillus acidophilus NCFM. Submitted to PLoS ONE. 
Joakim Mark Andersen, Rodolphe Barrangou, Maher Abou Hachem, Sampo Lahtinen, Yong 
Jun Goh, Birte Svensson, Todd R. Klaenhammer. Mapping the uptake and catabolic pathways of 
prebiotic utilization in Bifidobacterium animalis subsp. lactis Bl-04 by differential 
transcriptomics. In preparation for BMC genomics. 
Joakim Mark Andersen, Morten Ejby, Jonas Rosager Henriksen, Thomas Lars Andresen, 
Maher Abou Hachem, Birte Svensson. Dual substrate specificity of a prebiotic transporter from 
Bifidobacterium animalis subsp. lactis Bl-04. In preparation. 
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Y.J., Lahtinen, S.J., Lo Leggio, L., Coutinho, P.M., Jacobsen, S., Abou Hachem, M., 
Klaenhammer, T.R., Svensson, B.: Prebiotic galacto-oligosaccharide utilization by 
Lactobacillus acidophilus NCFM. Establishment of a methodological platform for protein 
discovery. 7th Danish Conference on Biotechnology and Molecular Biology, Vejle (Denmark), 
May 2012. 
Andersen, J.M., Barrangou, R., Abou Hachem, M., Svensson, B., Goh, Y., Klaenhammer, T.R.: 
Gene induction patterns of prebiotic metabolic loci within Lactobacillus acidophilus NCFM. 
Symposium for Biotechnological Research 2011, Kgs. Lyngby (Denmark), November 2011. (1st 
Poster prize) 
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Gene induction patterns of prebiotic metabolic loci within Lactobacillus acidophilus NCFM. 9th 
Carbohydrate Bioengineering Meeting, Lisbon (Portugal), May 2011. 
Andersen, J.M., and Barrangou, R., Abou Hachem, M., Svensson, B., Goh, Y. and 
Klaenhammer, T.R.: Transcriptional analysis of prebiotic utilization by Lactobacillus 
acidophilus NCFM. American Society for Microbiology 110th General Meeting: San Diego 
(USA), May 2010. 
 
Additionally, I have been co-authoring the following publications involving characterization of 
protein-carbohydrate interactions and bacterial utilization of candidate prebiotic:  
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Hachem M., Petersen B.O., Duus J.Ø., Meyer A.S., Licht T.R., and Svensson B. In vitro growth 
of individual human gut bacteria on potential prebiotic oligosaccharides produced by 
chemoenzymatic synthesis. Submitted to J. Agric. Food Chem. (2012) 
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Summary 
 
Microorganisms that when administered in sufficient amounts exert a beneficial effect to the host 
are defined as probiotics. The positive clinical effects of probiotics, mainly belonging to the 
Bifidobacterium and Lactobacillus genera in treatments of irritated bowel disorders, gut 
infections and lifestyle diseases are currently well documented. Selective utilization, of primarily 
non-digestible carbohydrates, termed prebiotics, by probiotics has been identified as an attribute 
of probiotic action, however the molecular mechanisms of prebiotics utilization and in particular 
the specificities of carbohydrate transporters and glycoside hydrolases that confer this remain 
largely unknown, limiting a robust understanding for the basis of selective utilization of known 
prebiotics and the discovery and documentation of novel prebiotics.  
The aim of this Ph.D. thesis was to identify the genes involved with uptake and catabolism of 
potential prebiotics by the probiotics Lactobacillus acidophilus NCFM and Bifidobacterium 
animalis subsp. lactis Bl-04 as model organisms, using DNA whole genome microarrays and by 
in silico pathway re-construction to identify key genes for further functional analysis by gene 
deletions and recombinant protein characterization. 
Transcriptional analysis was used to measure the global gene expression, in both bacteria, grown 
on glucose and various prebiotics and potential prebiotics covering diverse types of glycoside 
linkages and compositions: β-galacto-oligosaccharides, cellobiose, gentiobiose, isomaltose, 
panose, raffinose, stachyose and selected strain-specific potential prebiotics – L. acidophilus 
NCFM: barley β-glucan hydrolysate, lactitol, isomaltulose and polydextrose, while for B. lactis 
Bl-04: maltotriose, melibiose, xylobiose and xylo-oligosaccharides were used.  
The differential transcriptional analysis of L. acidophilus NCFM revealed upregulation of genes 
encoding phosphoenolpyruvate-dependent sugar phosphotransferase systems mainly associated 
with disaccharide uptake, galactoside pentose hexuronide permease and ATP-binding cassette 
transporters were upregulated by dominantly oligosaccharides. Glycoside hydrolases from 
families 1, 2, 4, 13, 32, 36, 42, and 65 were found associated with the various transporters for 
carbohydrate catabolism.  
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The differential transcriptional analysis of B. lactis Bl-04 identified carbohydrate transporters of 
the major facilitator superfamily and galactoside pentose hexuronide permeases for disaccharide 
uptake and ATP-binding cassette transporters mainly for uptake of oligosaccharides. These 
transporters were found in gene clusters with glycoside hydrolases from families 1, 2, 13, 36, 42, 
43 and 77. 
Based on gene landscape analysis and the transcriptional findings, reconstruction of utilization 
pathways were done in silico. Hereafter the role of essential gene products in uptake of β-
galacto-oligosaccharides putatively facilitated by a galactoside pentose hexuronide permease and 
the involvement of an ATP-binding cassette transporter and an α-galactosidase for uptake of 
raffinose family oligosaccharides and catabolism, respectively, were confirmed by gene deletion 
mutants in L. acidophilus NCFM.  
The B. lactis Bl-04 homologous protein of the L. acidophilus NCFM raffinose specific solute 
binding protein displayed dual substrate specificity for raffinose family oligosaccharides and 
isomalto-oligosaccharides. The binding affinities (KD) to a set of α-1,6 glycosides representing 
both classes of ligands were in the µM range, notably lower than typical values for 
oligosaccharide binding to solute binding proteins. The binding was enthalpically dominated and 
the lower affinity owed to a large unfavorable binding entropy suggestive of a high plasticity of 
the ligand binding site needed to accommodate different ligands varying in size, and 
monosaccharide composition, but recognizing a core structure comprising an α-D-(1,6)-linked 
galactose or its glucose C4 epimer. Biochemical characterization of the recombinant protein 
validated the broad substrate specificity, however the binding affinity was 100–1000 fold lower 
for the preferred substrates panose and raffinose, than seen for mono-specific carbohydrate 
transporters previously described although any biological implication of the weaken affinities is 
yet to be investigated.  
In conclusion, differential transcriptomics revealed the global regulated gene response of L. 
acidophilus NCFM and B. lactis Bl-04 to potential prebiotic carbohydrates from which novel 
specificities for carbohydrate transporters and glycoside hydrolases were identified and validated 
through functional characterization. The work adds to the understanding of how probiotic 
bacteria can selective utilize prebiotics and how novel prebiotics can be discovered.  
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Dansk resumé (summary in Danish) 
 
Mikroorganismer, der når de tilføjes i tilstrækkelig dosis udviser en positiv effekt på modtageren, 
er defineret som probiotika. Det er dokumenteret, at probiotika, hovedsageligt fra genera 
Bifidobacterium og Lactobacillus, kan anvendes i behandlingen af irriteret tyktarm, 
tarminfektioner og livsstilssygdomme. Selektiv udnyttelse af primært ufordøjelige kulhydrater, 
kaldet præbiotika, er én virkningsmekanisme benyttet af probiotika, dog er de specialiserede 
molekylære interaktioner primært specificiteter af kulhydrattransportører og glykosid-hydrolaser 
stortset ukendt. Den manglende viden begrænser opdagelsen samt anvendelsen af nye 
præbiotika. 
Formålet med denne Ph.D. afhandling var at identificere de gener, som er involveret i optag og 
katabolisme af potentielle præbiotika i de probiotiske bakterier Lactobacillus acidophilus NCFM 
og Bifidobacterium animalis subsp. Lactis Bl-04, som model organismer, ved at benytte 
transkriptomanalyse og in silico rekonstruktion af metaboliske reaktionsveje for at kortlægge 
centrale gener til videre funktionel analyse ved hjælp af gen-deletioner og rekombinant 
proteinkarakterisering. 
Transkriptionsanalyse blev anvendt til at måle det globale gen-udtryk i begge bakterier, dyrket 
med glukose og en række præbiotika samt potentielle præbiotika dækkende en bred vifte af 
glykosid-bindinger og glykosid-kompositioner: β-galacto-oligosakkarider, cellobiose, 
gentiobiose, isomaltose, panose, raffinose, stachyose samt udvalgte stamme-specifikke 
potentielle præbiotika – L. acidophilus NCFM: byg β-glykaner, lactitol, isomaltulose og 
polydextrose, imens de følgende blev benyttet til B. lactis Bl-04: maltotriose, melibiose, 
xylobiose og xylo-oligosakkarider. 
Differential transkriptionsanalyse af L. acidophilus NCFM afslørede opregulering af gener 
kodende for phosphoenolpyrovatafhængige sukker-phospho-transferase systemer primært knyttet 
til optag af disakkarider. En galaktosid pentose hexuronid permease og ATP-bindende kasette 
transportører var opreguleret af hovedsageligt oligosakkarider. I tilknytning til de forskellige 
kulhydrattransportører var glykosid-hydrolaser involveret i kulhydratkatabolismen fra familierne 
1, 2, 4, 13, 32, 36, 42 og 65 opreguleret. 
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Differential transkriptionsanalyse af B. lactis Bl-04 identificerede kulhydrattransportører 
klassificeret som ’Major facilitator superfamily’ og galaktosid pentose hexuronid permeaser 
involveret i disakkaridtransport samt ATP-bindende kasette transportører primært for 
oligosakkaridoptag. Disse transportører blev fundet i genklynger med glykosid-hydrolaser fra 
familierne: 1, 2, 13, 36, 42, 43 og 77. 
Reaktionsveje for oligosakkaridudnyttelse blev genskabt in silico ud fra gen-landskabsanalyse og 
de transkriptionelle resultater. Betydningen af tre formodede essentielle gener kodende for en 
galaktosid pentose hexuronid permease, en ATP-bindende kasette transportør samt en α-
galaktosidase blev undersøgt for deres rolle i optag af β-galakto-oligosakkarider; for optag og 
katabolisme af raffinose-lignende oligosakkarider eftervist ved gen-deletioner i L. acidophilus 
NCFM. 
Det homologe B. lactis Bl-04 protein af det raffinose specifikke solute binding protein fra L. 
acidophilus NCFM udviste en dobbelt substratspecificitet for raffinose-lignende oligosakkarider 
og isomaltooligosakkarider. Bindingsaffiniteterne (KD) for et sæt af α-1,6-glykosider, der 
repræsentere begge typer af ligander, var i µM skala, hvilket er mærkbart lavere end typiske 
værdier for oligosakkarid binding til andre solute binding proteiner. Bindingen var entalpisk 
drevet og den lavere affinitet skyldtes en større ufavorabel entropi. Dette var muligvis resultat af 
ligang-bindingslommen ændrede form, som krævet for at binde de forskellige ligander 
varierende i længde og glykosid komposition, selvom α-D-(1,6) galaktose, eller den C-4 epimere 
glukose, blev genkendt i bindingslommen. 
Biokemisk karakterisering af rekombinant protein validerede den brede substratspecificitet, dog 
var affiniteten 100–1000 gange lavere for de fortrukne substrater panose og raffinose end for 
tidligere beskrevet mono-specifikke kulhydrattransportører omend det endnu ikke er undersøgt 
om de lavere affiniteter har biologisk relevans.  
Som konklusion har differentiel transkriptionsanalyse vist det globalt regulerede genudtryk af L. 
acidophilus NCFM og B. lactis Bl-04 i forhold til potentielle præbiotiske kulhydrater, hvorfra 
nye specificiteter bekræftet ved funktionel karakterisering er fundet for kulhydrattransportører og 
glykosid-hydrolaser. Dette studie tilføjer forståelse af hvordan probiotiske bakterier selektivt kan 
omsætte præbiotika samt hvordan nye præbiotika kan udvælges.  
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1 Introduction  
 
The use of probiotic microorganisms for improvement of human health (1) has been clinically 
well-documented within the recent years as reviewed in the following. Probiotics can be 
supplemented with selectively metabolized prebiotics, mainly carbohydrates, for synergistic 
effects (2). 
Advances within genomics have shed new light into the diversity and functions of the human 
gastrointestinal tract (3) pushing for more defined consideration in design of probiotic treatments 
(4). In this context, next-generation probiotic products are estimated to be knowledge-driven, 
focused on the molecular mechanism of their effects (5) including deeper understanding of 
selective prebiotic metabolism. Hence it is the purpose of the following sections to introduce pre- 
and probiotics, their role in the gastrointestinal tract and their mechanisms of actions leading to 
molecular understanding of the protein facilitating prebiotic uptake and catabolism. This sets the 
stage for presentation of differential transcriptomics for gene identification induced by potential 
prebiotics, and the targeted functional genomics and recombinant protein work for 
characterization of carbohydrate transporters. The presented work adds to the fundamental 
understanding of probiotic bacteria in particular with respect to their utilization of carbohydrate 
prebiotics by pathway mapping, comparative gene landscaping of identified genetic loci and 
biochemical characterization of a novel dual specific carbohydrate transporter. 
1.1 Beneficial modulation of the human gastrointestinal tract 
1.1.1 Probiotics 
Microorganisms positively modulating human health have been long known and were pioneered 
by the studies of Ilya Mechnikov in the early 20th century (6). The initial work focused on 
fermented milk containing lactic acid bacteria and their impact on human health and longevity. 
Subsequent scientific investigations established the knowledge on positive health impact elicited 
by supplementing diet with beneficial microorganisms and this eventually led to the first 
definition of probiotics (7) which was followed-up by WHO’s definition of probiotics as: “live 
2 
 
microorganisms, which when administered in adequate amounts, confer a health benefit on the 
host.” (8). Continuous development in the field produced numerous supporting studies 
addressing molecular mechanistic and clinical work, which consolidated the above definition of 
probiotics into a state of consensus lead by the scientific community for continuously critical 
review (1). Following regulatory demands from governmental agencies, regarding 
documentation and increased substantiation of probiotic related health claims for commercial 
products containing probiotics (9, 10). The scientific focus changed to go beyond clinical studies 
into the areas of genetics and molecular mechanisms of action for probiotics interactions by 
techniques such as proteomics, transcriptomics, functional genomics and recombinant protein 
characterization (5). In the following sections probiotics will be introduced, with emphasis on 
their synergetic effects with carbohydrate prebiotics and role in the gastrointestinal tract leading 
to the molecular level genomics and identification of genetic loci involved with observed 
probiotic effects and subsequently including the corresponding gene products and mechanism of 
action. 
Probiotic organisms have been found within the following microbial genera: Bifidobacterium, 
Enterococcus, Escherichia, Lactobaccilus, Lactococcus, Leuconostoc, Pediococcus, 
Ruminococcus, Saccharomyces and Streptococcus (11). Yet the main topic for probiotic 
research, as it is also the case of the present work, has been the bifidobacteria and lactobacilli. 
Table 1-1 summarizes some of the investigated beneficial roles that probiotic bifidobacteria and 
lactobacilli exert on the host upon supplementation. It is recognized through interventions for 
modulation of the microbial activity within the human gastrointestinal tract (GIT) that probiotics 
have impact on the immune system throughout life and can target illnesses described as major 
health issues such as dietary related lifestyle diseases and bowel disorders, colonic cancer and 
infant malnutrition (12–14). 
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Table 1-1: Selected probiotic clinical trials in humans. The types of probiotic modulation are 
divided into: short term treatments covering mainly acute infection, age influenced treatments and 
chronic diseases within the GIT to illustrate the broadness of positive interventions. 
Type of probiotic modulation Intervention focus References 
Short term treatment Viral infections (15, 16) 
 Urinal tract infections (17, 18) 
 Allergies (19, 20) 
 Acute diarrhea (21, 22) 
Age dependent grouping of subjects Preterm newborn  (23) 
 Infants with diarrhea  (24) 
 Elderly and improve immunity (25) 
Irritated bowel syndromes Ulcerative colitis (26, 27) 
 Crohn’s disease (28, 29) 
 Colonic cancer prevention (30, 31) 
 
The mechanism of probiotic actions include functions as bacterial bulking agent hence 
hampering colonization potential of opportunistic pathogens and exogenous microorganisms 
(32), production of secondary metabolites such as short chain fatty acids stimulating the 
epithelial cell metabolism and turnover (33), acidification of the local GIT environment to 
suppress viability of undesirable lesser acid tolerant microorganisms (34), and the modulation of 
the host immune system (35). By the current understanding of probiotics, there is a need to 
correlate the underlying mechanisms linked to probiotic proliferation and activity in the GIT 
with the beneficial effects (36). This includes highlighting the selective stimulation by dietary 
food components bypassing the host digestive breakdown and uptake systems for entry into the 
colon where the non-digestible fraction, dominantly carbohydrates, is selectively utilized by a 
sub-population of the microbes residing in the GIT (37). 
1.1.2 Prebiotics 
The microbial inhabitants of the GIT rely on components of the human diet not digested in the 
upper GIT of the host. This fraction is mainly oligo and polysaccharides of plant origin (38) 
which are utilized by the diverse community of microbes residing in the lower GIT. Thus some 
of these carbohydrates (both oligosaccharides and polysaccharides) were found to be 
preferentially utilized by probiotic microorganisms with subsequent increase in their cell 
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numbers and activity in the GIT and hence the term prebiotics was coined to describe this 
category of compounds (11). Prebiotic lipids and proteins have been mentioned in the literature 
but are sparsely reported (11) while more recently plant isoflavones (39) and polyphenols (40) 
have been suggested to exhibit prebiotic effects. The current definition set three criteria for 
prebiotics (41): 
1. Resistance to gastric acidity, hydrolysis by mammalian enzymes and gastrointestinal 
absorption 
2. Ability to be fermented by intestinal microbiota 
3. Selective stimulation of the growth and/or activity of intestinal bacteria associated with 
health and wellbeing 
The selective metabolism of prebiotics and selected studies supporting their impact on human 
health are summarized in Table 1-2. The chemical structures of the prebiotics listed in Table 1-2 
and in the following section are summarized in Table 1-4 showing diversity of glycosidic 
linkages and composition of prebiotics. Numerous in vivo human and animal studies have 
investigated the proposed prebiotic effects. Yet to date, documentation has only been obtained 
sufficiently for a few carbohydrates to grant a status as prebiotics, namely: β-galacto-
oligosaccharides (GOS), lactulose, fructo-oligosaccharides (FOS) and inulin (2). The level of 
documentation obtained through clinical studies to grant the status of prebiotic is a matter of 
debate (42). As this debate is yet unsettled, this work will adopt the currently accepted and 
previously published classification of prebiotics, although selective utilization pathways for 
novel candidate prebiotic will be proposed later, potentially acting as supportive claims for 
prebiotics classification. 
Dual supplements of pro- and prebiotic, termed synbiotics, have shown great potential for 
increased efficiency of GIT associated disorders (43–47) substantiating the selective metabolism 
by probiotics leading to improvement of GIT treatments. 
Novel potential prebiotics have been proposed (gentiobiose, panose, polydextrose, raffinose 
family oligosaccharides (RFO)) although mainly based on in vitro methodology hence making 
more studies needed to fully document them as prebiotics based on in vivo studies (42, 58). Table 
1-3 summarizes selectively fermented potential prebiotics. 
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Table 1-2: Selected studies of prebiotic effects in vivo. 
Prebiotic Observed positive effect Reference 
FOS Host immune modulation (48) 
FOS Prevention of diarrhea (49) 
FOS Increased fecal bifidobacteria counts (50) 
FOS Treatment of Crohn’s disease (51) 
GOS Increased bifidobacteria counts (52) 
GOS Prevention of diarrhea (53) 
GOS Review of clinical trials (54) 
GOS/FOS Modulation of vaccine response in mice (55) 
Inulin Increased bifidobacteria counts (56) 
Inulin Review of immune-modulation (48) 
Lactulose Review of prebiotic effects (57) 
 
Table 1-3: Selected studies proposing novel potential prebiotics. 
Carbohydrate Screening system Observed effect  Reference 
Polydextrose Fecal fermentations Improved short chain fatty acid profile production (59, 60) 
Polydextrose Humans Increased bifidobacteria and lactobacilli counts (61) 
RFO Humans Selective fermentation by bifidobacteria (62) 
RFO Rats Improved mineral uptake (63) 
AXOS Rats Improved mucin turnover (64) 
XOS Humans Increased bifidobacteria and lactobacilli counts (65) 
IMO Humans Review of clinical trials (66) 
IMO Humans Increased lactobacilli count in rats (67) 
IMO Humans Bowel functions in elderly (68) 
Panose Fecal fermentations Increased bifidobacteria counts (58) 
Lactitol Humans Immuno-modulation (69) 
Xylitol Fecal fermentations Improved short chain fatty acid profile production (59) 
Gentio-
oligosaccharides 
Fecal 
fermentations Fermentation by bifidobacteria and lactobacilli (70, 71) 
Pectic-
oligosaccharides 
Fecal 
fermentations Some selective fermentation by bifidobacteria (72, 73) 
α-manno-
oligosaccharides Weaning pigs Positive immune-modulation and reduced diarrhea (74, 75) 
 
Dietary prebiotics elicit both a proliferational effect and enhanced activity of probiotics, yet 
prebiotics are not only linked to selective metabolism. It has been shown in vitro how GOS may 
prevent adhesion of pathogenic Vibrio cholera and Cronobacter sakazakii to protein receptors on 
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the surface of epithelial cells (76–78) and inhibit adhesion of Salmonella enteric serovar 
Typhimurium via murine enterocytes (79). These effects have been explained by GOS 
structurally mimicking human surface glycoproteins (80) where prebiotics may also act as 
decoys for pathogens hence reducing their adhesion to the mucosa barrier being a first step in 
infection (81). Similar observations for pathogenic inhibition of adhesion has been reported for 
XOS (82). 
Despite the promising nature of prebiotics, recent studies highlight a controversy regarding the 
use of prebiotics: The capabilities of potential pathogenic Listeria monocytogenes to utilize 
known prebiotics (83), increase the severity of Salmonella enteric serovar Typhimurium 
infections when stimulated with prebiotics (84) and the identification of genetic loci enabling 
FOS utilization, have been identified in E. coli (85, 86). These observations reflect a shortage of 
sufficient documentation of pre- and probiotics (42), motivating discovery of novel prebiotics, 
combined with further understanding of molecular mechanism of selective prebiotic metabolism 
and how this applies to the microbiome in the GIT. 
Table 1-4: Chemical structures of reported prebiotics and potential prebiotics. The size ranges of 
each oligosaccharide are defined as footnotes below with the range of raffinose oligosaccharides 
listed with common names. The size distributions are reported in the respective references to each 
oligosaccharide listed for documented prebiotics in Table 1-2 and candidate prebiotics in Table 1-3. 
Common names Chemical Structure 
Fructo-oligosaccharides (FOS) [β-D-Fruf-(1-2)]a -(β2,α1)-D-Glcp 
Inulin As FOS with a > 20 
β-galacto-oligosaccharides (GOS) [β-D-Galp-(1–4)]b-D-Glcp 
Lactitol β-D-Galp-(1–4)-D-Glc-ol 
Lactulose β-D-Galp-(1–4)-D-Fruf 
Raffinose family oligosaccharides (RFO) [α-D-Galp-(1–6)]c- D-Glcp-(α1,β2)-D-Fruf 
Melibiose  α-D-Galp-(1–6)- D-Glcp 
Isomalto-oligosaccharides (IMO) [α-D-Glcp-(1–6)]d-D-Glcp 
Panose α-D-Glcp(1–6)-α-D-Glcp-(1–4)-D-Glcp 
Gentio-oligosaccharides [β-D-Glcp-(1–6)]e-D-Glcp 
β-xylo-oligosaccharides (XOS) [β- D-xylf-(1–4)]f-D-xylf 
Arabinose-decorated XOS (AXOS) α-D-Araf-(1–2) and/or α-D-Araf-(1–3) linked to XOS 
Xylitol β- D-xylf-(1–4)-D-xyl-ol 
Polydextrose Primarily mixed α-glucans, DP=2–30 
Pectic-oligosaccharides [α-L-Rhap-(1,2)-α-D-GalAf-(1,4)]g 
Manno-oligosaccharides [α- D-Manp-(1–4)]-D-Manp 
a = [1–5]; b = [1–5]; c = [1=raffinose, 2=stachyose, 3=verbascose]; d = [1–5]; e = [1–5]; f = [1–7]; g = [1–4] 
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1.1.3 Health, dietary and commercial aspects of pre- and probiotics 
The above definitions of pro- and prebiotics are well documented. Pre- and probiotics, however 
are although not confined to humans, indeed markets are emerging in animal feed, driven by 
regulations to reduce application of antibiotics in livestock production (87) and aquaculture (88), 
showing widespread use of pre- and probiotics.  
The total global sale for probiotic products reached 15.9 billion $ (12.4 billion €) in 2008 and the 
average annual growth rate has been estimated to around 7% (89) with the main consumer 
markets being Northern America (90), Japan (91) and Europe (92).  
To ensure the efficiency of probiotic products, regarding levels and activity of supplemented 
functional ingredients and consumers’ safety based on manufacturers claims, the application of 
probiotic supplemented commercial dietary products is being regulated by governmental 
agencies (Food and Drug Administration in Northern America and European Food Safety 
Authority within the European Union) (10). New regulations, as exemplified by the EU 
regulation No. 1924/2006 (93), have increased the level of documentation needed to propose 
claims of efficacy for probiotic products emphasizing the needs for further documentation on 
specific applications of pre- and probiotics (9, 94, 95). 
1.2 The gastrointestinal tract and beyond: the probiotic perspective 
1.2.1 The gastrointestinal tract as a microbial habitat 
The main function of the human gastrointestinal tract (GIT) is to process, digest and absorb 
nutrients from the diet to supply energy to the various organs of the body. This requires an 
interplay of α-amylases, acidification, bile salts, proteases and lipases all secreted by the human 
digestive system through a strict compartmentalization of the GIT, yet these processes are by far 
insufficient to handle the complexity of the diet and provide nutritional requirements for the 
human body. Through evolution the lower GIT (colon) has evolved to become a niche habitat 
(Figure 1-1) for commensal microorganisms (the GIT microbiome in generic terms) dependent 
on commensalisms and in some cases mutualism with the host or negatively affected under 
specific conditions by opportunistic pathogenesis (96).  
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Figure 1-1:Compartments of the GIT, the bacterial genera predominantly found herein and the 
food transit time showing fermentation in the colon by the duration of food transit enabling 
microbial colonization (Modified from (97)). 
 
Among the many roles of the GIT microbiota, catabolism of non-digestible components of the 
human diet is one of the best examples of commensalisms (98, 99). This is illustrated by the 
estimated 100–150 fold higher number of genes found from sequencing of the GIT microbiome 
compared to the human genome (100) showing metabolic capabilities beyond the genetic 
information stored in the human genome and thus how harboring a microbiota can be very 
advantageous for biosynthesis of vitamins and detoxication of xenobiotics (101), and at times 
challenging by imbalance of the microbiome leading to inflammatory bowel syndromes (3). 
1.2.2 Homeostasis and microbial diversity in the gastrointestinal tract 
Given the wide metabolic capabilities of the GIT microbiome and interplay with the host, it is a 
crucial area of research to classify the microbial span and phylogenetics of the GIT microbiota. 
This work has been greatly aided with advances within high-throughput sequencing and 
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bioinformatics in the recent decade (102). A key area in understanding the mutualism and 
pathogenesis in the GIT is the attempt to classify what can be regarded as a stable microbiome in 
homeostasis with the host as discussed by Sansonetti and Medzhitov (103) and the measurable 
changes observed in disease states of the GIT (3). The GIT bacterial composition at the phylum 
level was recently mapped by ribosomal 16S RNA sequencing to highlight the major phyla and 
their diversity, dominated by Bacteroidetes and Firmicutes in adults (102). Building from the 
established reference of the GIT microbiota in homeostasis it has been possible to map the 
microbiome establishment in neonates, the maturation into adulthood (104) and the decline and 
changes induced by aging (105). This included incorporating a marked individual variation in 
microbiome composition resulting from genetic variation and environmental differences of the 
geographical habitat (106) combined with long-term diet influence (107). The above factors 
allow microbiome differentiation into enterotypes, which can be applied to link the differences of 
the microbiome into functional groups and disease states respectively (108) for targeted 
treatments with probiotics. 
Thanks to the gained insight into the diversity and dynamics of the GIT microbiome as outlined 
above, greater understanding of how disease states arise and negatively modulate the GIT has 
been obtained (109–112). In turn this can be developed and validated to enable targeted pre- and 
probiotic treatment (113) taking into account the multitude of mechanism of actions as listed 
above (Section 1.1.1 and 1.1.2) and highlighted in the following section. 
1.2.3 Molecular mechanisms of probiotic functions 
Probiotics’ mechanism of actions include competitive exclusion of opportunistic pathogens (114, 
115), production of secondary metabolites for acidification of the GIT (34) or short chain fatty 
acids such as propionate which is absorbed through the epithelia and stimulate lower lipogenesis 
(116). Furthermore proteinacious products such as bacteriocins may inhibit pathogen 
colonization (117, 118) and bacterial membrane associated proteins (119) or cell-membrane 
anchored lipids (120) may regulate the host immune response. Notably, prebiotics were indicated 
to enhance the probiotic functions, beyond stimulating selective growth of probiotics, e.g. FOS 
mediated increased bacteriocin production (121) and utilization of various prebiotics were shown 
to increase stress resistance, e.g. oxidative stress, in lactobacilli (122). The following sections 
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will present the genomics of probiotics, and genetic loci encoding proteins involved with 
prebiotic utilization, to emphasize the molecular mechanisms of pre- and probiotic interactions. 
1.3 Genomics and phylogenetics of probiotics 
The advances within bacterial genomics have been essential to link phylogenetics and functional 
studies leading into a systems biology perspective (3, 123–125). In this light, genomic analysis 
has proved to be valuable for high through-put screening of bacterial genomes to identify 
markers of antibiotic resistance and virulence factors within the GIT (126) and comparative 
assessment of bacterial phage resistance (127) or loci specifically linked to probiotics as 
reviewed by Ventura et al. (128). 
Genome-scale analysis of probiotic strains focusing on bifidobacteria and lactobacilli has been 
extensively reviewed to highlight genomic features promoting the adaption to the GIT and 
probiotic mechanism of action (129, 130). In relation to prebiotics, a common feature of 
probiotic genomes is the large proportion (15–20% of the total numbers of genes) of putatively 
carbohydrate metabolism genes (131–133). The following will introduce the genera 
Lactobacillus and Bifidobacterium, which despite functional similarities in the GIT show 
phylogenetic distant diversity (128, 134). 
1.3.1 Lactobacillus  
The Lactobacillus genus consists of Gram-positive, low genomic C+G content, acid-tolerant, 
non-sporulating, aero-tolerant or anaerobic bacteria (135). Lactobacilli have been isolated mainly 
from natural food fermentations of diary, meat and plants, and from the intestine of animals 
giving rise to a significant industrial potential for fermented foods products, starter cultures and 
probiotics (136). Genomic analysis of lactobacilli showed strain differentiation to depend on the 
original habitat (137) where the GIT associated lactobacilli mainly comprise L. acidophilus, L. 
gasseri, L. johnsonii and L. casei (138). Comparative analysis of strains isolated both from plant 
material and GIT have highlighted genomic loci associated with niche adaption (129) leading to 
increased understanding of the protein facilitated mechanisms underlying probiotic actions of 
lactobacilli from the GIT (139, 140).  
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The combined approach of genomics (selectively summarized in Table 1-5), functional genomics 
(141, 142) and high-throughput gene identification (143) has substantiated the potential for 
identification of genetic loci specific for prebiotic utilization (144). 
Table 1-5: Selected probiotic Lactobacillus strains. Genome sizes are given in mega-basepairs (Mb) 
Strain Genome size (Mb) Accession number Reference 
L. acidophilus NCFM 2.0 NC_006814.3 (131) 
L. rhamnosus GG 3.0 NC_013198.1 (145) 
L. plantarum WFCS1 3.1 NC_004567.1 (146) 
L. johnsonii NCC553 2.0 NC_005362.1 (147) 
L. gasseri 33323 1.9 NC_008530.1 (148) 
L. casei BL23 3.1 NC_010999.1 (149) 
L. crispatus ST1 2.0 NC_014106.1 (150) 
 
1.3.1.1 Lactobacillus acidophilus NCFM 
L. acidophilus NCFM has been reported as a probiotic in clinical studies (44, 151, 152) and in 
combination with oligosaccharide prebiotics (69). The probiotic character have been analyzed by 
functional studies to reveal the molecular mechanisms for important probiotic traits, such as bile 
acid resistance (153, 154), cell adhesion (155, 156) and involvement of lipoteichoic acid in 
immunomodulation (120). The carbohydrate uptake and catabolism genes comprise 17% of the 
L. acidophilus NCFM genome (131). Broad carbohydrate utilization of L. acidophilus NCFM 
was demonstrated and included transporters for trehalose (141), fructo-oligosaccharides (142), 
and several mono-, di- and tri-saccharides (143, 157). Yet the potential for in silico identification 
of genes involved in prebiotic utilization is still hampered by the lack of functional studies within 
strains of lactobacilli harboring multitudes of transporters and families of glycoside hydrolases 
(137, 158). 
The following experimental work (Appendices 6.1 and 6.2) focuses on L. acidophilus NCFM as 
an important representative of the acidophilus cluster of GIT associated lactobacilli (159) to 
elucidate novel potential prebiotic utilization. 
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1.3.2 Bifidobacterium 
Bifidobacteria are non-motile, non-sporulating and non-gas producing, anaerobic high genomic 
C+G Gram-positive, bacteria from the Actinobacteria phylum, (160, 161). Bifidobacteria are 
mainly isolated from ecological niches associated with the human (or animal) GIT indicating 
their significance in the microbiome (162). Phylogenetic analysis showed clustering of 
bifidobacteria into the following groups: B. asteroids, B. adolescentis, B. longum, B. pollorum, 
B. boum and B. pseudolongum (162, 163) where the latter group harbors the B. animalis subsp. 
lactis taxon, utilized commercially for its probiotic characteristics (164).  
To date, 53 bifidobacterial genomes are publicly available (May 2012) and selected 
bifidobacteria strains associated with probiotic effects are listed in Table 1-6. General size of the 
genomes ranges from 1.9 to 2.9 Mb and display an overall low level of genomic diversity (165) 
with a core of 1000 common genes estimated from pan-genomics (166). 
Table 1-6: Selected genomes of probiotics strains of bifidobacteria.  
Strain Genome size (Mb) Accession number Reference 
B. animalis subsp. lactis Bl-04 1.9 NC_012814 (167) 
B. adolescentis ATCC15703 2.1 NC_008618 Only in database 
B. longum subsp. infantis ATCC15697 2.8 NC_011593 (168) 
B. longum subsp. longum NCC2705 2.3 NC_004307 (169) 
B. bifidum PRL2010 2.2 NC_014638 (170) 
B. breve UCC2003 2.4 CP000303.1 (171) 
 
The GIT adaption, linked to defined genetic loci within bifidobacteria has been proposed for 
complex dietary carbohydrate utilization (169, 172, 173). Alternative adaption, although not yet 
considered a probiotic characteristic, has been identified for mucin degradation and utilization of 
B. bifidum strains (170). Furthermore colonization of B. dentium strains as opportunistic 
cariogenic pathogens in the oral cavity as been reported through the mechanisms of adhesion and 
utilization of human saliva-derived compounds (174). 
1.3.2.1  Bifidobacterium animalis subsp. lactis Bl-04 
B. animalis subsp. lactis strains have documented effects as probiotics (175–179) and are widely 
used in commercial products (180). Characterization of B. lactis strains on the genomics and 
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molecular level (181–183) has identified elements potentially conferring probiotic characteristics 
such as oxidative stress tolerance (184, 185), XOS utilization (186) and bile resistance (187). 
Although clinical well-documented and with excessive pan-genomic data available showing 
multiple genes putatively involved with prebiotic utilization, functional work is lacking to 
substantiate the pre- and probiotic interactions (188–190). The present work focuses on the strain 
B. lactis Bl-04 (167) as a representative of the highly important probiotic B. animalis species. 
1.4 Molecular elements of pre- and probiotic interactions 
1.4.1 The paradigm of non-digestible carbohydrate utilization by the gut 
microbiome 
The impact of the GIT microbiome on the digestion of dietary polysaccharides in the colon, 
primarily plant cell wall material and starch, has been studied to explain the functionalities of 
host non-digestible carbohydrates and their metabolic effects on the host (191). Genomic 
analysis of GIT associated sub-groups of commensal bacteria, exemplified by Bacteroides 
thetaiotaomicron harboring 88 putative polysaccharide utilization loci mainly specific for mucin 
O-glycan utilization (192), showed strains harboring extensive genes encoding secreted 
hydrolytic enzymes for polysaccharide breakdown (193). Functional studies of selected 
polysaccharide utilizing GIT bacteria such as Roseburia inulinivorans (194) identified gene 
clusters and pathways for inulin and starch utilization and xylan utilization in Prevotella bryantii 
(195). Other GIT microbes, and most bifidobacteria and lactobacilli (128) do not encode 
enzymes for polysaccharide utilization to the same extent, but have rather evolved symbiotic 
relations for cross-feeding of polysaccharide breakdown products (38). The essential interplay of 
carbohydrate hydrolyzing enzymes and carbohydrate transporter have been reviewed (191, 196), 
and a schematic overview of the current understanding regarding microbial utilization of host 
non-digestible dietary polysaccharides is shown in Figure 1-2.  
Notably, identification of genetic loci encoding transport systems and carbohydrate hydrolytic 
enzymes showed gene organization in operons and clusters (197) which are tightly regulated on 
the Transcriptional level (143, 198–200). This prompts analysis of oligosaccharide transport 
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systems and genetically associated hydrolytic enzymes to provide a functional rationale for in 
silico predictions of these loci. 
 
 
Figure 1-2: Schematic utilization of host non-digestible polysaccharides in the GIT. Extracellular 
glycoside hydrolases are represented as circular pie shapes and the dotted lines indicate cell 
attachment elements. Carbohydrate transporters are represented by square blocks protruding of 
the microbial cells shown in light blue. The colors of glycoside hydrolases and transporters 
schematically represent different substrate specificities. (Inspired from (193, 201, 202)). 
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1.4.2 Bacterial carbohydrate transport systems  
There are three main classes of carbohydrate transporters identified within probiotic bacteria 
(132, 203): ATP-binding cassette transporters (ABC); phosphoenolpyruvate phosphotransferase 
(PTS) permeases; major facilitator superfamily (MFS) permeases, where glycoside-pentoside-
hexuronide (GPH) permeases form a sub-group of MFS permeases. Classification and annotation 
of transporters have been aided by the sequence homology based transporter classification (TC) 
(204, 205). The following will introduce the above classes of transporters and their protein 
organization (Figure 1-3). 
 
Figure 1-3: Schematic representation of carbohydrate transporters found in probiotics which may 
transporter di- and oligosaccharides. All permease domains are shown in blue. The substrate 
capturing solute binding protein of ABC transporters is shown in green where the dotted line 
represents the cell membrane anchoring domain found in Gram-positive bacteria and absent in 
Gram-negative bacteria, where the solute binding protein is secreted to the periplasm. ATP kinases, 
PTS domains EIIA and EIIB all involved with ATP hydrolysis and phosphate coupling are shown 
in red. 
 
ABC transporters (TC 3.A.1) 
ABC transporters are present in organisms from all domains of life and facilitate an ATP 
energized uptake (or export) of vitamins, carbohydrates, oligo-peptides and amino acids, ions 
and other organic compounds (206). The broad range of uptake is reflected by diversity in 
modularity of the domains constituting the transporter (207). Bacterial carbohydrate transporters 
are typically found as pentamers composed of an extracellular cell membrane attached solute 
binding protein for Gram-positive bacteria, whereas Gram-negative bacteria secrete the solute 
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binding protein into the periplasmic space, two membrane-spanning domains forming the 
permease and two nucleotide binding proteins coupling the hydrolysis of two ATP molecules to 
energize the transport (207). The molecular mechanism of carbohydrate ABC transporters has 
been pioneered based on structural work (208, 209) showing how the solute binding protein is 
the determinant of substrate specificity. Transport occurs via the solute binding protein, which 
upon substrate binding undergoes a conformational change allowing docking onto the permease 
sub-unit for release of the substrate into a transmembrane funnel like channel. Substrate 
translocation is finalized by the ATP coupled conformational change of the permease domains, 
closing the extracellular facing of the permease while opening the intracellular facing hence 
releasing the substrate to the cytoplasm. 
Comparative analysis of solute binding proteins showed structural differentiation which could be 
linked to the substrate specificities allowing further differentiation of carbohydrate ABC 
transporters into monosaccharide and oligosaccharide specific transporters (210). The 
specificities of oligosaccharide transporters can be analyzed by functional studies involving 
inactivation of the full ABC transporter by a single solute binding protein gene knock-out (142). 
The molecular architecture of ABC transporters featuring the solute binding protein as a non-
integral part of the transmembrane domain, has allowed recombinant production of solute 
binding proteins as a screening tool for ABC transporter specificities (211) and for biochemical 
characterization of carbohydrate affinities, usually in the sub-µM range (212–217). The family of 
oligosaccharide ABC transporters has been shown to facilitate prebiotic uptake (142, 198) yet 
annotation of novel ABC transporter is limited by low sequence similarity and lack of functional 
data. 
 
PTS permeases (TC 4.A.1–4.A.6) 
PTS permeases are found in prokaryotes (218) and facilitate an ATP energized uptake of mainly 
mono- and disaccharides, where the carbohydrate in the process is phosphorylated at the non-
reducing O-6 position. The PTS permease is part of the three component PTS system termed: 
PTS EIIA, EIIB, EIIC and in some cases a EIID domain (219) where the single domains may be 
encoded in single genes or as a multi domain single protein. The EIIC domain is the 
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transmembrane domain displaying initial binding of the transported carbohydrate whereas the 
remaining EIIA and EIIB domains are involved with a cascade reaction for transferring the 
inorganic phosphate from phosphoenolpyruvate to the carbohydrate. The structure of a cellobiose 
specific PTS EIIC permease has recently been solved, aiding in understanding substrate binding 
of PTS permeases (220). In silico prediction of PTS permeases is hampered by lack of functional 
data (158) beyond annotations of novel PTS permeases into six classes of substrate specificities 
(Glucose/glucoside, fructose-mannitol, lactose/β-glucoside, glucitol, galactitol and mannose-
sorbose) (205, 219). These six classes, however, does not represent for the amount of putative 
PTS permeases identified in some GIT associated strains, hence limiting annotations of novel 
PTS permeases (131, 137, 158).  
  
MFS (TC 2.A.1) and GPH permeases (TC 2.A.2) 
MFS and GPH permeases are secondary active transporters with broad substrate specificity 
including simple mono- and disaccharides such as melibiose (221), sucrose (222), lactose and 
galactose (143, 223, 224). The mechanism of MFS substrate binding and transport has been 
reviewed (225) and structural work has focused on the Escherichia coli lactose permease (226–
228) indicating a tight binding pocket restricted to transport voluminous substrates beyond 
disaccharides. 
In some Gram-positive bacteria, lactose permeases fused with a C-terminal PTS EIIA domain 
have been identified, linking regulation of the transporter activity to cellular energy levels (143, 
224, 229, 230). Notably, some GIT lactobacilli encode a lactose specific PTS permease (231) 
whereas other employ a lactose specific GPH permease (143) indicating diversely evolved 
lactose utilization systems 
The identification of carbohydrate transporters has been a key factor for understanding the 
selective utilization of prebiotic (142, 211). Yet, the push for novel prebiotics and the advances 
in microbiome genomics, as stated above, continues to necessitate further characterization of 
novel oligosaccharide transporters. 
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1.4.3 Classification and distribution of carbohydrate active enzymes  
Catabolism of dietary carbohydrates depends on a vast array of microbial enzymes in the GIT 
and is a key activity of the microbiome (232). These breakdown reactions require enzymes that 
catalyze the hydrolysis of the glycosidic linkages to release mono- or oligosaccharides for 
uptake. The known collection of these carbohydrate active enzymes has been categorized in term 
of sequence similarity into glycoside hydrolase families (GH) via the carbohydrate active 
enzyme database (CAZy) (233). This classification system allows functional deduction of 
putative enzyme specificities by amino acid similarity.  
Experimental assessment of the glycoside hydrolase repertoire encoded by the microbiome 
showed a highly dynamic and wide distribution of 73 glycoside hydrolase families (234, 235). In 
terms of selective prebiotics catabolism, the identification of glycoside hydrolase families 
predominantly found in probiotics is crucial to assess the catabolic capabilities. Figure 1-4 shows 
a comparative overview of the glycoside hydrolase families and their abundance found in 
probiotic bacteria compared to known pathogens (236–239). Notably enrichment of the 
following glycoside hydrolase families, displaying specificities for prebiotics, was observed: 
GH2 and GH42 encoding putative β-galactosidases involved with GOS catabolism (54, 240, 
241), GH13 encoding putative α-1,6-glucoside specific enzymes for IMO catabolism (Møller et 
al, J. Bacteriol. 2012, in press), GH32 encoding β-fructosidases for FOS catabolism (142, 242) 
and GH43 together with GH51 for XOS and arabinoxylan catabolism (202, 243, 244). Further 
understanding of the prebiotic catabolic potential of glycoside hydrolase families have been 
provided by biochemical characterizations (140, 202) and in silico sub-family separation (245–
249) to further improve annotation of genes potentially involved with prebiotic utilization. 
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Figure 1-4: Heatmap distribution of glycoside hydrolase families identified through the CAZy 
database from selected probiotic and pathogenic bacteria. Full strain names: Bifidobacterium 
animalis subsp. lactis Bl-04; Bifidobacterium longum subsp. infantis ATCC 15697; Lactobacillus 
acidophilus NCFM; Lactobacillus casei BL23; Clostridium difficile CD196; Listeria monocytogenes 
10403S; Salmonella enterica subsp. enterica serovar Typhimurium str. UK-1; Campylobacter jejuni 
RM1221 
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1.5 Experimental methods for gene and protein identification of 
probiotic properties 
Despite the evolutionary phylogenetic distant clustering of probiotic lactobacilli and 
bifidobacteria (Section 1.3), specific genomic loci linked to utilization of prebiotics was shown 
to vary on a strain dependent level (250) by adaptive mechanisms of genome reduction (251) and 
by horizontal gene transfer (234). Hence the initial functional characterization of probiotic 
strains is to assess their potential for prebiotic utilization by screening of the supported growth 
by potential prebiotics in mono-culture fermentations (252–255). Assessment of the genetic basis 
underlying strain phenotypic behavior has become crucial to deconvolute mechanism of 
probiotic actions, interpret comparative genomics and identify target proteins for molecular 
understanding of probiotics, as presented in the previous sections.  
Differential transcriptomics and proteomics methodologies have enabled high-throughput data 
generation for global analysis of the genes and protein respectively being upregulated to a 
defined growth condition or stimulation compared to an untreated control (256). Transcriptional 
analysis have proved to be suitable for identification of prebiotic induced gene expression as 
both carbohydrate transporters and hydrolases can be identified (143) whereas a gel-based 
proteomics approach in general does not enable identification of transmembrane proteins (186). 
Table 1-7 lists gene and protein identification within probiotics for increased understanding of 
molecular mechanisms of prebiotic utilization. 
However, to put the gene and protein findings into a biological relevance, validation is required 
either by complementary methods e.g. quantitative-PCR (259) or by more biologically relevant 
methods such as functional genomics, where phenotypic characterization of targeted gene knock-
outs can corroborate the proposed function (153, 260, 261). 
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Table 1-7: Selected studies employing high-throughput transcriptomics or proteomics for gene and 
protein identification within probiotic bacteria grown on prebiotic or potential prebiotic 
carbohydrates. 
Method Strain Carbohydrates Reference 
Proteomics B. animalis subsp. lactis Bl-04 GOS (Ejby and Majumder, manuscript in preparation) 
Proteomics L. acidophilus NCFM Lactitol (157) 
Proteomics L. acidophilus NCFM Cellobiose 
(Van Zanten and 
Majumder, manuscript in 
preparation) 
Proteomics L. acidophilus NCFM Raffinose (Ejby and Majumder, manuscript in preparation 
Proteomics 
Transcriptomics 
B. animalis subsp. lactis BB-12 XOS (182, 186) 
Transcriptomics L. plantarum WCFS1 FOS (257) 
Transcriptomics L. acidophilus NCFM 
Glucose, fructose, 
galactose, 
trehalose, lactose, 
sucrose, raffinose, 
FOS 
(143) 
Transcriptomics B. longum NCC2705 Maltose, lactose, raffinose, FOS (198) 
Transcriptomics B. longum LMG 13197 
Glucose, GOS, 
human milk 
oligosaccharides 
(258) 
 
1.6 Scientific basis and objectives for the current project 
Only few carbohydrates are classified as prebiotics and several candidate prebiotics are lacking 
sufficient documentation to gain status as prebiotics, hence it is desirable to expand the 
knowledge of the interactions of pre- and probiotics. It is the purpose of this thesis to 
functionally characterize prebiotic utilization by two clinically well-documented and 
commercially widely used probiotic strains, Lactobacillus acidophilus NCFM and 
Bifidobacterium animalis subsp. lactis Bl-04 using transcriptional analysis, functional genomics 
and biochemical characterization of recombinant proteins. A initial step for evaluating the 
potential prebiotic utilization was in silico genome mining of both strains (presented in Section 
3.1) showing the types of prebiotics putatively utilizable by L. acidophilus NCFM and B. lactis 
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Bl-04. This led to selection of two diverse sets of carbohydrates, covering linkage families and 
glycoside compositions postulated to be utilized by carbohydrate transporters and glycoside 
hydrolases with potential for selective utilization of prebiotics. Subsequently, the objective of the 
thesis was to investigate the differential transcriptomics of the L. acidophilus NCFM and B. 
lactis Bl-04 grown on the above carbohydrates. The findings from both bacteria have been 
presented as separate manuscripts (Appendix 6.1 and 6.2) followed by comparison and 
discussion of the results within the thesis (Section 3.2) to highlight pathway differences in 
prebiotic utilization of the two probiotics. The aim of following work was to characterize single 
key genes identified from the transcriptional work for gaining insight into molecular mechanism 
of prebiotic uptake. Targeted gene deletion within L. acidophilus NCFM confirmed GOS uptake 
(Appendix 6.3) and RFO utilization (Appendix 6.1). A putative dual specificity IMO/RFO ABC 
transporter was identified in B. lactis Bl-04 and the substrate specificity was characterized 
(Appendix 6.4). The differences with regard to substrate recognition by transporters are 
discussed in Section 3.3 and the pending protein structure determination of the IMO/RFO solute 
binding protein is presented. In summary, this work provides a robust functional basis for 
selection and design of novel prebiotics and for analysis of selective prebiotics utilization. This 
data integrates well into the context of advancing the understanding of biomarkers for selective 
metabolism by probiotics and metagenomics within the GIT.  
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2 Materials and methods 
 
The material and methods used for the experimental work have been described in the 
corresponding manuscripts (Appendices 6.1–6.4). Some of the obtained results have not been 
prepared into manuscripts and are only presented in the thesis hence the subsequent material and 
method section will expand and supplement the procedures used. 
2.1 Databases, prediction and modeling tools 
Table 2-1 lists the various bioinformatics online databases, servers and tools used in the present 
project. 
Table 2-1: Collection of databases and bioinformatics tools used throughout the study.  
Service Description URL (12th of May 2012) Reference 
SignalP Signal peptide prediction www.cbs.dtu.dk/services/SignalP/ (262) 
BLAST Sequence homolog detection blast.ncbi.nlm.nih.gov/ (263) 
Genbank Publicly available nucleotide sequences www.ncbi.nlm.nih.gov/genbank/ (264) 
TCDB 
Classification system 
for membrane 
transport proteins 
www.tcdb.org/ (204) 
CAZy 
Database of 
carbohydrate active 
proteins 
www.cazy.org/ (233) 
ClustalX Multiple sequence alignment www.clustal.org/ (265) 
Dendroscope Visualizing of phylogenetic trees ab.inf.uni-tuebingen.de/software/dendroscope/ (266) 
 
2.2 Construction of phylogenetic tree of carbohydrate solute binding 
proteins 
The phylogenetics of oligosaccharide solute binding proteins were analyzed (Section 3.1.7) by 
assembling a collection of homologous sequences. The sequence dataset was compiled from 
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initially 25 carbohydrate solute binding proteins all identified from previous work by 
transcriptomics or protein binding studies showing involvement of each protein to a type of 
oligosaccharides or identified from the current project to be involved with oligosaccharide 
binding. Sequence homologs for each protein entry were identified by BLAST (263) and 
restricted to either 100 hits or an e-value of 10-10 against the non-redundant database (264) before 
compiling all hit-sequences in a database collection made publicly available at the National 
Center for Biotechnology Information (MD, USA):  
 http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/10kLj68I56iVl63rf8w5buCAc 
 Short link: http://tinyurl.com/ca5rlrx (12th of May 2012) 
All redundant sequences were removed to result in 1649 unique entries, which were exported 
from the collection into FASTA format. Additionally, the 25 starting curated sequences were 
added together with a monosaccharide (fructose) binding protein (all entries listed with gi-
number and functional annotation in Table 3-6). All sequences were loaded into ClustalX for 
multiple sequence alignment (265). The multiple sequences alignment was done using the 
Blosum series substitution matrix and a gap opening penalty of 2, compared to the standard 
penalty of 10. The resulting phylogenetic tree file was visualized using Dendroscope (266) and 
the tree was rooted using the fructose binding protein.  
2.3 Experimental design of DNA microarray setup. 
The methodology and results of the transcriptional analysis of L. acidophilus NCFM and B. 
lactis Bl-04 is presented in Appendices 6.1 and 6.2, respectively. The aspect and the basis for the 
experimental design were however beyond the scope of the manuscripts and will be assessed in 
this section to leading to the discussion of powers and limitations of transcriptional analysis 
(Section 3.2). 
The gene expression of L. acidophilus NCFM was measured from cultures harvested in the early 
exponential phase and grown on glucose compared to 11 potential prebiotic oligosaccharides. An 
experimental dye-swapped loop-design (Figure 2-1) was used to generate two technical 
replicates from each biological replicate (one replicate culture per carbohydrate) as it was 
estimated from a previous study (143), using a round robin hybridization design (267), that the 
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number of samples and replicated would yield sufficient measurements for adequate statistical 
power in the ANOVA model to allow single gene identification with statistical significance 
(268). 
 
Figure 2-1: Loop-design for pairwise sample hybridization. Arrow heads indicate Cy5 labeled 
cDNA and the arrow tail indicated Cy3 labeled cDNA exemplified by the hybridization of Cy3 
labeled glucose cDNA hybridized with Cy5 labeled cellobiose cDNA to the chip. 
 
The gene expression of B. lactis Bl-04 was prepared similarly as for L. acidophilus NCFM 
regarding culture preparation, harvest and RNA isolation as presented in Appendix 6.2. For B. 
lactis Bl-04 however, a single dye RNA-labeling kit was used, resulting in one sample per 
hybridized chip with no need for dye-swap or loop design, although 24 chips were required 
compared to the 12 for L. acidophilus NCFM. 
2.4 Generation of L. acidophilus NCFM gene deletion mutants 
The construction of Lactobacillus acidophilus NCFM Δupp isogenic mutants with in-frame DNA 
excision of the genes LBA1438, LBA1442 and LBA1463 are presented in Appendices 6.1 and 
6.3. 
26 
 
Two additional gene deletion mutants, LBA0502 a FOS solute binding protein of an ABC 
transporter and LBA1866 a putative maltose binding proteins of an ABC transporter were done 
according to Goh et al. (261). The constructed strains are listed in Table 2-2. 
Table 2-2: Strains and plasmids used to construct gene deletion mutants of LBA0502 and LBA1866. 
Strain or plasmid Characteristics Reference or 
source 
E. coli strains   
NCK1831 EC101: RepA+ JM101; Kmr; repA from pWV01 
integrated in chromosome; host for pORI-based 
plasmids 
(269) 
NCK1911 NCK1831 harboring pTRK935  (261) 
NCK2120 NCK1831 harboring pTRK1012 Present work 
NCK2128 NCK1831 harboring pTRK1016 Present work 
L. acidophilus strains   
NCFM Human intestinal isolate (131) 
NCK1909 NCFM carrying a 315 bp in-frame deletion in the upp 
gene 
(261) 
NCK1910 NCK1909 harboring pTRK669, host for pORI-based 
counter selective integration vector 
(261) 
NCK2121 NCK1909 carrying a 1212 bp in-frame deletion in the 
LBA0502 gene 
Present work 
NCK2129 NCK1909 carrying a 1140 bp in-frame deletion in the 
LBA1866 
Present work 
Plasmids   
pTRK669 Ori (pWV01), Cmr RepA+ (270) 
pTRK935 pORI28 derived with an inserted upp expression 
cassette and lacZ´ from pUC19, serves as 
counterselective integration vector, Emr 
(261) 
pTRK1012 pTRK935 with a mutated copy of LBA0502 cloned 
into BamHI/EcoRI sites 
Present work 
pTRK1016 pTRK935 with a mutated copy of LBA1866 cloned 
into BamHI/EcoRI sites 
Present work 
 
The upstream and downstream flanking regions (approximate length of 750 basepair each) of the 
deletion targets were PCR-amplified either with the 0502A/0502B and 0502C/0502D or 
1866A/1866B and 1866C/1866D primer pairs, respectively, and fused by splicing by overlap 
extension PCR (SOE-PCR). The SOE-PCR products were ligated into pTRK935 linearized with 
compatible ends (BamHI and EcoRI for all constructs), and transformed into NCK1831. The 
resulting recombinant plasmids, pTRK1012 and pTRK1016, harbored in NCK2120 and 
NCK2128, were transformed into NCK1910 harboring pTRK669, for chromosomal integration 
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and following DNA excision to generate the ΔLBA0502 (NCK2121) or ΔLBA1866 (NCK2129) 
genotypes respectively. Confirmation of DNA deletion was done by PCR and DNA sequencing 
using primer pair 0502UP/0502DN and 1866UP/1866DN (Table 2-3). 
Table 2-3: Primers used for construction of gene deletion mutants. Restriction sites are highlighted 
in bold and underlined 
LBA0502 upstream flanking region 
0502A CGCGGATCC ACTATGCTACGAAAAGATGGTT 
0502B TGCAACTCCTAATTTCCATT 
LBA0502 downstream flanking region 
0502C AATGGAAATTAGGAGTTGCAGTACAAAAGGTAATGAACGAACA 
0502D CCGGAATTCTTCAGCTGCTTCATACAATG 
LBA0502 DNA excision control 
0502UP TTCCAACATTCCTTTTGTTAGC 
0502DN TGGGTCATGATCATTGGTTG 
LBA1866 upstream flanking region 
1866A CGCGGATCCATCAGACTGAAGCGATGACT 
1866B ACCTAAAGCCATTTTCTTCCA 
LBA1442 downstream flanking region 
1866C TGGAAGAAAATGGCTTTAGGTCCAAGTCAATACAAGGCACAA 
1866D CCGGAATTCGTTGGCAAGATGGTAAAGAA 
LBA1866 DNA excision control 
1866UP CAAAGACAGCGTGTTGCATT 
1866DN CAGCCCAATACTGGGAAGAA 
 
2.5 Crystallization setup of recombinant Bl16GBP  
Cloning and production of the protein encoded by Balac_1599 referred to as Bl16GBP is 
presented in Appendix 6.4. Crystallization of the recombinant Bl16GBP and data collection was 
done by Ph.D. student Morten Ejby at the Membrane Enzymology group, Department of 
Biochemistry, University of Groningen (the Netherlands) in collaboration with Associate 
Professor Dirk Slotboom and Post Doc. Andreja Vujicic-Zagar. 
Recombinant Bl16GBP and selenomethionine labeled Bl16GBP was produced and purified as 
described in Appendix 6.4 with the only expectation that selenomethionine labeled protein was 
grown in selenomethionine containing media as previously described for other proteins (271). 
Protein stocks in 10 mM 2-(N-morpholino)ethanesulfonic acid, pH 6.5 and 150 mM NaCl were 
concentrated to 15 mg/ml. Crystals of Bl16GBP were grown by vapor diffusion in hanging 
drops. Crystals was only obtained when Bl16GBP was in its closed complex conformation with a 
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ligand (1 mM) either panose or raffinose. Crystal conditions that yielded crystals consisted of a 
drop set up of 1:1 ratio of protein (Bl16GBP 15 mg/ml) and reservoir (0.1 M Tris pH 8.5, 25% 
PEG 4000 and 0.8 M MgCl2). Crystals grew after 60 h incubation at 5 °C. Due to the PEG in the 
reservoir solution no further cryoprotectant was applied and the crystals were flash frozen 
directly in liquid nitrogen. Data was collected to 1.6 Å for Bl16GBP in complex with raffinose, 
1.9 Å for Bl16GBP in complex for with panose and 8 Å for Selenomethionine labeled Bl16GBP 
at the SLS beamline PX III, Villigen, Switzerland.  
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3 Results and discussion 
3.1 Bioinformatics assessment and comparison of potential prebiotic 
utilization by L. acidophilus NCFM and B. animalis subsp. lactis Bl-04 
One of the cornerstones in the definition of prebiotics is the selective metabolism by specific 
organisms in the GIT (2). Hence in assessment and development of novel prebiotics it is 
desirable to predict the target probiotic uptake and catabolic systems to link selective metabolism 
to specific genetic loci. The types of potential prebiotics utilized by probiotic organisms can be 
predicted based on homology to already known utilization pathways and enable comparison of 
both differences among probiotic organisms on the genome level, but also by comparison to 
commensal GIT organisms and pathogens, to reveal taxonomical niche-specific gene clusters for 
selective targeting with prebiotics.  
3.1.1 Mapping of potential prebiotic utilization systems 
Ideally by the above approach both predicted and experimentally validated gene clusters 
encoding prebiotic utilization systems can be mapped in relation to the recently scientifically 
established GIT metagenome (101, 108) to predict the selective metabolism of the potential 
prebiotic by the GIT microbiome. However, the reconstruction of putative gene clusters by in 
silico methods primarily based on single gene homology within automatically annotated 
genomes is hampered by the complexity of predicting the interplay of the full genome or parts 
thereof. Databases describe most intracellular metabolic pathways of simple metabolic 
compounds, such as the Kyoto Encyclopedia of Genes and Genomes (272), but the multitude of 
uptake and hydrolytic pathways for oligosaccharides remain poorly described (158). Hence it is 
the aim to make a gene landscape analysis of gene clusters encoding putative oligosaccharide 
transporters and glycoside hydrolases to allow re-construction of the pathways for utilization of 
potential prebiotic, based on in silico predictions of L. acidophilus NCFM and B. lactis Bl-04 as 
described in the following. 
Initially, all carbohydrate transporters were identified and classified using the transporter 
classification (TC) database (205), while all glycoside hydrolases were identified and assigned a 
GH family number using the CAZy database (233). The cellular localization of glycoside 
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hydrolases were predicted using the signalP tool (262). Gene clusters were generated by gene 
landscape analysis of carbohydrate transporters and glycoside hydrolases by their neighboring 
encoded genomic location, and where applicable also with identification of transcriptional 
regulators. This combined in silico gene landscape analysis approach allowed to couple the 
annotation of both transporters and hydrolases to strengthen the overall prediction of the single 
clusters, as aided by BLAST homology searching (263) to the Uniprot database of characterized 
proteins (273). 
3.1.2 Genome-mining and assessment of the utilization of potential prebiotics by L. 
acidophilus NCFM  
The in silico annotation of the uptake and catabolic systems of L. acidophilus NCFM was done 
based on the available genome sequence (131). The constructed gene clusters are shown in Table 
3-1 including a putative function in relation to potential prebiotic utilization. Remaining genes 
encoding glycoside hydrolases and carbohydrate transporters, which could not be assigned into a 
gene cluster, are listed in Table 3-2 and Table 3-3, respectively. 
The majority of the identified glycoside hydrolases and carbohydrate transporters could be 
functionally connected into gene clusters and appeared to be organized with transcriptional 
regulators putatively associated with carbohydrate metabolism. This implies how each single 
gene cluster can be transcribed in response to sensing of available carbohydrates in the GIT. A 
total of three ABC, one GPH and eight PTS transporter containing gene clusters were identified 
(Table 3-1). Annotation of both the ABC and GPH systems was supported by earlier 
transcriptional work (141–143) for robustly assigning their functions. Evaluation of PTS systems 
in the present analysis could only be deemed reliable if supported by experimental work as in the 
case of trehalose and sucrose utilization. The remaining PTS permease encoding gene clusters 
showed specificities for β-glucosides but further experimental work is needed to determine if the 
gene clusters encode redundancies or specialized functions within β-glucosides utilization.  
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Table 3-1: In silico predicted gene clusters in L. acidophilus NCFM with putative involvement in 
carbohydrate utilization listed with any experimental evidence to support the predictions. All gene 
clusters are sub-grouped by the type of Transporter Classified numbering (TC) and all glycoside 
hydrolases are predicted to be localized intracellularly unless otherwise noted. Carbohydrate 
binding modules (CBM) are given in brackets after the GH family. 
ABC transporter encoding gene clusters 
ORF # Gene annotation by Altermann et al. 
(131) 
GH 
(CBM) 
TC Cluster function and level of 
predictive confidence  
0500 Msm associated regulator   FOS based on transcriptomics 
and functional genomics (142)  0502 Solute binding protein  3.A.1 
0503 Permease domain  3.A.1 
0504 Permease domain  3.A.1 
0505 β-fructosidase, EC 3.2.1.26 32  
0506 ATP-binding protein  3.A.1 
0507 Sucrose phosphorylase, EC 2.4.1.7 13_18  
1437 Sucrose phosphorylase, EC 2.4.1.7 13_18  Raffinose based on transcripto-
mics  (143) 1438 α-galactosidase, EC 3.2.1.22 36  
1439 ATP-binding protein  3.A.1 
1440 Permease domain  3.A.1 
1441 Permease domain  3.A.1 
1442 Solute binding protein  3.A.1 
1443 Msm associated regulator   
1864 Permease domain  3.A.1 Malto-oligosaccharides based 
on protein characterization of 
LBA1870 (274) and some 
homology to gene clusters from 
other bacteria (200, 213) 
1865 Permease domain  3.A.1 
1866 Solute binding protein  3.A.1 
1867 ATP-binding protein  3.A.1 
1868 Transposase   
1869 β-phosphoglucomutase, EC 5.4.2.6   
1870 Maltose phosphorylase, EC 2.4.1.8 65  
1871 Maltogenic α-amylase, EC 3.2.1.133 13_20 
(34) 
 
1872 Oligo-α-(1,6)-glucosidase,  
EC 3.2.1.10 
13_31  
1873 Acetate kinase   
1874 LacI type regulator   
GPH transporter encoding gene cluster 
1460 Truncated mucin binding protein   Lactose based on transcripto-
mics (143) 1461 Unknown type regulator   
1462 β-galactosidase, EC 3.2.1.23 42  
1463 GPH permease  2.A.2 
1464 Tranposase   
1465 LacI type regulator   
1467 β-galactosidase, large sub-unit,  
EC 3.2.1.23 
2  
1468 β-galactosidase, small sub-unit,  
EC 3.2.1.23 
2  
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PTS transporter encoding gene cluster 
ORF # Gene annotation by Altermann et al. 
(131) 
GH 
(CBM) 
TC Cluster function and level of 
predictive confidence 
0225 6-phospho-β-glucosidase, EC 3.2.1.21 1  β-glucosides, in silico 
prediction only 0226 Unknown type regulator   
0227 PTS EIIC domain  4.A 
0228 NagC type regulator   
0399 Sucrose operon regulator   Sucrose based on transcripto-
mics (143) 
 
0400 Sucrose-6-phosphate hydrolase, EC 
3.2.1.B3 
32  
0401 PTS EIIABC domain  4.A 
0724 LicT type regulator   Cellobiose based on functional 
genomics in the related L. 
gasseri (158) 
0725 PTS EIIC domain  4.A 
0726 6-phospho-β-glucosidase, EC 3.2.1.21 1  
0874 6-phospho-β-glucosidase, EC 3.2.1.21 1  β-glucosides, in silico 
prediction only 0875 GntR type regulator   
0876 PTS EIIC domain  4.A 
0877 PTS EIIA domain  4.A 
0878 Hypothetical protein   
0879 PTS EIIC domain  4.A 
0880 Hypothetical protein   
0881 6-phospho-β-glucosidase, EC 3.2.1.21 1  
0882 Unknown type regulator   
0883 Hypothetical protein   
0884 PTS EIIC domain  4.A 
0885 6-phospho-β-glucosidase, EC 3.2.1.21 1  
0886 NagC type regulator   
1012 PTS EIIC domain  4.A Trehalose based on functional 
genomics (141) 1013 Trehalose regulator   
1014 Trehalose-6-phosphate hydrolase,  
EC 3.2.1.93 
13_29  
1364 β-galactosidase, EC 3.2.1.23 42  β-glucosides, in silico 
prediction only 1365 α-glucosidase, EC 3.2.1.20 31  
1366 6-phospho-β-glucosidase, EC 3.2.1.21 1  
1367 AgC type regulator   
1368 XylR type regulator   
1369 PTS EIIC domain  4.A 
1574 6-phospho-β-glucosidase, EC 3.2.1.21 1  β-glucosides, in silico 
prediction only 1576 PTS EIIAC domain  4.A 
1577 RpiR type regulator   
1705 PTS EIIBC domain  4.A β-glucosides, in silico 
prediction only 1706 6-phospho-β-glucosidase, EC 3.2.1.21 1  
1707 PTS EIIABC domain  4.A 
1708 β-glucoside type regulator   
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Table 3-2: Glycoside hydrolases not co-encoded with a carbohydrate transporter within L. 
acidophilus NCFM. All Glycoside hydrolases are predicted to be localized intracellularly unless 
highlighted with bold face. Carbohydrate binding modules are given in brackets after the GH 
family. 
ORF # Gene annotation (131) GH (CBM) 
0107 β-glucanase, extracellular, EC 3.2.1.4 8 
0143 α-glucosidase, EC 3.2.1.20 31 (32) 
0176 N-Acetylmuramidase, EC 3.5.1.28 73 
0264 Glucan-α-(1,6)-glucosidase1, EC 3.2.1.70 13_31 
0527 N-Acetylmuramidase, EC 3.5.1.28 73 
0680 α-(1,4)-glucan branching enzyme, EC 2.4.1.18 13_9 (48) 
0686 Amylopullulanase, 3.2.1.41 13_20 
1140 Muramidase fragment, 3.2.1.17 25 
1336 6-phospho-β-glucosidase, EC 3.2.1.21 1 
1351 Muramidase, EC 3.2.1.17 25 
1352 Muramidase fragment EC 3.2.1.17 25 
1473 α-L-rhamnosidase, EC 3.2.1.40 78 
1689 Maltose-6-phosphate glucosidase 4 
1710 Pullulanase1, extracellular, EC 3.2.1.41 13_14 (41, 48) 
1812 α-glucosidase, EC 3.2.1.20 31 
1918 Muramidase, EC 3.2.1.17 25 
1Annotation based on biochemical characterization (Abou Hachem, M. personal communication). 
Table 3-3: Carbohydrate transporters identified in L. acidophilus NCFM and not co-encoded with 
one or more glycoside hydrolases. The transporters listed by locustag numbers are grouped by their 
Transporter classification numbering. 
ORF# Gene annotation (131) TC 
MFS 
0045 Unspecified monosaccharide uptake 2.A.2 
PTS 
0146 Monosaccharide regulation, PTS EIIA 4.A 
0452 Glucose uptake, PTS EIIAB 4.A 
0456 Glucose uptake, PTS EIIC 4.A 
0456 Glucose uptake, PTS EIID 4.A 
0491 β-glucose uptake, PTS EIIC 4.A 
0606 α-glucoside uptake, PTS EIIBC 4.A 
0609 α-glucoside uptake, PTS EIIA 4.A 
0618 β-glucose uptake, PTS EIIC 4.A 
0989 Monosaccharide uptake, PTS EIIC 4.A 
1478 Monosaccharide uptake, PTS EIIBC 4.A 
1484 Monosaccharide regulation, PTS EIIA 4.A 
1777 Fructose uptake, PTS EIIABC 4.A 
The Drug/Metabolite Transporter Superfamily 
1102 Ribose uptake 2.A.7.5 
1376 Ribose uptake 2.A.7.5 
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Notably, 8 of 16 glycoside hydrolases unassigned a gene cluster were predicted to be involved 
with other function then potential prebiotic hydrolysis such as intracellular glycogen metabolism 
(LBA0680 and 0686), lysozymes (LBA1351, 1352) and catabolism of modified glycoside or 
glycopeptides (LBA0176, 0527 1140 and 1918)). 
Nine of the 12 carbohydrate transporters, which could not be assigned to a gene cluster were 
predicted to be involved in monosaccharide uptake and hence would not be involved in uptake of 
potential prebiotic substrates. The remaining transporters (LBA0491, 0606–0609 and 0618) were 
all PTS permeases which could possibly be functionally linked to the above glycoside hydrolases 
(Table 3-2) based on their subtle putative specificities for α- and β-glucosides. The lack of 
structured gene clusters could be due to a recent gene uptake representing a adaption-mechanism 
within the GIT (235, 251).  
The observation of most glycoside hydrolases and oligosaccharide transporters being found in 
gene clusters supports the mechanism of L. acidophilus NCFM being highly adaptive to 
exogenous nutritional stimulation on the transcriptional level (143). 
3.1.3 Function deduction and interplay of genes identified within L. acidophilus 
NCFM            
The in silico analysis of the cellular localization of encoded glycoside hydrolases revealed only 
two cases with signal peptide being present; a putative β-glucanase (LBA0107) and a pullulanase 
(LBA1710). The sequence analysis identified an encoded membrane attachment domain 
(bacterial surface layer protein; pfam03217), suggesting that these enzymes act on the outer 
surface of the bacterial cell. None of these two identified genes could be assigned into a gene 
cluster for functional association with transporters or intracellular enzymes. However, a putative 
α-glucan utilization gene cluster was identified (LBA1864–1872) together with a putative α-
glucan PTS system (LBA0606, 0609), which indicated a functional link with the extracellular 
pullulanase (LBA1710), which could release oligomeric α-glucan fragments from partially 
degraded starch for uptake and intracellular catabolism. Sequence analysis of the putative β-
glucanase showed a mutated catalytic nucleophile acid residue (aspartic acid257 to asparagine) 
recognized as motif within a sub-family of GH8 (275). No enzymatic activity has so far been 
reported for this sub-family of GH8, but analysis of the genomic position of LBA0107 identified 
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a glycosyl transferase family 2 enzyme (LBA0106) to be encoded adjacent to LBA0107 
indicating a potential role in cell wall modifications or extracellular exo-polysaccharide 
modifications. 
In the view of the predicted specialized oligosaccharide transport systems and few extracellular 
glycoside hydrolases encoded by L. acidophilus NCFM it is evident that the organism has 
adopted a scavenging mechanism for oligosaccharides in the GIT (201). In the light of the 
predicted potential prebiotic utilization profile, L. acidophilus NCFM can clearly be targeted 
with a number of oligosaccharide prebiotic candidates. Further knowledge and analysis is 
required to assess, which compounds are the best substrates in the complex niche that L. 
acidophilus NCFM inhabits. Therefore, further work, of systems biology nature applying 
differential transcriptional and proteomics, is needed to reveal the efficiencies and specificities of 
the oligosaccharide transport systems. Candidate prebiotics to screen, based on the above 
analysis, would be of the following types: FOS, GOS, IMO, RFO, breakdown products of 
resistant starches, and fragmented β-glucans to support selective growth of L. acidophilus 
NCFM. 
3.1.4 Genome-mining and assessment of the utilization of potential prebiotics by B. 
animalis subsp. lactis Bl-04  
The in silico annotation of the uptake and catabolic systems of B. lactis Bl-04 was based on the 
recently published genome (167) to identify carbohydrate transporters and glycoside hydrolases 
for further annotation. All reconstructed gene clusters encoding both carbohydrate transporters 
and glycoside hydrolases are listed in Table 3-4. Only one putative carbohydrate transporter 
(Balac_1154) was identified, which could not be associated a gene cluster harboring a glycoside 
hydrolase encoding gene and thus being potentially implicated in oligosaccharide catabolism. 
Sequence analysis indicated the putative transporter to be of the MFS type specific for 
monosaccharides and hence having little relevance for uptake of potential prebiotics. Table 3-5 
lists the glycoside hydrolases not associated with a carbohydrate transporter.  
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Table 3-4: In silico predicted gene clusters in B. lactis Bl-04 with putative involvement in 
carbohydrate utilization listed with any experimental evidence to support the predictions. All gene 
clusters are sub-grouped by the Transporter Classification and all glycoside hydrolases are 
predicted to be intracellularly. CBMs are given in brackets after the GH family. 
ABC transporter encoding gene clusters 
ORF # Gene annotation by Barrangou et al. 
(167) 
GH 
(CBM) 
TC Cluster function and level of 
predictive confidence 
0483 Solute binding protein  3.A.1 Lactose and GOS based on 
transcriptomics analysis in the 
related B. longum (198) 
0484 β-galactosidase, EC 3.2.1.23 42  
0485 Permease domain  3.A.1 
0486 Permease domain  3.A.1 
0487 LacI type regulator   
0511 xylose isomerase   XOS based on proteomics and 
transcriptomics analysis B. 
animalis subsp. lactis BB-12 
(186) 
0512 β-xylosidase, EC 3.2.1.37 43  
0513 LacI type regulator   
0514 Solute binding protein  3.A.1 
0515 Permease domain  3.A.1 
0516 Permease domain  3.A.1 
0517 β-xylosidase, EC 3.2.1.37 43  
0518 Hypothetical protein   
0519 Carbohydrate esterase   
0520 β-xylosidase, EC 3.2.1.37 43  
0521 Xylulose kinase   
0522 NagC type regulator   
1562 Pullulanase, EC 3.2.1.41 13_14 (48)  Malto-oligosaccharides based 
on homology to gene clusters 
from other bacteria (200, 213) 
1563 Permease domain  3.A.1 
1564 Permease domain  3.A.1 
1565 Solute binding protein  3.A.1 
1566 α-(1,4)-glucosidase, EC 3.2.1.20 13_30  
1567 α-(1,4)-glucanotransferase, EC 2.4.1.25 77  
1568 Hypothetical protein   
1569 Permease domain  3.A.1 
1570 Permease domain  3.A.1 
1571 LacI type regulater   
1572 Solute binding protein  3.A.1 
1573 α-glucosidase, EC 3.2.1.20 13_30  
1593 Oligo-α-(1,6)-glucosidase, EC 3.2.1.10 13_31  Raffinose and isomaltose based 
on transcriptional analysis in 
Streptococcus mutans (276) 
1594 Short open reading frame   
1595 Short open reading frame   
1596 α-galactosidase, EC 3.2.1.22 36  
1597 Permease domain  3.A.1 
1598 Permease domain  3.A.1 
1599 Solute binding protein  3.A.1 
1600 NagC type regulator   
1601 α-galactosidase, EC 3.2.1.22 36  
37 
 
GPH transporter encoding gene clusters 
ORF # Gene annotation by Barrangou et al 
(167) 
GH 
(CBM) 
TC Cluster function and level of 
predictive confidence 
0475 GPH permease  2.A.2 Lactose based on transcriptional 
analysis in B. longum (198) 0476 β-galactosidase, EC 3.2.1.23 2  
0477 LacI type regulator   
1588 GPH permease  2.A.2 arabinoxylan fragments based 
on in silico predictions 1589 β-L-arabinofuranosidase, EC 3.2.1.X1 127  
1590 LacI type regulator   
MFS transporter encoding gene clusters 
0052 β-(1,6)-glucanase, EC 3.2.1.75 30  β-glycosides based on in silico 
predictions 0053 β-galactosidase, EC 3.2.1.23 42  
0054 MFS permease  2.A.1 
0055 TetR type regulator   
0137 LacI type regulator   Sucrose based on in silico 
predictions 0138 Sucrose phosphorylase, EC 2.4.1.7 13_18  
0139 MFS permease  2.A.1 
1239 LacI type regulator   Sucrose and FOS based on a 
Balac_1241 homolog from 
Bifidobacterium lactis (277)  
1240 MFS permease  2.A.1 
1241 Sucrose hydrolase, EC 3.2.1.26 32  
1 Enzymatic activity is not yet classified.  
A total of four ABC, and five MFS (divided into GPH and MFS types) transporter encoding gene 
clusters were assigned for B. lactis Bl-04, with a general tendency for ABC containing clusters to 
encode multiple glycoside hydrolases suggesting transport of oligosaccharides with such a 
complexity that additional glycoside hydrolases are required for hydrolysis or that the ABC 
transporters display multiple specificities and are able to facilitate uptake of a range of 
oligosaccharides, as discussed later in Section 3.2.3. Biochemical information on MFS 
permeases, and the GPH sub-group of MFS transporters, is limited for substrate specificity of 
uptake. Therefore the in-depth analysis of these gene clusters depends mainly on the associated 
glycoside hydrolases, which in the above table mainly indicate disaccharide hydrolysis and 
hence disaccharide uptake by the MFS types of transporters.  
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Table 3-5: Glycoside hydrolases not co-encoded with a carbohydrate transporter within B. lactis Bl-
04. All Glycoside hydrolases are predicted to be localized intracellularly unless highlighted in bold. 
Carbohydrate binding modules are given in brackets after the GH family numbering. 
ORF # Gene annotation (167) GH(CBM) 
0049 β-glucosidase, EC 3.2.1.21 3 
0065 α-L-arabinofuranosidase, EC 3.2.1.55 51 
0151 β-glucosidase, EC 3.2.1.21 1 
0268 β-galactosidase, EC 3.2.1.23 2 
0373 α-(1,4)-glucanotransferase, EC 2.4.1.25 77 
0376 Isoamylase, EC 3.2.1.68 13_11(48) 
0924 Truncated pullulanase, EC 3.2.1.41 13_? 
0952 α-amylase, EC 3.2.1.1 13_5 
0977 Isoamylase, EC 3.2.1.68 13_11(48) 
0995 α-(1,4)-glucan branching enzymes, EC 2.4.1.8 13_9(48) 
1025 β-N-acetyl-hexosaminidase, EC 3.2.1.52 3 
1418 Endo-β-(1,6)-glucanase, EC 3.2.1.164 30 
1421 Cellobiose phosphorylase, EC 2.4.1.20 94 
1450 endo-β-mannosidase, Extracellular, EC 3.2.1.25 5(10) 
1458 No known activity within sub-family 13_3 
1516 Muramidase, EC 3.2.1.17 25 
1517 Muramidase, EC 3.2.1.17 25 
1537 α-galactosidase, EC 3.2.1.22 36 
1551 β-N-acetyl-hexosaminidase, EC 3.2.1.52 3 
 
B. lactis Bl-04 encoded 19 glycoside hydrolases not predicted to a gene cluster, four of which 
were predicted to be specific for glycopeptides (Balac_1025, 1516, 1517 and 1551) albeit not 
constituting the full pathways for host glycopeptides utilization as identified in B. bifidum (170). 
The 15 remaining enzymes could not be assigned to a gene cluster and any functionality for 
prebiotic catabolism cannot be hypothesized beyond their putative EC numbering and CAZy 
classification.  
3.1.5 Functional deduction from gene identification within B. animalis subsp. lactis 
Bl-04 
First step in assessing the utilization of potential prebiotics was to identify any putatively 
extracellular enzymes within B. lactis Bl-04. Remarkably, only a single enzyme was predicted to 
be secreted, namely the putative endo-β-mannosidase (Balac_1450), which by the gene 
annotation is expected to release short β-manno-oligosaccharides by hydrolysis of polymeric 
substrates such as β-mannans. A β-manno-oligosaccharide transporter could not be identified in 
silico to support the uptake of released β-manno-oligosaccharide degradation products and with 
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respect to the intracellular glycoside hydrolases not found in gene clusters with oligosaccharide 
transporters (Table 3-5), only one entry were found in a glycoside hydrolase family (Balac_0268, 
GH2) harboring putative β-mannosidase activity. Thus, the utilization of β-manno-
oligosaccharides is either lacking beyond the extracellular endo-β-mannosidase or is facilitated 
by a to-date unpredictable transporter and intracellular exo-β-mannosidase. As for L. acidophilus 
NCFM, a scavenging profile of prebiotic utilization in the GIT is suggested for B. lactis Bl-04, 
indicating how the encoded transporters are the initial substrate interacting components being an 
important substrate determining factor for the potential prebiotic utilization. 
All identified oligosaccharide transporters could be allocated into gene clusters, which could be 
grouped based on the associated transporter to be either ABC or GPH/MFS type permease with a 
tendency of ABC containing gene clusters to encode additional glycoside hydrolases (the locus 
Balac_0483–0487 excluded) compared to generally one glycoside hydrolase in MFS permease 
specific gene clusters (the locus Balac_0052–0055 excluded). This observation suggests how 
ABC transporters within B. lactis Bl-04 may transport complex oligosaccharides requiring a 
multitude of intracellular glycoside hydrolases whereas the MFS type of permeases may 
facilitate disaccharide uptake.  
From the present genomic analysis it is suggested how B. lactis Bl-04 holds potential for 
utilizing oligosaccharide prebiotics such as: β-manno-oligosaccharides, GOS, IMO, RFO and 
XOS. 
3.1.6 Comparative genomics of potential prebiotic utilization of L. acidophilus NCFM 
and B. animalis subsp. lactis Bl-04 
Genomics analysis of the carbohydrate utilization systems of L. acidophilus NCFM and B. lactis 
Bl-04 was used to map and evaluate the carbohydrate uptake and catabolic potential of each 
organism to enable strain comparison. 
The established mechanism of action for dietary carbohydrate utilization by the GIT microbiome 
depends on the genus analyzed (202) where the general consensus for utilization of a given 
complex carbohydrate is initial extracellular hydrolysis within the GIT releasing shorter 
oligomeric, or monosaccharide, substrates for uptake and followed by intracellular hydrolysis to 
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monosaccharides (38, 194, 242). Notably, in silico secretome analysis of L. acidophilus NCFM 
and B. lactis Bl-04 identified two and one putative secreted glycoside hydrolases, respectively. 
This particularly low number of membrane attached hydrolytic enzymes suggests an overall 
alternative scavenging mechanism of prebiotic utilization for both strains, where the transport 
systems are the initial substrate recognizing component of the bacteria (201, 278). This has 
implications for the evaluation of the strains. First, from a scientific point of the view, the 
characterization of carbohydrate transporters becomes essential to understand the selective 
prebiotic utilization and secondly it can guide the design and selection of oligosaccharide 
prebiotics to stimulate selective growth of L. acidophilus NCFM and B. lactis Bl-04 and the 
related probiotic strains they both represent. 
The relative high number of carbohydrate transporters encoded in both strains supports the 
paradigm of bacterial interplay in the GIT where primary polysaccharide-degrading 
microorganisms cross-feed oligosaccharides to secondary users for utilization (191). Here the 
transporters would facilitate wide substrate specificity for readily uptake of available 
oligosaccharides in a densely populated, competitive environment. Thus understanding of the 
prebiotic/probiotic interactions lies to a great extent in understanding the carbohydrate transport 
systems.  
Analysis of the encoded putative transporters revealed 17 putative oligosaccharide transporters in 
L. acidophilus NCFM as compared to nine in B. lactis Bl-04. This difference in distribution of 
transporters and the gene cluster associated glycoside hydrolases further highlights the overall 
routes of carbohydrate utilization. L. acidophilus NCFM seemingly processes a ‘one transporter, 
one substrate’ mechanism of action as exemplified by the PTS containing gene clusters mainly 
associated with disaccharide uptake (219) and GH1 enzymes with exo-acting activity (279), 
linking these pathways to uptake of disaccharides released from polysaccharide breakdown. In 
comparison B. lactis Bl-04 encodes five ABC transporter gene clusters with GH profiles 
suggesting broad substrate specificity as illustrated by the XOS and IMO/RFO specific gene 
clusters as shown in Appendix 6.2.  
Another striking difference in L. acidophilus NCFM compared to B. lactis Bl-04 is the gene 
organization of ABC encoding cluster, where L. acidophilus NCFM encodes a transporter 
specific ATP-binding protein within each of the three identified gene cluster. A similar 
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organization is lacking for B. lactis Bl-04, where only a single oligosaccharide ABC transporter 
associated ATP binding proteins was identified in the genome (Balac_1610), as also previously 
reported for B. longum NCC2705 (198). The ability of an ATP binding protein with specificity 
towards multiple ABC transporters was shown previously (280). This suggests divergent 
regulatory mechanisms of the two organisms’ responses to nutritional changes. 
3.1.7 Functional map of carbohydrate-specific solute binding proteins of ABC 
transporters 
ABC transporter associated uptake of carbohydrates is widespread in nature with the solute 
binding protein being the main substrate specific component (210). The extracellular nature of 
this class of proteins compared to transmembrane carbohydrate transporter types such as MFS or 
PTS permeases, allows sequence identification of the specific substrate binding domain for 
functional assignment and biochemical characterization. Furthermore, the previous in silico 
observation of oligosaccharide transport by ABC transporters made the solute binding proteins 
interesting to study within the scope of prebiotic transport. In silico approaches have so far 
shown how monosaccharide solute binding proteins can be distinguished from oligosaccharide 
solute binding proteins by structural fold and sequence length and how oligosaccharide solute 
binding proteins all adopt the same overall structural fold, yet still the overall protein sequence 
similarity is modest (25–35%) making functional predictions difficult (210). 
The functional phylogenetic relationship of prebiotic and related oligosaccharides solute binding 
proteins from ABC transporters was prepared as described in Section 2.1. This revealed 
evolutionary grouping of functionalities driven by their niche habitat and taxonomical drift as 
illustrated in Figure 3-1. The graphical analysis first show how all identified clusters are mono-
specific as only one functionally determined specificity was found (except cluster 5C) and how 
related functions sub-cluster as for GOS (5A) and lacto-N-biose (5B), a lactose based potential 
prebiotic disaccharide isolated from human milk (215). Also, differentiation is observed for 
maltose-like binding proteins indicated (cluster 4), where specificities are reported for 
cyclodextrins (281), malto-oligosaccharides (213) and various disaccharides (212) or 
cellodextrins (250, 282), all together representing a diverse landscape largely driven by protein 
specificity rather than taxonomy which is however reflected within the single sub-groups.  
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Figure 3-1: Phylogenetic tree of oligosaccharide binding proteins showing the distribution of 
characterized oligosaccharide binding proteins. The tree has been rooted with a fructose specific 
solute binding protein as an out-group and manually divided into clusters based on protein 
functionality (shown by numbers) and sub-clusters (shown by letters and color codes) listed clock-
wise from the root. Table 3-6 lists details to each cluster and sub-cluster. Protein entries, which 
could not be assigned a cluster are shown in grey. 
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Table 3-6: Identified clusters of oligosaccharide binding proteins from Figure 3-1. Clusters are 
shown by numbers and if possible sub-clusters are listed with letters and color coding. The 
experimentally identified oligosaccharide binding proteins used to generate the tree are listed in the 
corresponding cluster. 
Cluster Sub-cluster Substrate specificity Identified Organism Reference 
1 A β-(1,4)-gluco-oligosaccharides Clostridium thermocellum ACTT 27405 (282) 
 B β-(1,4)-gluco-oligosaccharides B. breve UCC2003 (250) 
2 - FOS L. acidophilus NCFM (142) 
3 - Arabino-oligosaccharides1 Geobacillus stearothermophilus  (283) 
4 A Maltose  
L. casei BL23 
L. acidophilus NCFM 
(199) 
Appendix 6.2 
 B Putative maltose  B. animalis subsp. lactis Bl-04 Appendix 6.2 
 C α-(1,4)-malto-oligosaccharides 
Listeria monocytogenes 
Streptococcus pneumoniae 
(200) 
(213) 
 D β-Cyclodextrin, maltose Bacillus subtilis  (281) 
 E Trehalose, maltose, palatinose Thermus thermophilus HB27 (212) 
 F Maltose Maltotriose 
B. longum NCC2705 
B. animalis subsp. lactis Bl-04 
(198) 
Appendix 6.2 
5 A Lactose 
β-galacto-oligosaccharides 
B. longum NCC2705 
B. animalis subsp. lactis Bl-04 
(198) 
Appendix 6.2 
 B Lacto-N-biose2 B. bifidum B. longum 
(211) 
(215) 
 C Unknown None specified - 
6 - β-(1,4)-xylo-oligosaccharides 
B. animalis subsp. lactis Bl-04 
Streptomyces thermoviolaceus OPC-520 
Appendix 6.2 
(284) 
7 A Raffinose Raffinose and isomaltose 
L. acidophilus NCFM 
Streptococcus mutans 
Appendix 6.1 
(276) 
 B Raffinose RFO and IMO 
B. longum NCC2705 
B. animalis subsp. lactis Bl-04 
(198) 
Appendix 6.4 
8 - Gal-α-(1,3)-Fuc-α(1,2)-Gal Streptococcus pneumonia SP3-BS71 (214) 
9 - Laminaribose3 Clostridium thermocellum ACTT 27405 (282) 
Root - Fructose B. longum NCC2705 (285) 
1 α-(1,5)-arabino-oligosaccharides DP 2–8. 2 (Galp-β-(1–3)-GlcNAc). 3 (β-D-Glcp-(1–3)-D-Glcp). 
Notably, analysis of species distribution within the maltose binding protein containing sub-
clusters (4A–4F) show the sub-clusters 4A, 4B and 4F to be dominated by probiotic lactobacilli 
and bifidobacteria as compared to sub-cluster 4E (extremophile bacteria), 4C (human pathogenic 
bacteria) and 3D (soil associated bacteria). The present level of relatively little biochemical 
characterization beyond that of maltose binding proteins (286) does not allow detailed 
discrimination of the functional differentiation although analysis of the ABC transporter 
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associated gene clusters indicates functional distinction between transporters, and the gene 
clusters where they are encoded from thermophiles and mesophile bacteria (212).  
The shortcomings of the sequence analysis of the solute binding proteins can be amended by 
mapping co-encoded glycoside hydrolases within related gene clusters of solute binding proteins 
for additional specificity information to assess the functionality of ABC transporters (Appendix 
6.2). The observation of niche specificity of the identified clusters, and sub-clusters, relating both 
to functionality and selected species supports the paradigm of selective metabolism by probiotic 
organisms, as also observed within sub-cluster 7B, being almost exclusively populated by 
bifidobacteria, for uptake of the proposed prebiotic lacto-N-biose fraction of human milk 
oligosaccharide (211, 287). Gene landscape analysis of co-encoded glycoside hydrolases to 
solute binding proteins from sub-cluster 5C, with no experimentally characterized solute binding 
protein representative or defined taxonomical group, identified three combinations of GH 
families. The first sub-cluster encoded a GH2, the second sub-cluster a GH42 with a GH31 and 
lastly the third sub-cluster encoded a GH42 with a GH53 as exemplified by the protein entries 
YP_001222851, YP_004242545 and YP_003493824, respectively, in comparison to the sub-
clusters 5A, encoding a GH42, and 5B, encoding a GH112, respectively. This observation 
theoretically links sub-cluster 5C to β-galactoside utilization, but also highlights a weakness in 
homology-based deduction of function, where the potential future work lies in annotation of gene 
clusters rather than single genes and furthermore experimentally characterize novel solute 
binding proteins within microbial niche areas to understand part of the underlying mechanisms 
for selective metabolism of probiotics in comparison to GIT commensal and pathogenic bacteria. 
In summary, genome mining within L. acidophilus NCFM and B. lactis Bl-04 identified putative 
genes involved in uptake and hydrolysis of oligosaccharides several of which were proposed to 
possess prebiotic activity. Gene landscape analysis of the identified genes enabled functional 
assessment of the specificity regarding prebiotic utilization by L. acidophilus NCFM and B. 
lactis Bl-04 showing that both likely adopt a scavenging role in the GIT for carbohydrate 
utilization, and are dependent on other organisms to process polysaccharide into 
oligosaccharides. Evaluation of identified gene clusters proposed a higher number and more 
substrate specific transporters for L. acidophilus NCFM compared to the fewer transporters for 
B. lactis Bl-04, which however probably have broader specificities. Interestingly, both L. 
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acidophilus NCFM and B. lactis Bl-04 encode putative oligosaccharide transporters, where no 
functional homolog could be identified hence hampering the deduction of functions in silico to a 
speculative level and requiring experimental characterization. 
3.2 Transcriptional analysis of potential prebiotic utilization  
3.2.1 Selection of potential prebiotics for transcriptomics analysis 
From the in silico assessment of potential prebiotic utilization by B. lactis Bl-04 and L. 
acidophilus NCFM, it was possible to hypothesize metabolic pathways for uptake and hydrolysis 
of various oligosaccharides. In parallel with the genome mining, the abilities of selected 
carbohydrate prebiotic candidates to support the growth of L. acidophilus NCFM and B. lactis 
Bl-04 were screened in mono bacterial cultures (van Zanten et al, manuscript submitted to PLoS 
ONE). These growth data showed a comparative overview of potential prebiotics utilizable by 
the tested probiotics with respect to the total bacterial growth. The growth data of potential 
prebiotics selected for transcriptional analysis within the current PhD project are summarized in 
Table 3-7. All potential prebiotics specified were selected based on the presence of predicted 
pathways and the criteria below: 
Human indigestibility. The ability of prebiotics to bypass human digestion and reach the lower 
GIT is a fundamental part of the definition of prebiotics (41) and hence a key property for 
potential prebiotics to fulfill. Maltotriose does not fulfill this criterion but the functional 
glucoside composition is relevant as discussed for the functional glycoside compositions below. 
Growth parameters. Oligosaccharides yielding a higher growth than a glucose reference would 
indicate efficient metabolism and hence a potential efficient synbiotic combination.  
Functional glycoside composition. With the character of the present study to primarily map 
proteins involved with potential prebiotic uptake and catabolism, the selected carbohydrates were 
all covering related groups of glycoside structures and linkage types, to correlate the 
transcriptional findings to specific glycoside compositions (included in Table 3-7). 
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Table 3-7: Growth yield of L. acidophilus NCFM and B. lactis Bl-04 on carbohydrates used for 
preparation of cultures for transcriptional analysis (van Zanten et al, manuscript submitted to 
PLoS ONE). The carbohydrate linkage type defines the functional groups of oligosaccharides. 
Growth yield given in brackets denote combinations of bacteria and carbohydrates not used for 
transcriptional analysis. No growth data were obtained on XOS yet B. lactis Bl-04 cultures were 
prepared for transcriptional analysis. 
Carbohydrate1 Principal carbohydrate linkage type 
Relative growth of L. 
acidophilus NCFM2 
Relative growth of B. 
lactis Bl-042 
Glucose none 100 100 
Melibiose α-galactoside (4) 95 
Raffinose α-galactoside 133 118 
Stachyose α-galactoside 81 98 
Isomaltose α-glucoside 129 109 
Isomaltulose α-glucoside 133 (13) 
Panose α-glucoside 87 125 
Polydextrose α-glucoside 30 (14) 
Maltotriose α-glucoside (4) 140 
GOS β-galactoside 80 97 
Lactitol β-galactoside 47 (3) 
Cellobiose β-glucoside 131 40 
Gentiobiose β-glucoside 125 72 
Barley β-glucan 
oligomers β-glucoside 10 (5) 
Xylobiose β-xyloside (4) 82 
XOS β-xyloside (Not tested) Not tested 
1 The chemical structures for all listed oligosaccharides are given in Table 1-4. 2 Relative to glucose 
3.2.2 Summary of potential prebiotics induced differential transcriptomics  
The differential transcriptomics analysis of the utilization of the potential prebiotic by L. 
acidophilus NCFM and B. lactis Bl-04 have been prepared as separate research articles 
(Appendices 6.1 and 6.2 respectively). These manuscripts cover the observations from the global 
transcriptomics, differential gene upregulation and in silico comparative analysis of the identified 
genes in context of selective prebiotic utilization. It is hence the purpose of the following 
sections to combine the findings of the two studies, to discuss the comparative assessment of the 
identified genes in relation to uptake and catabolism of potential prebiotics within two 
phylogenetically distant probiotic bacteria. A main observation for both bacteria, grown on the 
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different oligosaccharides and glucose, was how the global transcriptome remained largely 
unchanged regardless of the source of carbohydrate utilized and only single gene clusters were 
seemingly differentially upregulated when compared to the carbohydrate utilized. Analysis of 
variance (ANOVA) of the differential transcriptome revealed upregulation of selected loci 
involved with oligosaccharide uptake and catabolism constituted in operons and structured gene 
clusters. The encoded set of carbohydrate transporters and glycoside hydrolases are summarized 
in Table 3-8. 
Table 3-8: Upregulated pathways for uptake and hydrolysis of potential prebiotics in L. acidophilus 
NCFM and B. lactis Bl-04. The transporter and hydrolase(s) for each identified pathway are listed 
horizontally and for those oligosaccharides were two pathways were identified, each pathway is 
shown on a separate line. Oligosaccharides not included in the transcriptional setup for the given 
strain are listed as not investigated (N.I.). 
Carbohydrate L. acidophilus NCFM B. lactis Bl-04 Transporter GH families Transporter GH families 
Melibiose  N.I. N.I. ABC 36 
Raffinose ABC 13_18, 36 ABC 13_18, 36 
Stachyose ABC 13_18, 36 ABC 13_18, 36 
Isomaltose PTS 4 ABC 13_? 
Isomaltulose  PTS 4 N.I. N.I. 
Panose PTS 4, 65 ABC ABC 
13_? 
13_30, 77 
Maltotriose  N.I. N.I. ABC 13_30, 77 
Polydextrose PTS ABC 
4, 65 
32 N.I. N.I. 
GOS GPH 2, 42 MFS ABC 
2 
42 
Lactitol  GPH 2, 42 N.I. N.I. 
Gentiobiose PTS 1 MFS 42 
Cellobiose PTS 1 MFS 1 
β-glucan 
oligomers 
PTS 
PTS 
1 
1, 1 N.I. N.I. 
Xylobiose N.I. N.I. ABC 43, 43, 43 
XOS N.I. N.I. ABC 43, 43, 43 
 
The performed transcriptional studies corroborated the wide capabilities of both bacteria to 
utilize ranges of potential prebiotics and substantiated the in silico predictions of oligosaccharide 
utilization (Section 3.1.6). Especially the identification of several PTS systems for L. acidophilus 
NCFM and MFS permeases for B. lactis Bl-04 represents a significant resource for annotation of 
protein homologs suffering from the limitations of the current lack of biochemical 
characterizations. The number of identified ABC transporters in both bacteria further verified 
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and supported the diversity of oligosaccharide solute binding proteins of ABC transporters as 
presented earlier (Section 3.1.7). Notably, also differences in glycoside hydrolase facilitated 
catabolism of potential prebiotics were observed as discussed in the following. 
3.2.3 Comparative pathway analysis of potential prebiotic utilization by L. 
acidophilus NCFM and B. lactis Bl-04  
Based on the functional glycoside composition of the selected potential prebiotics (listed in 
Table 3-7), it is of interest to compare the routes of utilization to map how representative 
probiotics bacteria potentially excel in selective utilization of prebiotics. The comparison of L. 
acidophilus NCFM and B. lactis Bl-04, by composition of the oligosaccharides utilized, will aid 
in comparative genomics studies, beyond the scope of the current project, to understand the 
functional differences between probiotic lactobacilli and bifidobacteria, the commensal 
microbiota and opportunistic pathogens entering the GIT, as they are becoming available from 
emerging large-scale sequencing projects (108, 113, 288). 
α-galactosides (melibiose, raffinose and stachyose). Commonly for both bacteria, an ABC 
transporter and a GH36 α-galactosidase were upregulated by raffinose and stachyose, and 
melibiose for B. lactis Bl-04. Notably, the B. lactis Bl-04 transporter showed a dual specificity 
by also being upregulated by the α-glucosides isomaltose and panose, which was not observed 
for L. acidophilus NCFM where a PTS transporter was identified (see the α-glucosides section 
below). The dual specificity was also suggested for a ABC transporter from Streptococcus 
mutans (276, 289), indicating that the dual specificity is not a feature only found within 
bifidobacteria. Sequence analysis (Section 3.1.7) did not indicate any differentiation of the two 
types of ABC mediating raffinose transport, hence lacking the predictive power to differentiate 
whether a novel raffinose transporter would exhibit a dual specificity for RFO and α-glucosides. 
This currently requires experimental work to be answered. Noticeably, crystal structures of 
relevant solute binding proteins in complexes with oligosaccharides may disclose structural 
determinants for future annotations of sub-specificities at the gene sequence level as later 
discussed (Section 3.3.2). 
α-glucosides (isomaltose, isomaltulose, panose, maltotriose, polydextrose). As listed above, B. 
lactis Bl-04 encoded a dual specificity ABC transporter indicated also to transport α-(1,6)-
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linkage containing glucosides (isomaltose and panose), but not the α-(1,4) linked maltotriose, 
which was possibly transported by an annotated dedicated maltose/malto-oligosaccharide ABC 
transporter highly specific for GIT associated actinobacteria. Yet a complementing transport 
mechanism was found by a PTS permease (LBA0606–0609) in L. acidophilus NCFM for uptake 
of isomaltose, isomaltulose, panose and possibly also fractions of polydextrose. The putative 
specificity and potential for trisaccharide uptake of this PTS permease is novel. As was the 
hydrolytic interplay with a novel GH4 isomaltose-6-phosphate hydrolase, selectively found in 
GIT associated lactobacilli (290), revealing a metabolic pathway expanding the knowledge of 
previous studies of α-glucan disaccharide specific PTS permeases coupled with a GH4 enzyme 
(LBA1689) activity (291–293). Notably L. acidophilus NCFM also encodes a putative maltose 
ABC transporter yet the lack of tested purely α-(1,4) linked glucosides apparently precluded 
upregulation of this locus. Maltose specific genes were though found to be upregulated in both 
strains by two different hydrolytic pathways. In L. acidophilus NCFM a GH65 maltose 
phosphorylase (LBA1872) was upregulated with LBA1689 (which is proposed to hydrolyze the 
phosphorylated α-1,6 linked-glucose from panose to release maltose) whereas in B. lactis Bl-04 
maltotriose upregulated an α-glucosidase (Balac_1573) and a α-1,4-glucanotransferase 
(Balac_1567). This highlights strain differences also on the level of catabolic pathways of L. 
acidophilus NCFM and B. lactic Bl-04. 
β-glucosides (cellobiose, gentiobiose and barley β-glucan hydrolysate). Clear metabolic 
differentiation was observed for β-glucoside utilization within L. acidophilus NCFM where 
dedicated PTS encoding loci were revealed for differential recognition of β-(1,4) and β-(1,6) 
glucosidic linkages. With the lack of PTS permeases in B. lactis Bl-04, uptake of gentiobiose 
was facilitated by a MFS transporter and interestingly indicated to be hydrolyzed by a GH42 
putative β-galactoside. This indicates the first observation of gentiobiose uptake by an MFS 
permease and a novel specificity within GH42 to date only harboring β-galactosidases. The in 
silico phylogenetic mapping of the GH42 family showed the gentiobiose specific GH42 to differ 
significantly from enzymes of known specificities within the GH42 family, supporting this novel 
observation (Alexander Viborg Holm, unpublished results). No specific cellobiose transporter 
was found in B. lactis Bl-04 neither from the in silico nor the transcriptional analysis, in 
agreement with the relatively low growth observed on cellobiose. 
50 
 
β-galactosides (GOS and lactitol). Both bacteria displayed common catabolic pathways for 
intracellular GOS by hydrolysis by GH2 and GH42 β-galactosidases, yet B. lactis Bl-04 encoded 
two GOS transporters in different loci (an ABC transporter associated with a GH42 β-
galactosidase and an MFS permease associated with the GH2 β-galactosidase) for GOS uptake 
compared to the GPH permease identified in L. acidophilus NCFM. It is unknown from the 
present study what fraction of GOS chain-lengths are utilized by B. lactis Bl-04, yet the relative 
high growth yield (Table 3-7) indicates utilization also of GOS with a higher degree of 
polymerization. From previous knowledge of transporters, it can hypothesized that the two 
transporters may act in parallel with uptake of short chain GOS by the MFS and longer chain 
GOS to be facilitated by the ABC transporter. In comparison the GPH permease encoded by L. 
acidophilus NCFM has evolved a wide substrate specificity to comprise lactose, GOS and the 
sugar alcohol lactitol with hydrolysis by both a GH2 and a GH42 β-galactoside (Appendix 6.3). 
β-xylosides (xylobiose and XOS). The ability of B. lactis Bl-04 to utilize β-xylosides, compared 
to L. acidophilus NCFM, which cannot utilize XOS, may reflect the organism’s adaption to 
utilization of dietary plant derived human non-digestible carbohydrates. Biophysical 
characterization of the solute binding protein of the XOS ABC transporter demonstrated binding 
of arabinosylated xylo-oligosaccharides (Ejby et al., manuscript in preparation). This supports 
the prediction of GH43 arabinofuranosidases within the XOS utilization locus of B. lactis Bl-04, 
signifying how the locus may also enable the utilization of arabinosylated XOS. No methylated, 
acetylated or feruloylated XOS substrates were tested to support the predictions of novel putative 
esterases found within the locus, although these esterifications are commonly found in plant 
xylan and removed by various xylan acetyl esterases (294, 295), to which the putative estereases 
identified in B. lactis Bl-04 showed, however, less than 30% amino acid sequence identity 
towards. 
3.2.4 Correlation of in silico predictions and transcriptional observations  
The transcriptional identification of oligosaccharide transporters and hydrolases validates the in 
silico predictions for ABC transporter containing pathways, but also highlighted novel 
specificities which could not be deduced from amino acid sequence similarity e.g. in the case of 
PTS transporters where no homologs had been identified in related organisms previously. 
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However, the interpretation of the differential transcriptomes for heterogeneous oligosaccharide 
preparations such as polydextrose and barley β-glucan hydrolysate, becomes complicated as it 
cannot be deduced by the applied methods, which fractions of the carbohydrate sample have 
been utilized at the time of culture harvest in this setup with induction of multiple transporters. 
Here data on disaccharides, e.g. isomaltose or cellobiose, assist in determining the linkage and 
glycoside specificity of single transporters. Such knowledge for the single transporters can in 
turn support theoretical utilization of more complex oligosaccharide mixtures.  
From the genome mining of B. lactis Bl-04 a putative extracellular β-mannosidase (Balac_1450) 
was proposed. Likewise a putative extracellular pullulanse (LBA1710) was identified in L. 
acidophilus NCFM, yet no oligosaccharides being potential substrates for these enzymes were 
included in the experimental setup, hence no upregulation of these genes was observed. Yet 
recombinant proteins of both genes showed enzymatic activity towards β-mannan and pullulan, 
respectively (Personal communication, Abou Hachem, M.) validating the proposed specificities 
of these enzymes and their possible involvement in potential prebiotic utilization. 
3.2.5 Experimental design and limitations of DNA microarrays for gene 
identification  
A key step in analysis of differential transcriptomics is the ANOVA modeling to identify 
upregulated genes with statistical significance among the total gene transcriptome data. Hence it 
is a consideration of how many samples, biological- and technical replicates to include in the 
experimental design to obtain a useful statistically reliable data analysis. Based on a previous 
study using the same experimental platform for studying gene expression in L. acidophilus 
NCFM (143), it was estimated that a 12 samples setup with two technical replicates would yield 
sufficient quality data to allow detection of single gene upregulation with statistical significance. 
No biological replicates are included as bacterial cultures were assumed to be genetically 
identical and introducing a biological replicate would show data variance based on undesirable 
differences in culture preparation and handling rather than the potential variance in mRNA 
preparation and labeling, and hybridization inefficiencies reflected by technical replicates (296, 
297). Nonetheless analysis of genes below the significance threshold (p-value = 10-4.74) for L. 
acidophilus NCFM showed how the putative extracellular pullulanase (LBA1710), despite being 
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more than 20 fold upregulated by polydextrose compared to glucose, was below the cut off with 
a p-value of 10-4.73 suggesting transcriptomics data need experimental validation to support the 
observations, or lack of observations, based on the in silico and transcriptional analysis. 
Transcriptional analysis revealed genes with constitutively high gene expression values for both 
bacteria throughout all tested carbohydrate conditions. Yet such genes with functions for 
carbohydrate utilization, as the glucose PTS (LBA0452, 0455–0456) transporter in L. 
acidophilus NCFM or the putative β-(1,4)-glucosidase (Balac_0151) from B. lactis Bl-04, could 
not be identified from ANOVA models and thus these genes require functional validation. This 
could be done by semi-quantitative polymerase chain reaction of the analyzed genes compared to 
house-keeping genes (such as genes encoded RNA polymerase or ribosomal RNA) with 
constantly high expression. Especially validation of transcriptional analysis is essential to 
support the claims of gene annotations presented in the previous sections, as differences in 
mRNA levels are not linearly related to quantitative levels of functional protein or assist in 
deduction of protein functions. The following section will evaluate the functional validation of 
the transcriptional findings by functional genomics and recombinant protein characterization. 
3.3 Functional characterization of genes and proteins involved with 
potential prebiotic uptake and catabolism 
Transcriptional analysis of genes involved with the utilization of potential prebiotic by L. 
acidophilus NCFM and B. lactis Bl-04 identified putative gene products facilitating uptake and 
hydrolysis of oligosaccharides. A natural next step in understanding the molecular mechanisms 
of potential prebiotic utilization is functional characterization of these key proteins. This serves 
both as validation of the proposed new gene annotations based on the transcriptional findings and 
to characterize the broadness of protein specificity, being it of transporters or glycoside 
hydrolases. This section will present protein function deduction by complementing gene 
deletions as well as characterization of produced recombinant proteins. 
3.3.1 Functional genomics of L. acidophilus NCFM 
The recently developed counter-selective gene replacement system in L. acidophilus NCFM 
(261) enabled the construction of gene excision mutants. This was applied to generate in-frame 
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gene deletions of putative key gene’s coding regions (Table 3-9) involved with potential 
prebiotic utilization presented in the previous sections. The selection of genes for deletion was 
primarily based on genome mining (Section 3.1.3) as the experimental work of DNA microarray 
sample preparation from L. acidophilus NCFM cultures grown on prebiotic candidates for 
transcriptional work was performed simultaneously with the construction of gene deletions. 
In the light of the previous work, ABC transporters were hypothesized to be the route of 
oligosaccharide uptake as discussed in Section 3.2.2, hence substrates such as panose, barley β-
glucan hydrolysate, raffinose, stachyose, polydextrose and GOS could be transported by ABC 
transporters, where two putative multiple sugar metabolism transporters and one maltose 
transporters were predicted (Table 3-1). With three ABC transporters identified, it was 
rationalized that these would display broad substrate specificities and hence the corresponding 
solute binding proteins were deleted for indirect functional characterization (as listed in Table 
3-9). Additionally a GH36 α-galactosidase was selected for gene deletion to further investigate 
RFO metabolism. Finally by gene landscape analysis of the putative lactose specific GPH 
permease, it was proposed how the GPH transporter could potentially facilitate uptake of GOS 
hence the permease was also targeted for gene excision. 
The phenotypic characterization of the GPH permease role in uptake of the prebiotic GOS and 
lactitol is presented in Appendix 6.3. Notably, this finding validate the hypothesized GOS uptake 
by a GPH permease, being the first identified GOS specific transporter within the Lactobacillus 
genus and adds functional support to the discussion of how lactose is either transported by GPH 
permeases or lactose specific PTS permeases (231) in lactobacilli. The phenotypic 
characterization of the GH36 α-galactosidase and raffinose ABC transporter is presented in 
Appendix 6.1, where the gene deletions serve to validate the two essential steps in the RFO 
utilization of L. acidophilus NCFM. The remaining two mutants were not yet phenotypic 
characterized based on the transcriptional findings and time limitations. 
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Table 3-9: L. acidophilus NCFM gene deletion mutants constructed in this project. The deleted 
genes are given by their locustag numbers and the gene annotation refers to the in silico predictions 
in Section 3.1.3 or experimental other work, if available. The references correspond to the 
construction and characterization of the mutant, where the mutants of LBA0502 and LBA1866 
were only constructed and not tested. 
Locus tag  Annotation Characterized phenotype  Reference 
LBA0502  FOS solute binding protein (142) Not characterized in this study This work 
LBA1438  GH36 α-galactosidase No growth observed on melibiose, raffinose and stachyose Appendix 6.1 
LBA1442  Raffinose solute binding protein No growth observed on melibiose, raffinose and stachyose Appendix 6.1 
LBA1463  Lactose GPH permease No growth observed on lactose, lactitol and GOS Appendix 6.3 
LBA1866  Putative maltose solute binding protein Not characterized in this study This work 
 
The differential transcriptomics, presented in Section 3.2.2, depicted a surprising alternative 
utilization pathway of potential prebiotics beyond what was earlier rationalized in silico. 
Especially the above functionally characterized RFO ABC transporter in L. acidophilus NCFM 
was found to be RFO specific and not to be upregulated by isomaltose as previously found for 
putative multiple sugar metabolism (Msm) ABC transporter (276). The identified utilization 
pathway of isomaltose and panose was based on a PTS permease for uptake rather than an ABC 
transporter as initially predicted (Table 3-1). In general, the impact of PTS permease facilitated 
transport was greater than expected and suggested novel specificities such as gentiobiose and 
panose to PTS permeases, which would be candidates for validation by functional genomics 
using the gene deletion system applied in the current work. 
The functional genomics presented, confirms the gene products involvement in utilization of 
prebiotic GOS and potential prebiotic RFO by L. acidophilus NCFM. Future work with these 
gene deletion mutants, linking their utilization phenotype to a proliferating role in the GIT, could 
further assess prebiotic utilization as an important probiotic characteristic. This hypothesis could 
be tested in a complex fermentation setup (59) or using an in vivo murine model to test the 
survivability of the L. acidophilus NCFM mutants unable to utilize otherwise selective utilizable 
substrates, as it was previously reported how a mannose specific PTS permease was linked to 
elongated gut persistence of L. johnsonii NCC553 (298). 
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3.3.2 Structure-function relationship of a solute binding protein with dual substrate 
specificity 
The identification of the RFO specific ABC transporter in L. acidophilus NCFM is in contrast to 
the transcriptional findings from B. lactis Bl-04, presented in Appendix 6.2, where a putative 
raffinose and isomaltose dual specific ABC transporter (Balac_1597–1599) was identified. 
The phylogenetic analysis of oligosaccharide solute binding proteins of ABC transporter (Figure 
3-1) showed a divergence of putative raffinose binding proteins into two clusters based on a 
taxonomical drift rather than functionality, hence not reflecting the functional diversity observed 
here by the mono-specificity represented by the solute binding protein of L. acidophilus NCFM 
LBA1442 and dual specificity represented by the solute binding protein Bl16GBP (Balac_1599) 
encoded by B. lactis Bl-04. The dual substrate specificity of Bl16GBP was functionally validated 
by recombinant protein production and biophysical characterization as presented in Appendix 6.4 
to confirm binding of RFO and IMO types of oligosaccharides. However, sequence comparison 
to explain the difference in substrate binding between the two raffinose binding proteins was 
hampered by the overall low amino acid sequence identity of 25.7% between LBA1442 and 
Balac_1599. 
To comprehend the molecular architecture underlying the broad specificity of Bl16GBP, protein 
crystallization of recombinant Bl16GBP performed (as described in Section 2.4) to identify 
residues and structural motifs unique to the RFO/IMO class of oligosaccharide solute binding 
proteins. Protein crystals were only obtained in the presence of either panose or raffinose, which 
could be explained by how binding of an oligosaccharide stabilizes the assumed flexible protein 
conformation of the solute binding protein (210) hence enabling tight and homogenous packing 
of the crystal lattice. Electron density maps were obtained for protein-carbohydrate complexes 
with panose and raffinose (Table 3-10), moreover a dataset of selenomethionine labeled 
Balac_1599 in complex with panose was obtained (Morten Ejby, Post doc. Andreja Vujicic-
Zagar and Associate Professor Dirk Slotboom, preliminary results). Despite high quality datasets 
of Bl16GBP in complex with panose or raffinose which theoretically could reach atomic 
resolution structures of the complexes, a final protein structure of Bl16GBP could not be 
modeled due to the lack of experimentally determined phases of the electron densities. 
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Table 3-10: Obtained electron density datasets of Bl16GBP protein complexes. 
Parameter  Bl16GBP Bl16GBP 
Ligand/soak Panose Raffinose 
Space group  P212121  P212121  
Cell dimensions     
a b c (Å) 55.5 90.9 146.6 55.5 90.9 146.6 
α β γ (°)  90.0 90.0 90.0  90.0 90.0 90.0  
No. of molecules/ 
AU  2 2 
Solvent content 
(%)  41.5 (Vm=2.1)  41.5 (Vm=2.1)  
Resolution range 
(Å)  47.3–1.9 50.2–1.6 
Rsym (%)  12.1 (64.6)  11.2 (63.8)  
I/σ(I)  12.0 (3.3)  11.9 (3.2)  
Completeness (%)  98.6 (96.7)  99.6 (97.7)  
Redundancy  7.4 (7.4)  7.4 (7.4)  
 
To overcome this, crystals were prepared of selenomethionine labeled Bl16GBP to aid in solving 
the phase problem, however currently only a too low resolution (~8 Å) dataset have been 
obtained. Alternatively, molecular replacement, using homologous previously determined 
protein structures, was attempted without success due to sequence identity below 30% to the 
most similar structurally reported homologs. Experimental work to determine the phases by e.g. 
obtaining higher resolution datasets of selenomethionine labeled Bl16GBP crystals continue and 
could lead to structural determination of the Bl16GBP in complex with raffinose and panose and 
thus reveal how the dual substrate recognition is structurally manifested. 
The characterization of recombinant protein and gene deletions, corroborate on the gene 
identifications and annotation from in silico genome mining and the two differential 
transcriptions analysis to substantiate the proposed pathways of prebiotic utilization. 
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4 Conclusions and perspectives 
 
The various health-benefits related to probiotic microorganisms is a major industrial and 
scientific area, expanding with the advances of clinical data and deeper understanding of the 
gastrointestinal microbiome as a significant parameter for human health. However, there is still a 
gap of knowledge related to the documentation of how probiotic strains confer their probiotic 
effects through mechanisms such as selective utilization of prebiotics. 
The overall aim of the current Ph.D. project was to identify and characterize genes involved with 
uptake and catabolism of potential carbohydrate prebiotics by two commercial probiotic strains, 
L. acidophilus NCFM and B. lactis Bl-04. This was achieved by a strategy of genome mining 
and gene-landscape analysis, differential transcriptomics followed by selection of key genes to 
further study by functional genomics and protein characterization.  
In silico assessment of the putative carbohydrate utilization systems of L. acidophilus NCFM and 
B. lactis Bl-04 revealed how both bacteria essentially lack extracellular glycoside hydrolases and 
hence scavenge polysaccharide degradation products form GIT symbionts. Thus the multitude of 
encoded oligosaccharide transport systems is the main determinant of substrate specificity of the 
bacteria. This lead to selection of potential oligosaccharide-prebiotics covering groups of α- and 
β-linked glycoside-types of galactosides, glucosides and xylosides used for preparation of 
cultures for transcriptional analysis.  
The differential transcriptomics of L. acidophilus NCFM revealed an extensive diversity of 
upregulated PTS permeases for α-1,6-glucosides and β-glucosides together with a broad 
specificity β-galactoside GPH permease and ABC transporters associated with uptake of 
oligosaccharides. Key genes, encoding the putative GOS permease, a raffinose solute binding 
protein and a GH36 α-galactoside respectively, were selected for deletion and their mutant 
phenotypes confirmed their roles in prebiotic utilization. The transcriptional analysis of B. 
animalis subsp. lactis Bl-04 showed putative gene products related to molecular probiotic 
functions being constitutively expressed hence linking to the probiotic nature of the bacterium. 
The differential gene findings identified specific gene cluster involved with oligosaccharide 
utilization, where novel specificities were found for MFS permeases and ABC transporter 
encoding gene clusters, displaying overall broad substrate specificity. In comparison of the two 
58 
 
strains, a seemingly homologous raffinose specific ABC transporter was cloned from B. lactis 
Bl-04 and produced. The biochemical characterization confirmed a dual substrate specificity for 
RFO and IMO, yet future protein structural work will aid in understanding this dual substrate 
specificity. 
The identified pathways within L. acidophilus NCFM and B. lactis Bl-04 revealed novel insight 
into prebiotic utilization leading the way to further substantiation of the mechanism of probiotic 
actions by documentation of protein molecular interactions with dietary carbohydrates. 
The current work with oligosaccharide transporter and glycoside hydrolase identification adds a 
significant contribution to the understanding of oligosaccharide uptake and how carbohydrate 
catabolism affects the global gene expression with a potential role beyond energy turn-over. The 
studied two strains represent highly important groups of probiotics. First, L. acidophilus NCFM 
as a member of the acidophilus-complex of lactobacilli and a model probiotic, which with the 
presented findings has been further characterized to support a crucial lack of knowledge for 
identification of novel carbohydrate transport systems. Second, B. lactis Bl-04 as a substantially 
less functionally characterized, yet clinically documented probiotic strain, serves with its 
commercial value as an interesting candidate to study on the molecular level of gene expression 
to understand the basis transcript and response to potential prebiotic carbohydrates. 
The current results have been presented in a defined scope of strain comparison, however with 
the recent availability of the human microbiome metagenomics, it will be possible to use the 
identified putative gene clusters as biomarkers to screen larger data set and quantify the presence 
in microbiome phylogenetic niches, thus hypothesize which subset of the microbiome can be 
selectively stimulated by supplemented (potential) prebiotic. 
The immediate future validation of this work will be to show the selection utilization of the 
applied potential prebiotics in a complex fermentation setup inoculated with either L. acidophilus 
NCFM or B. lactis Bl-04 (or both). Any synergistic combination of candidate prebiotic and 
probiotic will confirm a selective fermentation, dependent on the dose supplemented, and hence 
establish a functionally substantiated combination of pre- and probiotic for further in vivo 
validation of the synbiotic formulations.  
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Abstract 
The human gastrointestinal tract can be positively modulated by dietary supplementation of probiotic bacteria 
in combination with prebiotic carbohydrates. Here differential transcriptomics and functional genomics were 
used to identify genes in Lactobacillus acidophilus NCFM involved in the uptake and catabolism of 11 potential 
prebiotic compounds consisting of α- and β- linked galactosides and glucosides. These oligosaccharides 
induced genes encoding phosphoenolpyruvate-dependent sugar phosphotransferase systems (PTS), 
galactoside pentose hexuronide (GPH) permease, and ATP-binding cassette (ABC) transporters. PTS systems 
were upregulated primarily by di- and tri-saccharides such as cellobiose, isomaltose, isomaltulose, panose and 
gentiobiose, while ABC transporters were upregulated by raffinose, Polydextrose, and stachyose. A single GPH 
transporter was induced by lactitol and galactooligosaccharides (GOS). The various transporters were 
associated with a number of glycoside hydrolases from families 1, 2, 4, 13, 32, 36, 42, and 65, involved in the 
catabolism of various α- and β-linked glucosides and galactosides. Further subfamily specialization was also 
observed for different PTS-associated GH1 6-phospho-β-glucosidases implicated in the catabolism of 
gentiobiose and cellobiose. These findings highlight the broad oligosaccharide metabolic repertoire of L. 
acidophilus NCFM and establish a platform for selection and screening of both probiotic bacteria and prebiotic 
compounds that may positively influence the gastrointestinal microbiota.  
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Introduction 
The microbiota of the human gastrointestinal tract (GIT) can dramatically affect the immune system of the host through 
increased allergy resistance (1) and modulation of diabetes, obesity (2, 3) and autoimmune bowel disorders (4). The 
compositional balance and activity of the microbiota can be positively influenced by probiotic microorganisms (5), or 
shifted by prebiotic supplementation (6). One effective strategy to promote positive impacts on both commensal and 
probiotic microbes is GIT modulation with prebiotic substrates (7-9).  
Prebiotics are complex carbohydrates that are not digested or absorbed by the host, but catabolized by various 
commensal and health-promoting members of the GIT bacteria and selectively promoting their growth (10). Currently, a 
few carbohydrates are widely accepted as prebiotics, specifically GOS (β-galactooligosaccharides), inulin, FOS (fructo-
oligosaccharides) and lactulose (11). In vivo studies, however, have shown increases in the populations of probiotic 
microbes due to stimulation by candidate prebiotic carbohydrate compounds, e.g. panose (12), polydextrose (13) and 
lactitol (14). Advances in the genomics of lactobacilli and bifidobacteria have enabled modeling of transport and 
catabolic pathways for prebiotic utilization (15). Only a few such proposed models, however, have been experimentally 
validated (16-18), which hampers accurate functional assignment of novel specificities especially for carbohydrate 
transporters that are largely uncharacterized biochemically. Recent studies have shown transfer of genes enabling 
prebiotic catabolism in certain pathogenic strains (19) and growth on prebiotic substrates in mono-cultures of some GIT 
commensal and pathogenic bacteria (20). These findings emphasize the need to provide functional scientific support for 
novel prebiotic candidates and to address the molecular basis for selective prebiotic catabolism by probiotic microbes. 
The probiotic microbe Lactobacillus acidophilus NCFM has been investigated by in-depth functional studies to reveal the 
molecular mechanisms for important probiotic traits, such as bile acid resistance (21), involvement of lipoteichoic acid in 
immunomodulation (22), and positive outcomes reported in human intervention studies using L. acidophilus NCFM as a 
probiotic (23, 24) and when supplemented as a synbiotic (25). The potential of L. acidophilus NCFM to metabolize a 
diverse number of oligosaccharides is reflected by the large number of predicted glycoside hydrolases encoded by its 
genome (26), and by functional studies outlining routes for utilization of various oligosaccharides saccharides (16, 27, 
28). Accurate annotation of genes involved in prebiotic utilization is hampered by the paucity of functional studies, 
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especially of transporters and families of glycoside hydrolases that exhibit a multitude of substrate specificities. The 
scope of this study was to transcriptionally identify and functionally characterize genomic loci encoding catabolic 
pathways in L. acidophilus NCFM essential for the transport and utilization of a range of potential prebiotics spanning 
hexose families of α- and β- linked glucosides and galactosides.    
 
Results 
Carbohydrate dependent differentially expressed gene clusters 
Gene expression was measured in L. acidophilus NCFM harvested in the early exponential phase and stimulated by 
glucose compared to 11 different oligosaccharides (Table 1), representing different hexoses in varying groups of 
carbohydrate linkages. These groups contained the α-galactosides consisting of, raffinose and stachyose; the α-
glucosides, isomaltose, isomaltulose, panose and polydextrose; the β-galactosides, lactitol and GOS; and the β-
glucosides, β-glucan oligomers, cellobiose and gentiobiose. The overall gene expression pattern for growth on each 
carbohydrate was represented by cluster analysis (published online, Figure S1). The most extensive differential gene 
expression was observed for specific gene clusters, while the overall gene expression pattern remained essentially 
unchanged, thus indicating that L. acidophilus NCFM adaptation to complex carbohydrate metabolism is regulated at the 
transcriptional level. 
Statistical analysis of the global gene expression data was performed by a mixed model ANOVA to identify differentially 
expressed genes to each oligosaccharide treatment. A range of 1 – 45 genes were statistically differentially expressed 
(threshold p = 10-4,74 for α=0.05 using Bonferroni correction) for all treatments. The results of differential gene 
expression and statistical significance were illustrated by volcano plots that highlighted upregulated genes predicted to 
be involved in oligosaccharide transport and catabolism (Figure 1) summarized in Table 2 and with a heat map 
representation of expression of all the identified genes (Figure S2). None of the genes predicted to be involved in 
oligosaccharide catabolism were upregulated by growth on glucose, consistent with previous findings that glucose is 
transported by a constitutively expressed phosphoenolpyruvate-dependent sugar phosphotransferase system (PTS) 
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(LBA0452, LBA0455LBA0457) (27). Analysis of gene induction patterns by specific oligosaccharides showed a 
differential expression profile of carbohydrate active proteins (Table 2) depending on the carbohydrate linkages (α- vs. 
β-glycosidic linkages) and the monosaccharide constituents of glucoside and galactoside.  
 
β-galactoside differentially induced genes 
In the presence of GOS and lactitol, several genes (Table 2) were upregulated (7.1 – 64 fold) within the locus LBA1457 – 
LBA1469 encompassing genes encoding a galactose-pentose-hexuronide (GPH) LacS permease and two β-galactosidases 
(GH2 and GH42; CAZy glycoside hydrolase family (GH) classification (29)) together with the Leloir pathway genes for 
galactoside metabolism. These data indicate how these oligosaccharides are transported by the LacS permease and 
hydrolyzed by the action of two different β-galactosidases into galactose, glucose in the case of GOS and galactose and 
glucitol for lactitol, which are shunted into the Leloir and glycolytic pathways, respectively, as reported previously (18, 
28). 
β-glucoside differentially induced genes 
Cellobiose induced genes within two loci (LBA0724–LBA0726 and LBA0877–LBA0884; 6.1 – 65.8 fold upregulation), both 
encoding a PTS permease EIIABC and a putative GH1 6-phospho-β-glucosidase. Growth on gentiobiose as a carbon 
source upregulated (9.2 fold) the PTS permease EIIC (LBA0227), albeit at a lower level by panose (5.4 fold), indicating 
either a dual specificity of the PTS permease or a more complex transcriptional co-regulation of the transport system. 
The oligomers obtained by hydrolysis of mixed linkage β-1,3/β-1,4 β-glucan stimulated upregulation of both the 
cellobiose-induced PTS permease gene cluster mentioned above, and notably the α-glucoside induced gene cluster 
LBA0606–LBA0609 and LBA1684 (encoding a PTS EIIA component). The patterns of upregulated gene clusters for β-
glucosides indicate differential recognition of the β-1,4 and β-1,6 linkages and the specialization of different PTS 
permeases and their corresponding GH1 enzymes that recognize phosphorylated β-glucosides at the C6 position.  
α-glucoside differentially induced genes 
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Both isomaltose and isomaltulose upregulated the LBA0606-LBA0609 locus (13.4 – 65.8 fold), putatively encoding a PTS 
permease (EIIABC). This regulatory RpiR family protein and a hypothetical protein, together with LBA1684 (11.7 fold 
upregulated), annotated as a PTS IIA regulatory components. LBA1689 (65.9 fold upregulated) annotated as a GH4 
maltose-6-phosphate glucosidase. This suggested that the two α-1,6 linked glucosides are phosphorylated concomitant 
with their transport by the PTS EIIABC (LBA0606 and LBA0609) permease, and that these phosphorylated disaccharides 
are hydrolyzed by a specific intracellular (predicted by SignalP (30)) GH4 disaccharide 6-phospho-α-glucosidase into 
glucose-6-phosphate and either glucose from isomaltose or fructose from isomaltulose, which enter glycolysis. Notably, 
the trisaccharide panose elicited a similar upregulation pattern as isomaltose, including upregulation of LBA0606-
LBA0609 and LBA1689, and also up- LBA0227. The locus LBA0224-LBA0228 was annotated to include a cellobiose-
specific PTS permease EIIC domain, a regulatory protein, and a GH1 6-phospho-β-glucosidase.  
The diverse structural elements present in polydextrose constitute a complex oligosaccharide mixture of mostly 
different α-linked glucosides. Accordingly, a complex upregulation pattern was observed that involved genes encoding 
both an ABC (LBA500-0504) and a PTS permease (LBA0606) and several hydrolases (LBA0505, LBA1689 and LBA1870). 
The highest upregulation involved the above PTS permease (LBA0606-0609) together with LBA1870 encoding a GH65 
maltose phosphorylase (31) and LBA0505-0506 identified as a part of a locus determined previously as a FOS 
metabolism operon (16).  
 
α-galactoside differentially induced genes 
The tetrasaccharide stachyose induced the gene locus LBA1438 – LBA1442 (9.3 – 35.9 fold upregulated) encoding an 
ABC transporter, a GH36 α-galactosidase and a part of the Leloir pathway enzymes (LBA1458, LBA1459 and LBA1469). 
This suggests that stachyose is transported into the cytoplasm by this ABC transporter and initially hydrolyzed into 
galactose and raffinose, which is further processed to galactose and sucrose that subsequently can be phosphorolyzed 
by LBA1437 encoding a sucrose phosphorylase (GH13_18). This gene cluster was previously found to be upregulated by 
raffinose (27). From the DNA microarray presented in the present study, no upregulated genes were involved with 
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oligosaccharide metabolism by stimulation of raffinose, suggesting glucose as an impurity in the medium or raffinose 
preparation.  
 
Functional characterization of genes involved with α-galactoside metabolism  
To corroborate the identification of gene clusters from L. acidophilus NCFM (25, 27, 32) involved in the metabolism of α-
galactosides of the raffinose family oligosaccharides, two single gene deletions were constructed within the stachyose 
induced locus, i.e. ΔLBA1438 (α-galactosidase) and ΔLBA1442 (solute binding protein of the ABC transporter) using the 
upp-based counterselective gene replacement system (33). It was predicted by genome mining that L. acidophilus NCFM 
encoded single locus responsible for the transport and hydrolysis of α-galactosides. Phenotypic confirmation of the roles 
of these genes was accomplished by constructing mutations in these genes. Mutations of LBA1438 and LBA1442 were 
in-frame deletions of 92% and 91% of the coding regions, respectively. The α-galactosidase (LBA1438) deletion mutant 
lost the ability to grow on raffinose (Figure 2B), melibiose (α-D-Galp-(1–6)-D-Glcp) and stachyose (data not shown). The 
ability of the LBA1442 mutant to grow on galactose (Figure 2A), but not raffinose (Figure 2C) provides evidence for the 
specificity of the transporter for α-galactoside oligosaccharides. The phenotypes of single gene deletion variants confirm 
that the genes identified through differential transcriptomics are functionally crucial for growth on these prebiotic 
compounds. 
 
Structure, divergence and function of induced gene clusters  
The transcriptional gene induction patterns and the essential roles of single proteins responsible for carbohydrate 
uptake and catabolism demonstrated how specific gene clusters conferred the ability to utilize the prebiotics 
investigated in this study. Identification of gene clusters selectively upregulated in response to prebiotic substrates 
(Figure 3) showed that multiple genes within these operons are typically expressed as single transcripts. However, genes 
LBA1684 (PTS EIIA component) and LBA1689 (putative maltose-6-phosphate-hydrolase), were predicted in silico to be 
monocistronically transcribed. All gene clusters induced by prebiotic substrates were analyzed for regulatory elements. 
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Catabolite repression elements (CRE) were found upstream of all non-PTS permease containing transcripts and LBA1684, 
encoding a PTS EIIA. . The molecular responses to oligosaccharide stimulation are likely mediated through CRE sites via 
catabolite control protein A (ccpA, LBA0431), phosphocarrier protein HPR (ptsH, LBA0639), and HPr 
kinase/phosphorylase (ptsK LBA0676) linking the regulation to the phosphorylation cascade of EI through EIIA to the PTS 
permeases (27). 
Amino acid sequence comparisons to previously characterized bacterial PTS EIIC trans-membrane substrate binding-
domains (Figure S3), including β-1,4 or β-1,6 glucoside specific PTS permeases, showed a clear segregation of LBA0227 
and LBA0725, the latter clustering with a functionally characterized cellobiose PTS permease from L. gasseri ATCC 33323 
(34), consistent with the observed upregulation of LBA0725 on cellobiose. Notably, the PTS permease EIIC domains 
LBA0879 and LBA0884 were also upregulated by cellobiose, albeit at a lower level than LBA0725. These two proteins 
clustered distantly on the phylogenetic tree, indicating functional divergence and a likely preference for structurally-
related substrates such as sophorose (β-D-Glcp-(1–2)-D-Glcp), a candidate prebiotic supporting growth of L. acidophilus 
NCFM (12). A schematic overview (Figure 4) summarizes the uptake and catabolism pathways of potential prebiotic 
oligosaccharides in L. acidophilus NCFM.  
Notably, the most highly induced gene in the present study was LBA0608 (Figure S4) encoded a hypothetical protein 
within a PTS permease locus. No function could be assigned for the protein, which was predicted to have a four 
transmembrane helical topology using the Phobius prediction tool (35). The same topology was found for LBA0878 
(Figure 3D), another hypothetical protein encoded in locus with a PTS permease, but no significant amino acid sequence 
similarity was found for the two proteins.   
 
Discussion 
Carbohydrates supplemented for enrichment of specific commensal or probiotic microbes of the GIT can exert selective 
increases in certain beneficial populations , and decrease pathogens and symptoms of some GIT disorders. Recent 
studies of prebiotic catabolism (17, 34, 36) have shown a wide array of metabolic capabilities that cannot be deduced 
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based on in silico gene annotations or even on experimental work in homologous organisms. The pathways and the 
molecular elements for transport and catabolism of FOS, lactitol and GOS have been analyzed in L. acidophilus NCFM 
(16, 18, 28). This serves as a methodological basis to identify the molecular and genetic foundation for screening of 
potential prebiotic compounds in vitro and/or in vivo and specific enrichment of health-promoting bacteria in complex 
microbial ecosystems (37–39). 
Importance of carbohydrate transporter variety  
The general structure of the identified gene clusters indicates that typically, a three component system consisting of a 
regulator, transporter and glycoside hydrolase(s) can be sufficient for utilization of potential prebiotics, irrespective of 
the type of transporter identified (ABC, GPH, or PTS permease, Figure 3). Remarkably, PTS permeases had higher 
selectivity towards disaccharides, whereas ABC and GPH permeases appeared to be also induced by the longer 
oligosaccharides e.g. stachyose, and GOS. Furthermore, similar upregulation patterns of gene expression by widely 
different prebiotics was surprising, notably  the FOS-ABC transporter that was also induced by the mixed linkage 
polydextrose. This suggests that transporters either possess more than one specificity or less strigent molecular 
recognition of substrates, indicating  a wide range of carbohydrates can be metabolized by L. acidophilus NCFM, and 
likely similar commensal lactic acid bacteria. This capability is also expanded by transporters that  possess a broad 
specificity for oligosaccharides sharing structural elements e.g. the α-1,2 glycosidic linkages found in both FOS and 
polydextrose.  
Gene deletions confirm GOS and α-galactosides utilization  
Functional corroboration of the specificity of prebiotic transport loci has been facilitated by their identification using 
differential transcriptomics. We previously confirmed that the GPH-type LacS permease is involved in uptake of β-
galactosides, GOS and lactitol (28). Two associated β-galactosidases were involved (LBA1462, GH42, and LBA1467-68, 
GH2, Figure 3H). The differential expression levels (Figure 1 and Table 2), suggested that GH42 is the main hydrolase for 
GOS degradation in L. acidophilus NCFM. Gene deletions validated both uptake and catabolism for the α-galactosides 
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raffinose, stachyose and melibiose by the locus containing the ABC transport system and GH36 α-galactosidase 
(LBA1437-LBA1442, Figure 3G).  
Distinct PTS systems and GH1 hydrolases mediate utilization of cellobiose and gentiobiose 
Transcriptomics data suggested that the two β-glucoside disaccharide regio-isomers, cellobiose and gentiobiose, only 
differing in the glucosidic linkage are internalized by two different PTS systems and hydrolyzed by two different GH1 
putative 6-phospho-β-glucosidases having 49% overall sequence identity (Figure 3A and 3C). To validate these findings, 
the sequences of the PTS transporters and the GH1 hydrolases were analyzed in silico. The phylogenetic tree 
constructed for the PTS systems showed clear segregation of the cellobiose and the gentiobiose induced PTS systems 
(Figure S3). Notably, the cellobiose induced PTS system clustered together with the functionally characterized cellobiose 
PTS transporter from L. gasseri 33323 that apparently lacks a homolog of the gentiobiose-induced PTS system. Currently 
there is no biochemical characterization of PTS systems with gentiobiose specificity. Similarly, the two GH1 6-phospho-β-
glucosidases from L. acidophilus clustered in two distinct GH1 subgroups, whereas a third subgroup was represented by 
a biochemically and a structurally characterized cellobiose specific GH1 β-1,4-glucosidase (40) (Figure S5). The structure 
of the 6-phospho-β-glucosidase from L. plantarum (PDB: 3QOM, The Midwest Center for Structural Genomics), 
containing a phosphate ion bound in the active site, has the three conserved residues involved in the recognition of the 
phosphate moiety of phosphorylated disaccharide substrates (Figure S6A). This, together with sequence alignments 
(Figure S6A) suggests that the catalytic residues and the phosphate recognition pocket are conserved in LBA0225 and 
LBA0726, together with all amino acid residues defining the pivotal substrate binding subsite –1, where the non-
reducing end 6-phospho-glucosyl residue is bound, are completely conserved (Figure S6B). This is consistent with both 
putative enzymes being catalytically competent and with their induction together with different PTS transporters, 
congruent with their recognition of non-reducing end phosphorylated substrates at the C-6 position. Clear differences, 
however, were observed in amino acid residues of LBA0225 and LBA0726 corresponding to those flanking the putative 
subsite +1 in the structure of the L. plantarum putative 6-phospho-β-glucosidase (Figure S6C), in accordance with the 
specificity differences suggested by the transcriptomics data. A combination of the GH1 structure-function relationship 
(Figure S5 and S6) and phylogenetic analysis of PTS permeases (Figure S3) corroborates the transcriptomics findings 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 94
11 
 
implicating two β-glucoside isomers in the differential upregulation of the two loci (LBA0225-0228 and LBA0724-0726, 
Figure 3A and 3C). Improved annotations of both PTS permeases (34) and GH1 6-phospho-glycosidases have previously 
been limited due to difficulties in working with the transmembrane PTS permeases and the lack of phosphorylated 
substrates for GH1 or GH4 enzymes. In this light, both transcriptomics and site-specific gene deletions will serve as 
powerful tools for further functional characterization. The present data offer an important view of the metabolic 
diversity for L. acidophilus NCFM that is differentiated by the type of transporters, GH families and sub-specificities 
within single GH families. 
Remarkably, the LBA0606-0609 locus encoding a PTS permease, was induced by isomaltose and panose revealing a 
novel pathway for the transport and hydrolysis of short isomaltooligosaccharides, emerging as potential prebiotics (41). 
L. acidophilus NCFM additionally encodes a canonical GH13 subfamily 31 (GH13_31) glucan-α-1,6-glucosidase homolog 
to an enzyme from Streptococcus mutans shown to be more active on isomaltooligosaccharides longer than isomaltose 
(42). However, this locus (LBA0264, GH13_31) was not significantly upregulated in the current study. It is possible that 
this latter enzyme is induced on longer isomaltooligosaccharides, which may be transported via a different route. Such 
size dependent differentiation of the utilization pathway has been reported for maltooligosaccharides in other Gram 
positive bacteria (43). Furthermore, the locus contained a putative protein with no predictable function (LBA0608), 
which was the highest induced gene of the study. Sequence analysis indicated a transmembrane topology potentially 
linking this gene product to the function of the PTS transporter encoded in the locus. 
Comparative genomics of niche specific genes relating to prebiotic utilization 
A previous comparative genomics approach predicted LBA1689 orthologs to be selectively found only in GIT associated 
lactobacilli (44). This would indicate that the identified novel isomaltose catabolism pathway utilizing the novel 
isomaltose-6-phosphate hydrolase LBA1689 to be a potential target for α-1,6-glucoside probiotics (e.g. panose and 
polydextrose) and complementing the conventional route of degradation mediated by the putative α-1,6 glucosidase 
(LBA0264) encoded in the genome of L. acidophilus NCFM.  
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The important potential for GIT adaption of L. acidophilus NCFM by genetic loci encoding specific oligosaccharide 
utilization is further emphasized from genomic comparisons to the phylogenetically related, but milk adapted L. 
helveticus DPC 4571 (45) where loci, identified in the current study, have been lost through evolution and adaption to 
milk fermentation for the following oligosaccharides: gentiobiose, FOS, raffinose, isomaltose and panose. These 
observations underscore how prebiotic stimulation can be considered as a species-specific attribute reflecting 
evolutionary adaptation to nutritionally rich environments, like the GIT, by either gene gain and functional 
diversification, or gene-loss associated genome simplification (15).  
In conclusion, genes involved in the uptake and catabolism of prebiotic compounds by L. acidophilus NCFM were 
identified using differential transcriptomics. This study revealed the extensive ability of L. acidophilus NCFM to utilize a 
diversity of prebiotic compounds, employing a broad range of carbohydrate uptake systems, including ABC, GPH and PTS 
transporters, as well as an expansive repertoire of hydrolases that can readily catabolize α- and β-linked glucosides and 
galactosides.  
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Materials and methods 
 
L. acidophilus NCFM mRNA sample preparation and DNA microarray platform 
Whole genome oligonucleotide microarrays were designed as described by Goh et al. (33) with four replicate spots for 
each of the 1,823 predicted genes. Hybridization quality was assessed as described previously (28). For preparation of 
cultures for the DNA microarray transcriptome analysis, a semi-synthetic medium (SSM, (16) used for cultivation of L. 
acidophilus NCFM was filtered through a 0.22 µm filter and oxygen was removed by the Hungate method (46). L. 
acidophilus NCFM cultures were propagated in parallel in SSM media supplemented with 1% (w/v) of various 
carbohydrates as listed for structure and manufacturer in Table 1. Cultures were transferred for five passages on each 
carbohydrate before harvested at the early logarithmic phase (OD600= 0.35–0.5) by pelleting at 4°C (3,000 x g, 15 min) 
and flash freezing the pellets for storage at -80°C. 
Cells were mechanically disrupted by beadbeating and total RNA isolated using Trizol-chloroform extraction (Invitrogen, 
Carlsbad, CA). Genomic DNA was removed with Turbo DNAse (Ambion, Austin, TX), followed by RNA purification using a 
RNeasy Mini Kit (Qiagen Inc., Valencia, CA) (33). 
Reverse transcription of total RNA, fluorescent labeling of cDNA and hybridizations were performed using 20 µg of total 
RNA for each replicate as described by Goh et al. (33). Total RNA from each carbohydrate treatment was labeled 
with both Cyanine3 and Cyanine5 for two technical dye-swapped replicates to each growth condition, and 
pairwise hybridized using a loop-design for a total of 12 hybridizations. 
Hybridized chips were scanned at 10 µm resolution per pixel using a ScanArray Express microarray scanner 
(Packard BioScience, Meriden, CT) for 16-bit spot intensity quantification. Fluorescent intensities were 
quantified and background-subtracted using the QuantArray 3.0 software package (Packard Bioscience). 
Median values were calculated for all ORFs (Open Reading Frames) using tetraplicate intensities and log2-
transformed before imported into SAS JMP Genomics 4.0 (SAS Institute Inc, Cary, NC) for data analysis. The full 
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data set was interquantile normalized and modeled using a mixed model ANOVA for analysis of the differential 
gene expression pattern, and visualization using heat maps and volcano plots.  
 
Bacterial strains and growth conditions  
All bacterial strains and plasmids used throughout this study are listed in Table 3. Lactobacillus broth cultures 
were cultivated in MRS (Difco Laboratories Inc., Detroit, MI) or semi-defined medium (SDM) (47), 
supplemented with 0.5% (w/v) glucose (Sigma-Aldrich, St. Louis, MO)) or 1% (w/v) sucrose (Sigma), galactose 
(Sigma), melibiose, raffinose (BDH chemicals, Poole, England) and stachyose (Sigma) as carbon sources, in non-
shaking batch cultures, aerobically at 37 °C or 42 °C. Chloramphenicol (Cm, 5 µg/ml) or/and erythromycin (Em, 
2 µg/ml) were used when necessary for selection. Escherichia coli strains were cultivated in Brain Heart 
Infusion medium (Difco) aerobically at 37 °C with aeration, and Em (150 µg/ml) and/or kanamycin (Km, 40 
µl/ml) were/was added for selection. Solid media were prepared by the addition of 1.5% (w/v) agar (Difco). 
 
Construction and phenotypic determination of deletion mutants in the α-galactoside gene cluster 
Genomic DNA of L. acidophilus NCFM was isolated by the method of Walker and Klaenhammer (48) or by the 
Mo Bio Ultraclean microbial DNA isolation kit (Mo Bio Laboratories, Carlsbad, CA). Plasmid DNA from E. coli 
was isolated using a QIAprep Spin miniprep kit (Qiagen). Restriction enzymes (Roche Molecular Biochemicals, 
Indianapolis, IN) were applied according to the instructions supplied by the manufacturer. DNA ligation was 
done using T4 DNA ligase (New England Biolabs, Beverly, MA) as directed by the manufacturers’ 
recommendations. All PCR primers were synthesized by Integrated DNA Technologies (Coralville, IA). PCR 
reactions, preparation and transformation of competent L. acidophilus NCFM and E. coli cells, analysis by 
agarose gel electrophoresis, and in gel purification were done as described by Goh et al. (33). 
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The construction of a Δupp isogenic mutant with in-frame DNA excision of the LBA1438 and LBA1442 coding 
region was done according to Goh et al. (33). In short, the upstream and downstream flanking regions 
(approximate length of 750 bp each) of the deletion targets were PCR-amplified either with the 1438A/1438B 
and 1438C/1438D or 1442A/1442B and 1442C/1442D primer pairs, respectively, and fused by splicing by 
overlap extension PCR (SOE-PCR). The SOE-PCR products were ligated into pTRK935 linearized with compatible 
ends (BamHI and EcoRI for all constructs), and transformed into NCK1831. The resulting recombinant 
plasmids, pTRK1013 and pTRK1014, harbored in NCK2122 and NCK2124, were transformed into NCK1910 
harboring pTRK669, for chromosomal integration and following DNA excision to generate the ΔmelA or 
ΔmsmE genotypes respectively. Confirmation of DNA deletion was done by PCR and DNA sequencing using 
primer pair 1438UP/1438DN and 1442UP/1442DN (see Table S1). 
Carbohydrate utilization of the gene deletion mutants was tested by comparative growth to wild type L. 
acidophilus NCFM and NCK1909 (upp mutant and parent strain of the ΔmelA and ΔmsmEII mutants). All strains 
were grown in SDM supplemented with 1% (w/v) glucose before inoculation (1% (v/v)) of an overnight culture 
into SDM supplemented with 1 % (w/v) of the following carbohydrates in separate batches: raffinose, 
stachyose, sucrose and galactose. Growth was monitored by measuring optical density (OD600) using a Fluostar 
spectrophotometer (BMG Labtech, Cary, NC)) in triplicate wells of a 96-well plate (200 µl per well) covered 
with an airtight seal. 
 
Microarray Data Submission 
All raw data have been deposited in the GEO database under accession GSE35968 (can be provided during 
review) and complies with the MIAME guidelines. 
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Figure 1: Representative volcano plots of the oligosaccharide-induced differential global transcriptome within L. 
acidophilus NCFM. All genes are shown as black dots (·) and all statistically significant upregulated genes involved with 
oligosaccharide metabolism (Table 1) are depicted as white circles (○). 
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Figure 2: Phenotypic characterization of single gene deletions within L. acidophilus NCFM. Growth profiles are shown on 
galactose (A) and raffinose (B and C) for the mutants within the stachyose-induced gene cluster lacking the GH36 α-
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galactosidase ∆LBA1438 (∆) or the solute binding protein component of the ABC transporter ∆LBA1442 (○) compared to 
upp-wildtype (●).  
 
 
Figure 3: Organization of gene clusters encoding upregulated genes by potential prebiotic oligosaccharide stimulation. 
All genes are listed with locus tag number and gene name (PTS permeases are shown with domain name; regulators, 
hypothetical proteins and transposons are abbreviated as reg, hyp. and trans respectively). Gene product functions are 
colored red for glycoside hydrolases, light grey for transcriptional regulators, blue for PTS permease domains, dark grey 
for proteins unrelated to carbohydrate metabolism, green for ABC transporter domains and yellow for the GPH 
permease. All upregulated genes (Table 2) are shown with framed boxes, CRE regulatory sites are represented by arrows 
and predicted rho-independent transcription terminators (49) by stem loops. 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 108
25 
 
 
Figure 4: Reconstructed uptake and catabolic pathways in L. acidophilus NCFM. Proteins are listed by locus tag LBA 
numbers, transporters are colored by class (Figure 3) and glycoside hydrolases are listed with GH family number. The 
Polydextrose fraction transported by the ABC transporter (LBA0502–LBA0505) is uncertain and thus the hydrolytic 
pathway is marked as unknown. The present data outlines the PTS permease LBA0606 (higher level of induction 
compared to LBA0502–LBA0505) and associated hydrolytic pathway, as the main route of Polydextrose utilization by L. 
acidophilus NCFM.  
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Figure S1: Hierarchical two-way clustering of the global gene expression patterns across 1823 genes for all carbohydrate 
growth conditions. Up-regulated genes are shown in red while downregulated genes are shown in blue. 
 
Figure S2: Two-way clustering of identified statistically significant genes involved in carbohydrate utilization listed with 
locus tag LBA numbers. Up-regulated genes are shown in red while downregulated genes are shown in blue. 
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Figure S3: Phylogenetic diversity of β-glucoside specific PTS EIIC domains of L. acidophilus NCFM.  
Clustering of identified L. acidophilus NCFM PTS EIIC domains (highlighted in bold) is visualized by a phylogenetic tree 
where representative sequences are used to illustrate functional segregation. Reference sequences are from L. gasseri 
33323 or PTS EIIC homologs (>50 % amino acid identity) from reference genomes of the human microbiome (50). PTS 
EIIC domain sequences are identified by homology search of the Swiss-prot database (51) and all phylogenetic distances 
were calculated using ClustalW2 (52). All known substrate specificities are given in parentheses, otherwise amino acid 
identity to LBA0227 is stated. Uniprot references: Bacillus subtilis, lichenan (P46317), Geobacillus stearothermophilus, 
cellobiose (Q45400), Bacillus subtilis, mannobiose and cellobiose (O05507), Lactobacillus casei, lactose (P24400), 
Streptococcus mutants, lactose (P50976), Lactococcus lactis, lactose (P23531) and Escherichia coli, N,N’-
diacetylchitobiose (P17334.2). 
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Figure S4: Gene expression levels for highest induced gene (LAB0608) and gene cluster. The locus encoded an α-1,6-
glucoside specific PTS EIIBC (LBA0606), a transcriptional regulator (LBA0607), a putative transporter associated protein 
(LBA0608) and PTS EIIA component (LBA0609) showed consistent high expression of the full locus indicating a functional 
connection of LBA0608 and PTS permease uptake. Values are given as the mean value (○) of the technical replicates 
represented by bars. 
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Figure S5: Phylogenetic relationship of the two identified 6-phospho-β-glucosidases (LBA0225 and LBA0726) compared 
to characterized GH1 enzymes (the Bacillus circulans subsp. alkalophilus β-1,4-glucosidase (gi: 308070788) and L. 
plantarum 6-phospho-β-glucosidase structure (PDB accession: 3QOM)). The 10 closest homologs, all listed by gi-number, 
specie and strain name, were identified for LBA0227, LBA726 and the cellobiose specific Bacillus circulans subsp. 
alkalophilus β-1,4-glucosidase by BLAST searching against the non-redundant database (53) and all phylogenetic 
distances were calculated using ClustalW2 (52). Distinct clustering even of related taxa was observed reflecting 
differential substrate specificity for cluster (A) proposed to be gentiobiose-6-phosphate specific with LBA0227 
highlighted in bold, (B) cellobiose specific as represented by Bacillus circulans subsp. alkalophilus β-1,4-glucosidase and 
(C) proposed to be cellobiose-6-phosphate specific with LBA0726 highlighted in bold. 
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Figure S6: Functionally pivotal residues in 6-phospho-β-glucosidases of GH1. (A) The selected segments of the multi-
sequence alignment used to construct the phylogenetic tree (Figure S5 cluster A and C), showing conserved and variable 
putative substrate interacting residues of LBA0225 and LBA0726. Conserved residues of the –1 subsite are marked with 
green, the catalytic acid/base (E180) and nucleophile (E375) are marked with purple, the putative +1 subsite is marked 
with cyan and the residues that recognize the phosphate moiety in the phosphate binding pocket are marked with grey. 
All numbering corresponds to the L. plantarum 6-phospho-β-glucosidase structure (PDB accession: 3QOM) as reference, 
also used to depict functionally important residues in 6-phospho-β-glucosidases of GH1; (B) highly conserved active site 
residues are colored as in (A) and shown in sticks. (C) A surface representation of the active site (40% transparency) 
showing (cyan sticks) the proposed putative subsite +1 specificity determinants distinguishing 6-phospho-β-1,6-
glucosides represented by LBA0227, from 6-phospho-β-1,4-glucosides represented by LBA0725. The catalytic residues 
are surface colored in purple to denote the position of the –1 subsite. Pymol was used for molecular rendering (The 
PyMOL Molecular Graphics System, Version 1.3, Schrödinger, LLC.)  
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Tables: 
Table 1: List of carbohydrates used in this study.  
Carbohydrate Structure1 Carbohydrate 
linkage family 
DP 2 Manufacturer or 
supplier 
Purity (as given by 
manufacturer or 
supplier) 
Glucose Glcp - 1 Sigma > 99 % 
GOS [β-D-Galp-(1–4)]n-D-Glcp β-galactoside 2–6 Dupont > 94 % DP ≥ 2 
Lactitol 
β-D-Galp-(1–4)-D-Glc-ol 
β-galactoside 2 Dupont > 99 % 
Cellobiose β-D-Glcp-(1–4)-D-Glcp β-glucoside 2 Fluka AG > 99 % 
Gentiobiose3 β-D-Glcp-(1–6)-D-Glcp β-glucoside 2 Sigma  > 98 %  
β-glucan oligomers  [β-D-Glcp-(1–4)]m-β-D-
Glcp-(1–3)-β-D-Glcp-[β-D-
(1–4)-Glcp]o 
β-glucoside DP ≥ 2 Biovelop AB 
(Sweden) 
Essentially free of 
monosaccharides 
and cellobiose4 
Raffinose α-D-Galp-(1–6)-D-Glcp-
(α1,β2)-D-Fruf 
α-galactoside 3 Sigma > 99 % 
Stachyose [α-D-Galp-(1–6)]2-D-Glcp-
(α1,β2)-D- 
Fruf 
α-galactoside 4 Sigma > 98 % 
Isomaltose α-D-Glcp-(1–6)-D-Glcp α-glucoside 2 Sigma-Aldrich > 98 % 
Isomaltulose α-D-Glcp-(1–6)-D-Fruf α-glucoside 2 Dupont > 99 % 
Panose α-D-Glcp(1–6)-α-D-
Glcp(1–4)-D-Glcp 
α-glucoside 3 Sigma > 98 % 
Polydextrose5 Primarily mixed α-
glucans, reduced ends 
α-glucoside 2–30  Dupont Essentially free of 
monosaccharides 
 
Footnotes: 
1 n= [1–5], m=[0–2] and o=[0–3], ‘n’ is based on oligosaccharide product range of transglycosylation for GOS synthesis as 
previously described (27). ‘m’ and ‘o’ are predicted ranges from the theoretical β-glucan repeating polymeric structure 
and the enzyme used for partial hydrolysis of β-glucan. 
2 Degree of polymerization 
3 Isomaltose free, in-house HPAEC-PAD analysis. 
4 In-house HPAEC-PAD analysis 
5 Polydextrose Litesse® Ultra (Dupont) 
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Table 2: Statistically significant upregulated genes involved in carbohydrate uptake and catabolism. The genes are listed by ascending locus tag 
numbers. Only the oligosaccharide that elicited the highest induction level is listed for genes that are upregulated by more than one 
oligosaccharide.  
ORF 
Gene cluster 
identifier1 
Gene product annotation 
Highest inducing 
oligosaccharide 
Inducing 
linkage type2 
Volcano plot 
(Figure 2) 
Fold 
upregulated 
-log10 
(P-value) 
227 A PTS, EIIC Gentiobiose β-glc 2E 9.3 5.48 
505 F β-fructosidase (bfrA), EC 3.2.1.26, GH32 Polydextrose α-glc 2B 7.9 5.55 
506 F ATP-binding protein (msmK) Polydextrose α-glc 2B 11.7 6.75 
606 B PTS permease, EIIBC Polydextrose α-glc 2B 81.6 6.23 
607 B Transcriptional regulator, RpiR family Polydextrose α-glc 2B 36.9 5.14 
608 B Putative transporter accessory protein Polydextrose α-glc 2B 103.3 8.18 
609 B PTS, EIIA Polydextrose α-glc 2B 19.9 7.06 
724 C Transcriptional regulator, LicT family Cellobiose β-glc 2C 6.1 4.86 
725 C PTS, EIIC Cellobiose β-glc 2C 66.0 6.33 
876 D PTS, EIIB β-glucan oligomers β-glc 2F 27.1 7.97 
877 D PTS, EIIA Cellobiose β-glc 2C 7.6 5.42 
884 E PTS, EIIC Cellobiose β-glc 2C 6.4 5.42 
1438 G α-galactosidase (melA), EC 3.2.1.22, GH36 Stachyose α-gal 2E 30.1 5.31 
1439 G ABC, ATP-binding protein (msmKII) Stachyose α-gal 2E 31.2 5.99 
1441 G ABC, transmembrane permease (msmFII) Stachyose α-gal 2E 9.3 4.58 
1442 G ABC, substrate-binding protein (msmEII) Stachyose α-gal 2E 35.9 8.67 
1460 H Putative mucus binding protein (mucBP) Lactitol β-gal 2C 11.4 5.59 
1461 H Transcriptional regulator, TetR family GOS β-gal 2B 25.5 6.46 
1462 H β-galactosidase (lacA), EC 3.2.1.23, GH42 Lactitol β-gal 2C 64.0 9.89 
1463 H Lactose permease (lacS) Lactitol β-gal 2C 38.2 7.84 
1467 H β-galactosidase large subunit (lacL), EC 3.2.1.23, GH2 GOS β-gal 2B 24.6 8.06 
1684 NA PTS, EIIA Polydextrose α-glc 2B 11.7 6.19 
1689 NA Maltose-6-P glucosidase (malH), EC 3.2.1.122, GH4 Isomaltulose α-glc 2D 65.9 6.26 
1870 NA Maltose phosphorylase (malP), EC 2.4.1.8, GH65 Polydextrose α-glc 2B 28.8 5.01 
 
1 Genes not assigned a gene cluster (Figure 3) are listed as not assigned (NA). 
2 The predominant glycosidic linkage types have been abbreviated as: α-galactosides (α-gal), α-glucosides (α-glc), β-galactosides (β-gal) and β-
glucosides (β-glc).  
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Table 3: Strains and plasmids used in the study 
Strain or plasmid Characteristics Reference or 
source 
E. coli strains   
 NCK1831 EC101: RepA+ JM101; Kmr; repA from pWV01 
integrated in chromosome; host for pORI-based 
plasmids 
(54) 
 NCK1911 NCK1831 harboring pTRK935  (33) 
 NCK2122 NCK1831 harboring pTRK1013 This study 
 NCK2124 NCK1831 harboring pTRK1014 This study 
L. acidophilus strains   
 NCFM Human intestinal isolate (26) 
 NCK1909 NCFM carrying a 315 bp in-frame deletion in the 
upp gene 
(33) 
 NCK1910 NCK1909 harboring pTRK669, host for pORI-based 
counter selective integration vector 
(33) 
 NCK2123 NCK1909 carrying a 2029 bp in-frame deletion in 
the melA gene 
This study 
 NCK2125 NCK1909 carrying a 1141 bp in-frame deletion in 
the msmE gene 
This study 
Plasmids   
 pTRK669 Ori (pWV01], Cmr RepA+ (55) 
 pTRK935 pORI28 derived with an inserted upp expression 
cassette and lacZ´ from pUC19, serves as 
counterselective integration vector, Emr 
(33) 
 pTRK1013 pTRK935 with a mutated copy of melA cloned into 
BamHI/EcoRI sites 
This study 
 pTRK1014 pTRK935 with a mutated copy of msmEII cloned 
into BamHI/EcoRI sites 
This study 
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Table S1: Primers used for construction of gene deletion mutants. Restriction sites are highlighted in bold and 
underlined. 
LBA1438 upstream flanking region 
 1438A CGCGGATCCCGAACCACTATCCAACCTTGA 
 1438B CCACCATCTTCAATAGAAAGC 
LBA1438 downstream flanking region 
 1438C GCTTTCTATTGAAGATGGTGGACCTTGGCTTTTATGATCCTATTG 
 14383D CCGGAATTCCCCAAATTTCTGGCTCTACAA 
LBA1438 DNA excision control 
 1438UP CACCAAAGTAGGCGATACTGAA 
 1438DN ACAGCCCCCTTCAAGTCTTC 
LBA1442 upstream flanking region 
 1442A CGCGGATCCTTGATGCAAGTAACGCTGAGA 
 1442B GTAGCCATCATGACTCCAATTAG 
LBA1442 downstream flanking region 
 1442C CTAATTGGAGTCATGATGGCTACGGTAATAAACAACAAATGGTTAATG 
 1442D CCGGAATTCGGGAGTTCAATCTTCCAGAAA 
LBA1442 DNA excision control 
 1442UP AAGGCCAAATGACAATAATGC 
 1442DN GCACCTTGAACTAATGGGAAA 
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6.2 Mapping the uptake and catabolic pathways of prebiotic utilization 
in Bifidobacterium animalis subsp. lactis Bl-04 by differential 
transcriptomics 
 
In preparation for BMC genomics.
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Abstract (BMC genomics max 300 words – currently 225)  
 
Background: Probiotic bifidobacteria in combination with carbohydrate prebiotics have documented positive 
effects on human health regarding gastrointestinal disorders and improved immunity, however the routes of 
uptake remains unknown for most candidate prebiotics. Differential transcriptomics of Bifidobacterium animalis 
subsp. lactis Bl-04, induced by 11 potential prebiotic oligosaccharides was analyzed to identify the genetic loci 
for uptake and catabolism conferring utilization of the applied α- and β-linked hexoses, and β-xylosides. 
Results: The global transcriptome was found to be modulated dependent of the utilized type of glycoside 
(galactoside, glucoside or xyloside). Carbohydrate transporters of the Major Facilitator superfamily (induced by: 
gentiobiose and galacto-oligosaccharides) and ATP-binding cassette transporters (upregulated by: cellobiose, β-
galacto-oligosaccharides, isomaltose, maltrotriose, melibiose, panose, raffinose, stachyose, xylobiose and β-xylo-
oligosaccharides) were differentially upregulated together with glycoside hydrolases from families 1, 2, 13, 36, 
42, 43 and 77. Sequence analysis of the identified ABC transporter’s solute binding proteins revealed patterns to 
the broadness and selective prebiotic utilization of bifidobacteria, which currently is a limiting factor to 
formulate and document novel prebiotics and synbiotics. 
Conclusion: This study identifies and emphasizes the extensive capabilities of Bifidobacterium animalis subsp. 
lactis Bl-04 to utilize oligosaccharide potential prebiotics. ATP-binding cassette transporters are further 
emphasized to be involved in prebiotic utilization with dedicated glycoside hydrolases. The identified genetic loci 
will assist the further substantiation of gene clusters conferring selective utilization of prebiotic by probiotic 
organisms. 
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Background 
Health-promoting microbes, defined as probiotics (1), have gained increased interest for improvement of human 
health through clinical studies. Research has shown bifidobacteria to be an important genus for probiotic 
interventions (2, 3). The areas of beneficial intervention applying bifidobacteria include among others 
prevention of necrotizing enterocolitis in infants (4), treatment of Crohn’s disease (5) and immune functions in 
elderly (6). Understanding of the mechanism of actions underlying the probiotic character of bifidobacteria on 
the molecular level is mainly restricted to functional extrapolation from genome sequencing (7). To date, 53 
bifidobacterium genomes have been deposited publicly and comparative analysis have shown the genetic 
diversity of bifidobacteria (8), leading to identification of genetic loci for colon adaption and colonization by host 
mucin degradation in B. bifidum (9) and foraging of dietary carbohydrates (10). 
Enhancement of probiotic activity within the gastrointestinal tract has been observed by supplementing 
selectively utilizable carbohydrates (11), defined as prebiotics (12). Prebiotics are dietary non-digestible 
nutrients, dominantly carbohydrates, resistant to the host digestive system and main commensal microbiome 
residing in the colon. To date, only a few carbohydrates have been documented as prebiotics, namely: β-galacto-
oligosaccharides, lactulose, fructo-oligosaccharides and inulin (13). Novel candidate prebiotics have been 
proposed primarily based on in vitro methodology, hence making more studies needed to fully document them 
as prebiotics being selectively utilized in the GIT (14, 15). The complex glycoside and linkage composition of 
prebiotics require broad uptake and hydrolytic pathways which have been proposed in silico within 
bifidobacteria (16, 17). Functional insight into proteins conferring the prebiotic uptake and catabolism rely 
mainly on the gene annotations failing to depict potentially novel pathways and sequence differences 
determining the prebiotic selectiveness of bifidobacteria. 
Bifidobacterium animalis subsp. lactis Bl-04 (B. lactis Bl-04) is a member of the animalis cluster of bifidobacteria 
(18) and has documented positive effects as a probiotic in clinical interventions (19, 20), and when 
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supplemented as a synbiotic combination with certain prebiotics (21). The genome sequence of B. lactis Bl-04 
extended the insight of putative probiotic abilities, revealing the bacterium to be highly GIT adapted with 
particular regards to utilization of dietary derived potential prebiotics (22), although in silico analysis precludes 
the broadness of substrate variety. This important knowledge could lead to improve understanding of B. lactis 
Bl-04 for applied use (23), and for design for novel prebiotics selectively stimulating probiotic bifidobacteria. 
In the present study, we used differential transcriptomics to identify genetic loci encoding uptake and hydrolytic 
pathways for potential prebiotics manifested by 11 structurally diverse galactosides, glucosides and xylosides 
within B. animalis subsp. lactis Bl-04. This work validates and expands tentative in silico predictions of 
oligosaccharide transporters and specificities of glycoside hydrolases while leading to functional understanding 
of pre- and probiotic interactions and sets the stage for functional understanding of prebiotic utilization within 
bifidobacteria. 
 
Results 
Oligosaccharide induced global transcriptome profile of B. lactis BL-04 
Global gene expression profiles were obtained for B. lactis Bl-04, exponentially growing on 11 potential 
prebiotics oligosaccharides (Table 1) and glucose representing α-galactosides (melibiose, raffinose and 
stachyose), β-galacto-oligosaccharides (GOS), α-glucosides (isomaltose, maltotriose and panose), β-glucosides 
(cellobiose and gentiobiose) and β-xylosides (xylobiose and xylo-oligosaccharides (XOS)). The gene expression 
intensities were quantified by whole genome DNA microarrays showing an overall comparable gene expression 
profile and high technical reproducibility (Figure 1) with only a subset of genes being upregulated differentially 
to each oligosaccharide although a slight deviation of the GOS and xylobiose samples was observed. The 10% of 
the highest constitutively expressed genes for all carbohydrates treatments (163 genes) were assigned clusters 
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of orthologous Groups (COG) categories (24) revealing the main cellular functions of cell growth and energy 
turn-over (Figure 1). Notably within these genes (listed by B. lactis Bl-04 locus tag numbers) were putative 
functions involved with fibronectin adhesion (Balac_1484-1485), host plasminogen interactions (Balac_1017 and 
Balac_1557), Phage immunity (25) (Balac_1305), bile-salt hydrolysis and peroxide reduction (Balac_0863 and 
0865) and oligosaccharide ABC transporter facilitated uptake by a solute binding protein (Balac_1565) and ATP 
binding protein associated with oligosaccharide uptake (Balac_1610). All highlighting molecular functions related 
to probiotics mechanisms in B. animalis as previously suggested (26). 
Table 1 
Figure 1  
 
Notably functional grouping of the global gene expression was observed based on the type of glycoside utilized 
(galactosides, glucosides or xylosides) from principal component analysis (Figure 2). This depicted a clear 
differentiation of the global transcriptome based on the type of glycoside utilized indicating how potential 
prebiotics can affect the global transcriptome and hence physiological functions in B. lactis Bl-04. In comparison, 
single gene clusters, differentially upregulated by specific carbohydrates, were observed in the heat map 
representation of the global gene expression profile (Figure 1) illustrating the specificity of the transcriptional 
response of carbohydrate utilization genes as compared to the differential global gene expression by a specific 
carbohydrates.  
Figure 2 
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Differentially upregulated genes conferring prebiotic utilization 
Analysis of the differential upregulation of specific genes mediating prebiotic utilization was done by one-way 
analysis of variance (ANOVA) and visualized by volcano plots (Figure 3) to identify statistically significant genes 
(cut off: p-value < 10-8,04) upregulated to each carbohydrate. An average of 56 genes was more than 2-fold 
differentially upregulated and above the statistical threshold for each pairwise comparison. Analysis revealed 
how subsets of genes involved with oligosaccharide utilization were consistently differentially expressed 
throughout the ANOVA (Table 2, and Figure 4 for real time quantitative-PCR validation of selected genes). This 
led to reconstruction of six putative gene clusters were based on the differential upregulation of specific genes 
to specific oligosaccharide treatments. Thus linking gene clusters encoding a transporter and glycoside 
hydrolase(s) to the uptake and degradation of substrates differing in the degree of polymerization or 
monosaccharide composition. 
Figure 3 
Table 2 
Figure 4 
Moreover, the relative induction of gene clusters involved in carbohydrate uptake and catabolism (Figure 5) 
evidently supports the identification of the differential specificities of upregulated proteins involved with 
prebiotics utilization.  
Figure 5 
Gene cluster analysis and functional assignment 
Sequence analysis of the differentially upregulated loci identified in the uptake and hydrolysis of prebiotic 
oligosaccharides was done to reconstruct six functional gene clusters predicted to be fundamental components 
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for prebiotic utilization (Figure 6A-F). Notably, transport of prebiotics was facilitated either by Major Facilitator 
Superfamily (MFS) or ATP binding cassette (ABC) types of transporters co-encoded with one of more glycoside 
hydrolases of varying glycoside hydrolase (GH) families (27) as a shared structural genomic element essential for 
prebiotic utilization. 
 Figure 6 
Gene cluster A, differentially up-regulated by gentiobiose, encoded an MFS class transporter, having only 25 % 
amino acid sequence identity to the closest characterized homolog, being a sucrose permease from Arabidopsis 
thaliana (uniprot: Q9FG00), and an intracellular GH42 putative β-galactosidase, as predicted by SignalP4.0 (28). 
Interestingly, GH42 enzymes have only been reported active on β-galactoside linkages (29) suggesting a novel 
specificity of GH42 for the β-glucoside gentiobiose.  
A similar gene organization was observed for cluster B, induced by GOS, encoding a GH2 β-galactosidase and an 
MFS class transporter with homology to a lactose transporter in B. longum NCC2705 (30). Likewise cluster C was 
upregulated by GOS and encoded a heterodimeric ABC transporter permease, a solute binding protein and a 
GH42 putative β-galactosidase, indicating functional divergence of GH42 enzymes within B. lactis Bl-04. 
Xylobiose and XOS induced locus D encoding an ABC transporter and one putative β-xylosidase (Balac_0517) and 
two putative arabinofuranosidases (Balac_0512 and Balac_0520) all three belonging to GH43 and annotated by 
homology to previously characterized GH43 enzymes (31, 32) suggesting that this gene cluster mediates the 
transport and hydrolysis of XOS or arabino-xylooligosacchardies into to α-L-arabinofuranose and β-D-
xylopyranose for isomerization and phosphorylation into xylulose-5-phosphate for entry into the bifid-shunt 
(33). Notably also two putative carbohydrate-esterases (Balac_0518 and Balac_0519) were upregulated 
indicating an additional functionality to process acetylated xylan fragments. 
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Cluster E showed structural resemblance to a previously identified maltose operons from B. longum NCC2705 
but differing by the encoded GH13 glycoside hydrolases from those gene clusters identified previously (34-36).  
A multiple sugar metabolism ABC transporter was identified in cluster F and was induced by both the raffinose 
family oligosaccharides (RFO) melibiose, raffinose and stachyose representing α-1,6 linked galactosides and 
isomaltose together with panose representing α-1,6 linked glucosides. As expected, a GH36 α-galactosidase 
belonging to subfamily I within GH36 conferred the hydrolysis of the transported α-1,6 linked galactosides (37), 
while a GH13 oligo-α-1,6-glucosidase was responsible for the hydrolysis of α-1,6 linked glucosides. B. lactis Bl-04 
encoded a total of three GH36 yet the remaining two (Balac_1537 and Balac_1596) were not found to be 
differentially expressed, indicating alternative functionalities. 
In summary, all proposed pathways deduced from the identified gene clusters are shown in figure 7, where 
potential prebiotic oligosaccharides are internalized and hydrolyzed into products that can readily be further 
metabolized by the Bifid shunt pathway (33). Notably, a single putative phosphoketalase gene was encoded in B. 
lactis Bl-04, suggesting how this gene product could phosphorylase both fructose-6P and xylulose-5P as the 
initial step of the bifid shunt, as previously described within B. lactis (38). 
Figure 7 
 
Discussion 
Bifidobacteria have been shown to exert a positive impact on the human gut (39) and may selective utilize 
oligosaccharides of plant derived prebiotics (40). Despite significant advances in bacterial genomics, 
understanding of carbohydrate uptake and catabolism mechanisms remain elusive by poor overall annotation of 
mainly oligosaccharide transporters.  
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The catabolic adaption potential of B. lactis Bl-04 became clear from analysis of the global comparison of 
prebiotic induced gene expression by principal component analysis (figure 2). The changed global gene 
expression by the type of glycoside catabolism (galactoside, glucoside or xyloside) was not influenced by the 
differentially expressed gene clusters involved with prebiotic uptake and catabolism and it is likely that the 
global expressions, induced by carbohydrate source, involves modulation of the metabolic equilibrium within 
the bacterium, as it was observed for B. longum regarding glycoside induced changes in exopolysaccharide 
production (41) and pathogenic prevention by acidification when metabolizing fructose rather than glucose (42), 
showing how the type of glycoside for bifidobacteria can change the overall behavior and potentially probiotic 
functionality in the GIT. Building on this and the importance for selective utilization of oligosaccharides, we 
hypothesized the importance of ABC transporters for prebiotic uptake. Interestingly a sole oligosaccharide ABC 
transporter specific ATP binding protein was found to be constitutively highly expressed suggesting how the 
single ATP binding protein energizes the multiple identified oligosaccharide ABC transporters, as previously 
described (43), for readily adaption for utilization to changes in oligosaccharides availability in the GIT. Likewise, 
various genes encoding proteins linked to proposed probiotic mechanism of actions were found to be highly 
expressed constantly supporting the probiotic and GIT adapted nature of B. lactis Bl-04. 
Analysis of the differentially expressed genes involved with prebiotic utilization of B. lactis Bl-04 revealed 
upregulation of explicit gene clusters under transcriptional regulation, as also observed from previously studies 
of oligosaccharide utilization in probiotic bacteria (30, 44). The uptake of oligosaccharides was facilitated by ABC 
and MFS types of oligosaccharide transporters, by the lack of PTS permeases in the BL04 genome (22), all 
associated with glycoside hydrolases.  
To differentiate the functionality of ABC and MFS transporters, the putative α-helical topology of the membrane 
spanning domains of all predicted oligosaccharide transporters in B. lactis Bl-04 was mapped (Table 3). Notably 
it was found how the gentiobiose specific MFS transporter (Balac_0054) was lacking a transmembrane helix, 
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indicating structural-functional divergence from homologous previously identified MFS permeases (45). 
Furthermore, one permease protein (Balac_1570) constituting part of the maltotriose upregulated ABC 
transporter was found to be N-terminally truncated and lacking two helices implicated in heterodimer-formation 
of the permease domain of the maltose ABC transporter from Escherichia coli (46). Comparison to an additional 
putative B. lactis Bl-04 maltose transporter (Balac_1562 – 1564) and experimentally verified maltose ABC 
transporters (Lactobacillus casei (35) and Streptococcus pneumoniae (47)) showed how they all harbored the 
additional two α-helical domain, indicating the maltotriose ABC transporter (Balac_1569, 1570 and 1572) to 
differ from known maltose ABC transporters by the topology of the permease heterodimer. 
In perspective of oligosaccharide utilization, four of the five in silico annotated ABC transporters (22), were 
found to be differentially upregulated while the last putative maltose ABC transporter was found to be 
constitutively expressed to a comparable level. To elaborate on these findings, and build on the novel 
specificities and broadness proposed for uptake by ABC transporters facilitated by the solute binding proteins, 
determining the specificity of ABC transporters (48). The phylogenetics of the ABC transporters solute binding 
proteins were analyzed and compared them to known protein homologs (Table 5) identified from bifidobacteria 
and pathogenic GIT associated bacteria (figure 8), hence displaying the functional and taxonomical distribution 
of oligosaccharide solute binding proteins. 
Figure 8 
The analysis showed clustering of solute binding proteins identified in the current study with other functionally 
characterized counter parts. Analysis of each subcluster revealed the taxonomical distribution of functional 
protein homologs, reflecting how evolutionary adaptation for uptake of lacto-N-biose within cluster LacN is close 
to exclusively found within bifidobacteria while XOS solute binding protein homologs where dominated by soil 
bacteria and few GIT associated bacteria mainly Actinobacteria, suggesting the XOS utilization of bifidobacteria 
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to oriented towards dietary plant material as a metabolic niche within the GIT benefitting from xylan utilizing 
commensal bacteria (49).  
From the phylogenetic analysis, a subset of maltose ABC transporters were found to have undergone a 
convergent evolution, as suggested above for the maltotriose upregulated ABC transporter (Balac_1569, 1570 
and 1572). Traditional maltose solute binding protein homologs was found to be widespread by the previously 
characterized binding proteins (clusters Mal1-4), where a taxanomical subclustering was observed, yet an 
additional subcluster, Mal5, of maltose binding proteins were identified and represented by the maltotriose 
upregulated binding protein (Balac_1572). Notably the associated transporter was found to be lacking the 
additional two α-helical domain of the permease (Table 3) supporting the proposed convergent nature of this 
type of maltose transport and linking the topological homology to the branches of raffinose and XOS type 
binding proteins (Figure 8).  
Identification of single genes being differentially upregulated by specific oligosaccharides revealed novel protein 
substrate specificities as compared to the initial gene annotation of the hydrolytic capabilities of B. lactic Bl-04 
(22). Interestingly, the observation of a GH42 β-galactosidase being induced by the β-1,6-glucoside gentiobiose 
was intriguing. The GH42 family is only comprised of β-galactosidases so the identification indicates a novel 
specificity of GH42 which is substantiated by low sequences identity (30%) to any characterized GH42. 
Additionally the GH42 was co-induced with a MFS type carbohydrate permease with a weak similarity to a plant 
sucrose permease (50)), suggesting a novel pathway for gentiobiose uptake and catabolism.  
No putative glycoside hydrolase was differentially up-regulated on cellobiose however genome mining of B. 
lactis Bl-04 identified a GH1 β-glucosidase (Balac_0151) being constitutively expressed. The β-glucosidase 
displayed 51% amino acid identity to a GH1 β-glucosidase found to catalyze cellobiose and cellodextrin 
hydrolysis transported by ABC transporter in B. brevis UCC2003 (51) supporting the involvement of the B. lactis 
Bl-04 GH1 for hydrolysis of cellobiose. Furthermore the only transporter differentially up-regulated on cellobiose 
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was the above ABC transporter also up-regulated by maltotriose (Figure 4) indicating a potential dual specificity 
of the transporter indicated to have evolved from multiple sugar metabolism-types of oligosaccharide ABC 
transporters (Figure 8) showing that even without a dedicated cellobiose transporter B. lactis Bl04 was evolve a 
capability to partially transport cellobiose. 
The uptake and catabolism of XOS within bifidobacteria was recently proposed (31, 52). Comparative genomic of 
genes involved with XOS utilization within bifidobacteria (Figure 9) reflected a core gene structure of the XOS 
ABC transporter with a β-1,4-xylosidase (Balac_0517), while the occurrence of arabino-furanosidases and 
xylanases of GH8 and GH120 suggested more specie and strain specific adaption.  
Figure 9. 
Putative oligosaccharide esterases, distantly related to previously identified xylan acetyl esterases (53), were 
found to be upregulated by XOS and xylobiose in B. lactis Bl-04, and conserved among bifidobacteria indicating a 
specialized mechanism for de-esterification of xylan fragments transported into Bifidobacteria suggesting uptake 
of both oligomeric, arabinoside substitued and diversely esterified xylosides. 
The ABC transporter driven uptake of GOS coupled with co-induction of a GH42 showed homology to a B. 
longum NCC2705 gene cluster upregulated by lactose (30). Interestingly this gene cluster diverges from those 
identified for human milk oligosaccharide uptake (54) both by the similarity of the associated SBP (Figure 8, LacN 
vs GOS) and the GH encoded in the gene clusters (GH42 versus GH112), indicating how B. lactis Bl-04 has 
evolved a broad oligosaccharide utilization profile for potential prebiotics.  
In conclusion, the overall global gene expression was found to be dependent of the type of glycoside utilized 
(galactosides, glucosides or xylosides) potentially linking the prebiotic catabolism of the bacteria to the overall 
behavior in the GIT. From the transcriptional analyses we identified the genetic loci within B. lactis Bl-04 
encoding MFS and ABC transporters with co-occurring glycoside hydrolases for utilization of potential prebiotic 
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oligosaccharides of α- and β-linkages and varying glycosides composition. This further establishes B. lactis Bl-04 
as a probiotic bacterium with potential for supplementation with novel prebiotics for increased bifidogenic 
effects.  
Materials and methods 
Culture preparation 
B. animalis subsp. lactis Bl-04 (ATCC SD5219) originally isolated from a human fecal sample (22). Cultures 
prepared for transcriptional analysis were propagated in 0.22 µm filtered LABSEM media (55) pretreated by the 
Hungate method for oxygen removal (56). The media was supplemented with 1% (w/v) of the 12 tested 
carbohydrates (Table 1) and each culture was transferred for five passages, under anaerobic conditions, on each 
carbohydrate before being harvested in the early logarithmic growth phase (OD600=0.3–0.5) by centrifugation at 
4 °C (3.000 g for 15 min) and flash freezing of the cell pellet for storage.  
 
RNA isolation and hybridization setup 
Cells were mechanically disrupted by beadbeating and total RNA isolated using Trizol-chloroform extraction 
(Invitrogen, Carlsbad, CA). Genomic DNA was removed with Turbo DNAse (Ambion, Austin, TX), followed by RNA 
purification using a RNeasy Mini Kit (Qiagen Inc., Valencia, CA) (57). 
Reverse transcription of total RNA, fragmentation and 3’ biotin labeling of cDNA was done using 10 µg of total 
RNA in duplicates for each of the 12 conditions and performed using the Affymetrix GeneChip® system 
(Affymetrix, Santa Clara, CA). Total RNA was reverse transcribed using random primers and SuperScript II 
Reverse Transcriptase (Invitrogen, Carlsbad, California) and purification of cDNA was done using MinElute PCR 
Purification kit using a final elution volume of 12 µL (QIAGEN, Inc., Valencia, CA). Following cDNA fragmentation 
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into 50–100 bp was done using DNase I (GE Healthcare, Waukesha, WI) and biotin-labeling done using GeneChip 
DNA labeling reagent (Affymetrix) and Terminal deoxynucleotidyl transferase (Promega, Madison, WI). 
Labeled cDNA fragments were hybridized at Utah State University using Affymetrix custom-made chips. All 
extracted data was imported into SAS JMP Genomics (SAS Institute Inc, Cary, NC) before being quantile 
normalized and modeled using a one-way ANOVA for identification of differentially upregulated genes using a 
threshold value of α=0.005 and Bonferroni correction.  
 
Real-time quantitative PCR validation of microarray 
Real-time quantitative PCR was performed on five selected genes (Table 3) found to be differentially 
upregulated. The DNAse treated total RNA, identical to the RNA used in microarray sample preparation, was 
used as template for each of the above 12 growth conditions, measured in triplicates. Experiments were 
conducted with a QRT-PCR thermal cycler (I-cycler; Bio-Rad, Hercules, CA) in combination with the QuantiTect 
SYBR Green PCR kit (Qiagen). 
 
Construction of phylogenetic tree of carbohydrate solute binding proteins 
The sequence dataset was compiled from oligosaccharide binding proteins all identified from previous work or 
identified from the current project (Table 5). Sequence homologs for each protein entry was identified by BLAST 
(58) and restricted to either 100 hits or an e-value of 10-3 against the non-redundant database. All redundant 
sequences were removed and the remaining sequences together with a monosaccharide (fructose) binding 
proteins were aligned using ClustalX (59) using the Blosum series substitution matrix and a gap opening penalty 
of 2, compared to the standard penalty of 10. The resulting phylogenetic tree file was visualized using 
Dendroscope (60). Bootstrap values were calculated by ClustalX using standard conditions (1000 iterations). 
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Microarray submission 
All raw data have been deposited in the GEO database and complies with the MIAME guidelines.  
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Figures: 
 
Figure 1: Two-way clustering of the global gene expression profile and COG distribution of constitutively 
expressed genes. Gene expression intensities are represented by red coloring: up-regulation, blue coloring: 
down-regulation. Technical replicates for each carbohydrate are numbered and showed overall high 
reproducibility. The highest expressed decile of the global transcriptome was assigned COG categories, 
highlighting the essential metabolism of B. lactis Bl-04. 
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Figure 2: Principal component analysis of the global transcriptome for B. lactis BL-04 cultivated with potential 
prebiotics showing a profound differentiation of the global gene expression profile depending on the type of 
carbohydrates utilized. Galactosides in red (GOS, melibiose, raffinose, stachyose), glucosides in green 
(cellobiose, Gentiobiose, glucose, maltotriose, isomaltose, panose) and xylosides in blue (XOS, xylobiose). 
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Figure 3: Representative volcano plots of pairwise comparison of oligosaccharide induced differential global 
transcriptome within B. animalis subsp lactis BL-04. All genes are shown by solid grey circles, and putative 
carbohydrate active protein encoding genes being statistically significant up-regulated are highlighted with solid 
circles and color-coded by gene cluster as by table 2. 
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Figure 4: Heatmap representation of rt-qPCR validation of gene expression values. The gene expression value of 
mRNA quantified for each of the five genes to each of the 12 growth conditions have been color-coded as the 
relative fold upregulation to the lowest value measured to each gene: Blue (1-2 fold), light blue (2-4), light red 
(4-8), red (8-16) and strong red (>16). 
 
 
Figure 5: Two-way clustering of the expression profile for genes identified to be differentially upregulated by 
ANOVA. The coloring of each ORF corresponds to the gene cluster of table 2. 
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Figure 6: Organization of differentially expressed gene clusters encoding proteins predicted to be involved with 
prebiotic utilization. Genes are listed with locustag and gene functions are colored as: Glycoside hydrolases in 
red, ABC transporter solute binding proteins (SBP) and permeases (perm) in green, MFS transporters in blue, 
transcriptional regulators (reg) in light grey and hypothetical proteins (hypo), carbohydrate esterases (ester1 
and ester2), xylose isomerase (xyl.iso) and xylulose kinase (xyl.kin) all in dark gray. Short putative nonfunctional 
ORF are highlighted by black triangles. 
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Figure 7: Proposed pathways for oligosaccharide uptake and catabolism in monosaccharides for entry into the 
bifid shunt. Transporters are colored as in figure 5 and all genes are given by their locustag. The schematic 
pathways for glucose (entering as glucose-1P), galactose, fructose (entering as fructose-6P) and xylose are 
shown with the main steps of the bifid shunt. All constitutive highly expressed genes (Figure 1) are denoted with 
an asterix (*). 
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Figure 8: Functional comparison of the identified oligosaccharide solute binding proteins of ABC transporters in 
B. lactis BL-04. The phylogenetic tree was rooted by a characterized fructose binding protein (61) as a functional 
and structural out group of oligosaccharide binding proteins (48). Sub-clusters were defined by bootstrap values 
in percentages and the characterized solute binding protein(s) identified within each sub-cluster where the 
numbers of sequences are listed in brackets. The tree was colored by substrate specificity (maltose binding 
proteins (green), cellodextrins (orange), GOS and lacto-N-biose (blue), XOS (light blue) and raffinose family 
oligosaccharides (red)) and sub-clusters were denoted by numbers as given in table 4. 
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Figure 9: Genomic content and organization of XOS utilization gene clusters identified within bifidobacteria. All 
strains were ordered top down by highest sequence similarity of the XOS binding protein to the XOS binding 
protein of B. lactis Bl-04 (balac_0514). Gene functions are colored as: Glycoside hydrolases (red), XOS ABC 
transporters (green), xylose ABC transporters (light green), transcriptional regulators (light grey), and putative 
XOS esterases, xylose isomerases (xyl.iso), xylulose kinases (xyl.kin) alcohol dehydrogenases (alcohol dehydro.) 
and a putative secreted amidase (lysM) (all dark gray). Short putative nonfunctional ORF are highlighted by black 
triangles. All GH43 enzymes were annotated and differentiated by protein similarity to previously characterized 
xylosidases (xyln) or arabinofuranosidases (arab) together with the GH8 enzyme (31, 32). 
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Tables: 
 
Table 1: Carbohydrates, used for DNA microarray cultures, listed with glycoside structure and type, supplier and purity 
Carbohydrate Structure1 Glycoside type DP 2 Manufacturer 
or supplier 
Purity (as given 
by Manufacturer 
or supplier) 
Glucose Glcp glucoside 1 Sigma > 99% 
GOS [β-D-Galp-(1–4)]n-D-Glcp galactoside 2–6 Dupont > 94% DP ≥ 2 
Melibiose  α-D-Galp-(1–6)- D-Glcp galactoside 2 Sigma > 98% 
Raffinose α-D-Galp-(1–6)- D-Glcp-
(α1,β2)-DFruf 
galactoside 3 Sigma > 99% 
Stachyose [α-D-Galp-(1–6)]2- D-Glcp-
(α1,β2)- D-Fruf 
galactoside 4 Sigma > 98% 
Isomaltose α-D-Glcp-(1–6)-D-Glcp glucoside 2 Sigma > 98% 
Panose α-D-Glcp(1–6)-α-D-Glcp-
(1–4)-D-Glcp 
glucoside 3 Sigma > 98% 
Maltotriose α-D-Glcp-(1–4)-α-D-Glcp-
(1–4)-D-Glcp 
glucoside 3  Dupont > 95% 
Cellobiose β-D-Glcp-(1–4)-D-Glcp glucoside 2 Fluka AG > 99% 
Gentiobiose β-D-Glcp-(1–6)-D-Glcp glucoside 2 Sigma  > 98%  
Xylobiose β- D-xylf-(1–4)- D-xylf xyloside 2 Dupont > 95% 
XOS [β- D-xylf-(1–4)]m-D-xylf xyloside 2-7 Shandong 
Longlive Bio-
technology 
Co., Ltd, 
(China) 
> 90% 3 
1 n=1-5 as previously described (62), m =1-6 as stated by manufacturer 
2 Degree of polymerization 
3 The XOS composition and purity was previously determined (52) 
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Table 2: Statistically significant upregulated genes involved in carbohydrate uptake and catabolism. The genes 
are listed by ascending locus tag numbers. Only the oligosaccharide that elicited the highest induction level is 
listed for genes that are upregulated by more than one oligosaccharide. 
ORF Gene annotation Inducing CHO type 
Volcano plot 
(Figure 3) 
Highest inducing 
CHO 
Gene 
cluster 
(figure 5) 
Fold 
upregulated 
-log10(P-
value) 
Balac_0053 β-galactosidase, GH42 Glucoside C gentiobiose A 6.5 13.8 
Balac_0054 MFS permease Glucoside C gentiobiose A 4.8 11.8 
Balac_0475 MFS permease Galactoside A GOS B 21.8 19.9 
Balac_0476 β-galactosidase, GH2 Galactoside A GOS B 36.9 17.9 
Balac_0484 β-galactosidase, GH42 Galactoside A GOS C 11.4 17.2 
Balac_0485 
ABC transporter, permease 
component 
Galactoside A GOS C 8.4 16.2 
Balac_0486 
ABC transporter, permease 
component 
Galactoside A GOS C 5.7 12.9 
Balac_0511 Xylose isomerase xyloside A,C XOS D 13.8 15.1 
Balac_0512 α-L-arabinofuranosidase, GH43 xyloside A,C XOS D 6.8 13.6 
Balac_0513 Transcriptional regulator (lacI type) xyloside A,C Xylobiose D 3.0 10.1 
Balac_0514 
ABC transporter, oligosaccharide-
binding protein 
xyloside A,C XOS D 9.0 16.0 
Balac_0515 
ABC transporter, permease 
component 
xyloside A,C XOS D 16.8 16.5 
Balac_0516 
ABC transporter, permease 
component 
xyloside A,C XOS D 18.3 17.5 
Balac_0517 β-xylosidase, GH43 xyloside A,C XOS D 17.9 16.1 
Balac_0518 Putative carbohydrate esterase xyloside A,C XOS D 14.2 11.3 
Balac_0519 Esterase xyloside A,C XOS D 6.9 15.1 
Balac_0520 α-L-arabinofuranosidase, GH43 xyloside A,C XOS D 10.2 15.2 
Balac_0521 Xylulose kinase xyloside A,C Xylobiose D 18.2 19.0 
Balac_1567 4-α-glucanotransferase glucoside B,D Maltriose E 9.7 14.5 
Balac_1569 
ABC transporter, permease 
component 
glucoside B,D Cellobiose E 5.2 13.7 
Balac_1570 
ABC transporter, permease 
component 
glucoside B,D Cellobiose E 3.7 15.1 
Balac_1571 Transcriptional regulator (lacI type) glucoside B,D Cellobiose E 3.7 13.1 
Balac_1572 
ABC transporter, oligosaccharide-
binding protein 
glucoside B,D Cellobiose E 3.2 12.1 
Balac_1593 oligo-1,6-α-glucosidase, GH13 
Galactoside, 
Glucoside 
B,D,E Isomaltose F 4.5 14.0 
Balac_1597 
ABC transporter, permease 
component 
Galactoside, 
Glucoside 
B,D,E Raffinose F 14.1 13.9 
Balac_1598 
ABC transporter, permease 
component 
Galactoside, 
Glucoside 
B,D,E Isomaltose F 20.1 18.6 
Balac_1599 
ABC transporter, oligosaccharide-
binding protein 
Galactoside, 
Glucoside 
B,D,E Isomaltose F 17.8 16.7 
Balac_1601 α-galactosidase, GH36 
Galactoside, 
Glucoside 
B,D,E Raffinose F 8.1 16.4 
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Table 3: Prediction of α-helical topology within oligosaccharide transporters identified in B. lactis Bl-04. 
ORF Function Class Predicted TMH1 Sequence length 
(aa) 
0054 Gentiobiose MFS 11 384 
0139 Sucrose (putative) MFS 12 537 
0475 GOS GPH homolog 12 505 
1240 FOS (putative) MFS 12 441 
1588 arabinofuranosides 
(putative) 
GPH homolog 12 481 
0485 GOS ABC 6 326 
0486 GOS ABC 6 322 
0515 XOS ABC 6 352 
0516 XOS ABC 6 289 
1563 Maltose (putative) ABC 6 322 
1564 Maltose (putative) ABC 8 457 
1569 Maltotriose ABC 6 278 
1570 Maltotriose ABC 6 284 
1597 RFO+IMO ABC 6 301 
1598 RFO+IMO ABC 6 330 
1 Transmembrane α-helices (TMH) predicted using the Phobius tool (63) 
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Table 4: Identified clusters of oligosaccharide binding proteins from Figure 7. Clusters are shown by numbers 
and if possible sub-clusters are listed with letters. The experimentally identified oligosaccharide binding proteins 
used to generate the tree are listed in the corresponding cluster and sub-cluster if possible. 
Cluster 
Sub-
cluster 
Substrate specificity Identified Organism Reference 
Malto-
oligosaccharides 
1 
α-(1,4)-gluco-
oligosaccharides 
Listeria monocytogenes 
Streptococcus pneumoniae 
(64) 
(65) 
 2 
β-Cyclodextrin and 
maltose 
Bacillus subtilis  (66) 
 3 Maltose 
L. casei BL23 
 
(35) 
 4 Putative maltose  B. animalis subsp lactis Bl-04 This study 
 5 
Maltose 
Maltotriose 
B. longum NCC2705 
B. animalis subsp lactis Bl-04 
(30) 
This study 
β-glucosides - 
β-(1,4)-gluco-
oligosaccharides 
B. breve UCC2003 (51) 
β-galactosides A 
Lactose 
β-galacto-
oligosaccharides 
B. longum NCC2705 
B. animalis subsp lactis Bl-04 
(30) 
This study 
 B Lacto-N-biose 
B. bifidum 
B. longum 
(67) 
(68) 
XOS - 
β-(1,4)-xylo-
oligosaccharides 
B. animalis subsp lactis Bl-04 This study 
RFO A 
Raffinose and 
isomaltose 
Streptococcus mutans (36) 
 B 
Raffinose 
Raffinose and 
Isomaltose1 
B. longum NCC2705 
B. animalis subsp lactis Bl-04 
(30) 
This study 
Root - Fructose B. longum NCC2705 (61) 
1 Including melibiose, panose and stachyose 
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Table 6: Primer pairs used for real time quantitative PCR.  
ORF Primer 5’ – 3’ Product size (bp) 
0054 
CACACTCGCTCGAGATTC 
140 
AGGCCAATCATGCATACG 
0475 
GCTGACGATGGGAATGAC 
160 
GCTCGACGTGTTCTACTC 
0483 
CGTCGGAGTTCTTGATGG 
142 
CAGGCAGCCTATGACTTC 
0514 
GGCTGACCTTGGATTCTT 
145 
CTTCTCGCCCATGTAGTTG 
1565 
GAACGCCGTAGATCTTGC 
148 
ATGTTCGCCAATGACCAG 
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Probiotic microbes rely on their ability to survive in the gastroin-
testinal tract, adhere to mucosal surfaces, and metabolize avail-
able energy sources from dietary compounds, including prebiotics.
Genome sequencing projects have proposed models for under-
standing prebiotic catabolism, but mechanisms remain to be
elucidated for many prebiotic substrates. Although β-galactooligo-
saccharides (GOS) are documented prebiotic compounds, little is
known about their utilization by lactobacilli. This study aimed to
identify genetic loci in Lactobacillus acidophilus NCFM responsible
for the transport and catabolism of GOS. Whole-genome oligonu-
cleotide microarrays were used to survey the differential global
transcriptome during logarithmic growth of L. acidophilus NCFM
using GOS or glucose as a sole source of carbohydrate. Within the
16.6-kbp gal-lac gene cluster, lacS, a galactoside-pentose-hexuro-
nide permease-encoding gene, was up-regulated 5.1-fold in the
presence of GOS. In addition, two β-galactosidases, LacA and
LacLM, and enzymes in the Leloir pathway were also encoded
by genes within this locus and up-regulated by GOS stimulation.
Generation of a lacS-deﬁcient mutant enabled phenotypic conﬁr-
mation of the functional LacS permease not only for the utilization
of lactose and GOS but also lactitol, suggesting a prominent role of
LacS in the metabolism of a broad range of prebiotic β-galacto-
sides, known to selectively modulate the beneﬁcial gut micro-
biota.
lactose permease | catabolite repression element
Increased interest in the ability of the human microbiota of thegastrointestinal tract (GIT) and selected probiotic microbes to
impact health has been supported by expanded documentation
on resistance to allergies (1), respiratory tract infections (2), and
various gastrointestinal conditions such as ulcerative colitis,
irritable bowel syndrome, and inﬂammatory bowel disease (3).
Research on probiotic bacteria (4) continues to accumulate fur-
ther knowledge about the biological mechanisms of action and
complex interplay between gut microbes and host health.
The functional attributes of gut microbes and those delivered
as probiotics rely on their ability to survive in the GIT, adhere to
mucosal surfaces, and metabolize available energy sources from
nondigestible dietary compounds (5). Notably, the ability to se-
lectively use a broad range of potentially prebiotic carbohydrates
(6), ranging from oligosaccharides to polysaccharides, provides
a competitive advantage to the beneﬁcial microbiota during
colonization of the GIT and to transient probiotic microbes (7).
Prebiotic oligosaccharides are not absorbed by the host and resist
degradation by intestinal acids, bile acids, and digestive enzymes,
allowing them to travel through the small intestine and colon,
where they may be selectively used by beneﬁcial microbes.
Commercial β-galactooligosaccharides (GOS) are typically pro-
duced by enzymatic transglycosylation using lactose as substrate
(8), to yield a mixed-length galactosylated product with a degree
of polymerization (DP) ranging from 2 to 6. The oligomeric
nature and β-galactoside linkages allow GOS to be used as
prebiotic supplements, notably for stimulation of particular lac-
tobacilli and biﬁdobacteria (9, 10). Speciﬁcally, GOS supple-
ments have been shown to exert positive impacts on intestinal
Biﬁdobacterium and Lactobacillus populations in infants (11), to
mitigate irritated bowel syndrome (12), and to reduce the se-
verity and duration of travelers’ diarrhea (13). GOS has also
been shown to inhibit pathogenic Vibrio cholerae and Crono-
bacter sakazakii binding to cell surface receptors of epithelial
cells (14, 15) and prevent adhesion of Salmonella enterica serovar
Typhimurium to murine enterocytes (16).
GOS are acquired naturally through the diet from the degra-
dation of galactan side chains of the rhamnogalacturonan I
fraction of pectin (17) and from human milk oligosaccharides
(HMOs) that are nondigestible by the host (18, 19). HMOs are
hypothesized to promote growth of speciﬁc beneﬁcial bacteria in
the infant’s early GIT colonization (20). Marcobal et al. (21)
veriﬁed that HMOs can support the growth of Lactobacillus
acidophilus NCFM, although the genetic complement of L.
acidophilus NCFM reﬂects a more speciﬁc potential for GOS
metabolism compared with other adapted GIT bacteria (22). L.
acidophilus is a widely used probiotic species, originally isolated
by Moro in 1900 from infant feces. The L. acidophilus NCFM
genome was recently sequenced to reveal that the molecular
machinery responsible for carbohydrate uptake and catabolism in
NCFM accounts for 17% of the genes present in the genome (23).
Broad carbohydrate utilization of L. acidophilus NCFM was
demonstrated and included transporters for trehalose (24), fruc-
tooligosaccharides (25), and several other mono-, di-, and tri-
saccharides (26).
The current understanding of the molecular and genetic basis
for uptake and catabolism of GOS by probiotic lactobacilli is
limited to in silico predictions based on genome sequencing
projects (27). The aim of the present study was to functionally
identify the genetic loci responsible for GOS transport and ca-
tabolism by L. acidophilus NCFM.
Results
GOS-Induced Differential Gene Expression. Global changes in gene
expression levels across the transcriptome were used to identify
genes differentially expressed in L. acidophilus NCFM during
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GOS fermentation in a semisynthetic medium (25). The single
differential gene expression proﬁle is depicted as a two-way
scatter plot showing an overall linear correlation of GOS and
glucose-induced gene expression (Fig. 1A). Notably, a subset of
genes for lactose metabolism (lac genes, shown in white circles)
were up-regulated in the presence of GOS, compared with glu-
cose (the full dataset of the lac genes are reported in Table S1).
Differentially expressed genes of interest were further charac-
terized as statistically relevant (P < 0.01 and induction fold >2)
in a volcano plot (Fig. 1B), conﬁrming GOS induction of the
speciﬁed lac operon (LBA1457–LBA1469). Statistically relevant
genes induced by GOS are listed in Table 1 with annotated
functions of the up-regulated genes. From Table 1, genes en-
coded within the 16.6 kbp lac operon locus were considered to be
potentially involved with GOS metabolism.
The lac gene cluster’s likely involvement in GOS utilization was
consistent with the presence of two β-galactosidase–encoding
genes (lacLM, LBA1467–1468, and lacA, LBA1462) assigned to
the glycoside hydrolase family 2 (GH2) and glycoside hydrolase
family 42 (GH42), respectively, using theCAZy classiﬁcation (28).
Both were predicted to be localized intracellularly using the Sig-
nalP tool (29). Enzymatic activity on β-linked galactosides was
demonstrated previously for both enzymes when expressed
from recombinant constructs in Escherichia coli (30, 31). Fur-
thermore, GH2 and GH42 β-galactosidases were proposed by
Marcobal et al. (21) to be involvedwithdegradation ofHMOs.The
identiﬁed galactoside-pentose-hexuronide (GPH) permease LacS
(LBA1463) showed 83% amino acid sequence identity to the
Lactobacillus helveticus functionally conﬁrmed lactose permease
(32). Two regulatory proteins, LacR (LBA1465), a LacI family
regulator, and a noninduced regulator (LBA1461) with an un-
known homology association, suggest regulation at the trans-
criptional level.
No genetic loci involved with carbohydrate metabolism were
identiﬁed from the list of genes induced by glucose, suggesting
that glucose is transported by the constitutively expressed man-
nose/glucose phospho-enolpyruvate–dependent phosphotrans-
ferase system (PEP-PTS) transporter (LBA0452, LBA0454-
LBA0456), as suggested previously (26). The transcription
analysis indicated that the lac operon in L. acidophilus NCFM is
solely responsible for the metabolism of GOS and potentially
other lactose-derived galactosides, because the gene induction
proﬁle of GOS is comparable to the lactose-induced lac gene
expression pattern (26). It also indicates that regulation occurs
at the transcriptional level, likely depending upon HPr (ptsH,
LBA0639), CcpA (ccpA, LBA0431), and HPrK/P (ptsK, LBA0676),
all of which are encoded in the L. acidophilus NCFM genome
(23) and as previously proposed for carbohydrate utilization in
L. acidophilus NCFM (26).
Analysis of lacS Inactivation. To investigate the potential in-
volvement of the identiﬁed GPH permease LacS in GOS uptake,
we inactivated the lacS gene using a upp-based counterselective
gene replacement system (33), to create an in-frame deletion of
96% of the lacS coding region. The gene deletion had no de-
tectable impact on cell morphology, growth in de Man, Rogosa,
and Sharpe medium (MRS) or semi-deﬁned medium (SDM)
Fig. 1. Differential gene expression proﬁle of GOS vs. glucose utilization by
L. acidophilus NCFM. Genes involved in lactose metabolism are highlighted
by open circles. (A) XY scatter plot of the overall normalized logarithmic
gene expression proﬁle. (B) Comparison of the statistical signiﬁcance and
gene expression differences of GOS (Right) vs. glucose (Left) depicted as
a volcano plot. The x axis represents the differential gene induction proﬁle
as the ratio of fold difference. The y axis indicates statistical signiﬁcance of
expression difference (P value from ANOVA).
Table 1. Differentially expressed genes in L. acidophilus NCFM
identiﬁed by DNA microarrays of cells grown in GOS or glucose
Locus tag Gene annotation
Fold up-
regulation
P
value
GOS-induced genes
1467 β-galactosidase, large
subunit, GH2
6.23 0.0007
1463 Lactose permease 5.10 0.0016
1462 β-galactosidase, GH42 4.79 0.0023
1459 Galactokinase 4.53 0.0038
1469 UDP-galactose-4-
epimerase
3.82 0.0051
152 Phosphonate transport
system ATP-binding
protein
3.23 0.0017
1458 Galactose-1-phosphate
uridylyltransferase
2.76 0.0067
1622 S-adenosylmethionine
synthetase
2.73 0.0064
965 Hypothetical protein 2.65 0.0049
1952 Putative xanthine-uracil
permease
2.29 0.0015
968 30S ribosomal protein 2.29 0.0010
Glucose-induced genes
1429 Bile efﬂux transporter 2.50 0.0002
424 Conserved hypothetical
protein
2.12 0.0054
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using glucose (Fig. 2A), sucrose, or galactose as sole carbohy-
drates, suggesting that the functionality of lacS is nonessential
for transport of monosaccharides during batch growth. Growth
of the ΔlacS mutant was signiﬁcantly impaired on lactose (Fig.
2B), conﬁrming the annotation to previously validated lacS
homologs and the previous ﬁndings of lactose induction of lacS
together with the remaining lac genes (26). More signiﬁcantly,
the utilization of GOS (Fig. 2C), as well as lactitol, another ga-
lactoside prebiotic (34), was also abolished, showing a divergent
and broader substrate speciﬁcity for GOS, including GOS with
a higher degree of polymerization. The identiﬁcation of a broad
speciﬁcity transporter combined with the up-regulation of genes
encoding two different β-galactosidases based on DNA micro-
arrays illustrates a strong niche adaption by an evolved GPH
β-galactosaccharide transporter.
Complete inhibition of growth by a single gene excision con-
ﬁrmed the hypothesis that the LacS permease was solely res-
ponsible for the transport of GOS in L. acidophilus NCFM and
that no PEP-PTS or ATP-binding cassette (ABC) transporter
systems were involved in this process. This ﬁnding indicates that
the molecular basis for GOS transport and catabolism in other
lactobacilli may also rely on GPH transporters and intracellular
enzymatic hydrolysis by β-galactosidases from the GH2 and
GH42 families before entering the Leloir and glycolysis pathways.
Sequence Analysis of GOS-Induced Gene Cluster. Additional genes
surrounding the lacS permease and β-galactosidases were an-
notated in the genome with functions related to lactose and GOS
metabolism, indicating a potential polycistronic operon structure
for cotranscriptions of 12 genes (Fig. 3). Terminator sites and
regulatory catabolite repression element (CRE) sequences were
analyzed in silico.
The Leloir pathway genes galM, galT, galK, and galE were
found with putative CRE sites, having palindromic homology
to the CRE site of the L. helveticus lactose operon (32), yet
markedly different from other lac CRE sites in L. acidophilus
NCFM, indicating that these genes can be transcribed in-
dependently of the lac genes when only galactose is present. The
lacS, lacA, and lacLM were all found to be under catabolite re-
pression with two of these CRE sites showing homology to a
CRE site found upstream of the scrB gene encoding a sucrose
hydrolase in L. acidophilus NCFM (25). Notably, a CRE site with
homology to the lacR CRE site was identiﬁed upstream of the
mucBP, indicating cotranscription of mucBP simultaneously with
the lac genes.
Sequence analysis of LacS predicts a two-domain structure
with an N-terminal GPH permease and a C-terminal EIIA-like
domain, homologous to the enzyme IIA (EIIA) of the PEP-PTS
phosphorylation regulation by histidine-containing phospho-
carrier protein (HPR) and enzyme I (EI). This indicates rapid
regulation of lactose and related galactoside transport by lacS on
transcriptional level in direct response to a decrease in glucose
concentration. The gene locus organization differs from other
characterized LacS uptake systems such as in Lactobacillus bul-
garicus (35), Leuconostoc lactis (36), Streptococcus thermophilus
SMQ-301 (37), and other Lactobacillus species (e.g., Lactoba-
cillus plantarum, Lactobacillus johnsonii, and Lactobacillus reu-
teri) (Fig. S1). The differences in gene arrangement and in the
types of encoded glycoside hydrolases reﬂect a speciﬁc adapta-
tion of the varied species of lactic acid bacteria toward a varied
β-galactosaccharide metabolism.
Phylogenetic relationships of the above LacS amino acid
sequences (Fig. 4A) compared with the overall phylogenetic sim-
ilarity of lactobacilli based on 16S rRNA homologies (38) dem-
onstrates, ﬁrst, how most lacS positive strains are associated with
GIT colonization; and second, that the diversity of gene sequences
and locus structure follow the evolutionary direction in all but
Lactobacillus delbrueckii subsp. bulgaricus ATCC 11842 (39).
The gene locus organization and LacS sequence homology sug-
gest that the speciﬁc locus originated by recent gene transfer from
an unrelated precursor, possibly from within a dairy environment.
Interestingly, it is observed that lacS genes from lactobacilli are
present in the loci together with GH42 β-galactosidases for all but
L. delbrueckii subsp. bulgaricusATCC 11842, which harbors a lacZ-
GH2 family enzyme. The phylogenetic tree of identiﬁed GH42
Fig. 2. Phenotype determination of lacS deﬁcient mutant (▲) of L. acid-
ophilus NCFM compared with wild type (•). (A) Growth proﬁle on glucose;
(B) growth proﬁle on lactose; (C) growth proﬁle on GOS.
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β-galactosidases, lacA, encoded within lacS-containing loci, re-
vealed no marked difference from the tree structure in Fig. 4A,
indicating the coevolution of LacS with GH42 β-galactosidases
(Fig. 4B).
Recently available human GIT microbiome sequencing data
from theHumanMicrobiome Project (40) was used to validate the
presence of the LacS permease and associated β-galactosidases in
the humanGITmicrobiota by BLAST analysis (41). Both lacS and
GH42 lacA genes were identiﬁed with robust statistical signiﬁ-
cance (threshold e-value <10−15) in L. acidophilus, L. helveticus,
Lactobacillus ultunensis, and L. reuteri strains from a current total
of 29 Lactobacillus reference genomes.
Discussion
The ability of GOS to selectively promote the growth of selected
GIT microbiota further establishes this prebiotic as an attractive
nutritional ingredient for foods and dietary supplements. Stim-
ulation of Biﬁdobacterium and Lactobacillus species by prebiotic
oligosaccharides, including GOS, is well documented by obser-
vational studies (13, 42–44). Despite this, only a few studies have
conﬁrmed the lactobacilli enrichment by GOS on the strain level
(45). In the present study we aimed to identify molecular ele-
ments linked to the selective GOS metabolism within Lactoba-
cillus to explain in vivo observations of GOS stimulation within
the GIT. Whole-genome DNA microarray analysis was per-
formed to differentiate the gene expression pattern of L. acid-
ophilus NCFM in the presence of GOS compared with glucose as
the sole carbohydrate source. It was found that GOS speciﬁcally
induced a cluster of genes encoding intracellular proteins in-
volved with galactose and lactose metabolism, notably a LacS
permease implicated in GOS transport. The GOS-induced gene
cluster was previously identiﬁed to be up-regulated by both lac-
tose and bile acids (26, 46), validating a role in metabolism of
lactose-derived GOS and suggesting an adaptive combination of
GIT-evolved traits for energy metabolism and bile tolerance.
The environment-adaptive nature of L. acidophilus NCFM and
the broad speciﬁcity of the LacS permease show the potential for
delivery of L. acidophilus NCFM in dairy-based synbiotic GOS
products, whereby a culture prefermented on lactose will rapidly
metabolize GOS for increased viability upon exposure in the gut.
This study considered multiple genome sequences of lactose-
fermenting lactobacilli to reveal operons encoding either a LacS
permease or a PEP-PTS transporter for lactose uptake. Pathway
reconstruction positioned these transporters adjacent to β-gal-
actosidases or phospho-β-galactosidases, respectively. However,
prediction of potential GOS PEP-PTS transporters was troubled
by low sequence similarity to known PEP-PTS transporters
families (47). Experimental validation of LacS permease as sole
transporter of GOS in L. acidophilus NCFM was performed by
gene deletion, which eliminated the ability to use lactose, GOS,
and lactitol. This serves as the ﬁrst identiﬁed GOS transporter in
the Lactobacillus genus and is the ﬁrst evidence that the LacS
permease is capable of transporting oligosaccharides such as GOS
with a DP of ≥2–6 and modiﬁed disaccharides (lactitol).
Bioinformatic identiﬁcation and analysis of other lacS genes
and their proximal genetic loci was based on the present study
and earlier functional characterization of lactose transport by
lacS homologs in lactic acid bacteria. Phylogenetic mapping of
lacS encoding strains revealed that lacS is, to date, mainly found
in Lactobacillus species that are commensals of the human gut.
This suggests that transport and metabolism of lactose and
complex carbohydrates are important energy sources for in-
testinal lactobacilli, because GPH permeases compared with
ABC and PTS systems do not require ATP for import, allowing
an energy-efﬁcient and rapid adaptive transport of GOS. Anal-
ysis of the adjacent genes of lacS showed three core genes: lacS,
lacR, and β-galactosidase of either GH2 (LacZ or LacLM) or
GH42 (LacA) family. Genes without apparent known function
for lactose metabolism were also found for some species (e.g.,
L. acidophilus and L. plantarum), and interestingly some proxi-
mal genes showed putative functional roles for mucin adhesion
or rhamno-galactoside metabolism, respectively. This suggests
that the base functionality of the lacS genetic locus is highly
conserved by evolutionary pressure and important for niche
survival in the GIT via transport and metabolism of lactose,
GOS, and likely fractions of HMOs.
The presence of lacS and lacA homologs among the intestinal
lactobacilli supports the importance of complex galactoside utili-
zation for energymetabolism. The related genetic loci were inclusive
within the acidophilus subfamily of lactobacilli (L. acidophilus,
L. ultunensis, and L. helveticus), whereas other species (e.g., Lacto-
bacillus fermentum and L. plantarum) include lacS-positive strains
and strains that have no homologs of either lacS or lacA. The re-
tention of lacS and lacA homologs in L. helveticus is consistent with
the known genetic lineage and adaptation of these lactobacilli to
milk (48). In that process,L. helveticus eliminated a number of GIT-
related functions (e.g., bile salt hydrolase and mucin binding pro-
teins) but retained the lac-related genes while losing most gal-re-
lated genes except the galactose-1-phosphate uridylyltransferase
gene (galT).
In conclusion, we identiﬁed LacS as the sole transporter for
lactose, GOS, and lactitol. A future combination of tran-
Fig. 3. Gene structure of the GOS-induced genome locus. Predicted ρ-independent transcription terminators (52) are shown as hairpin loops. Regulatory CRE
sites are shown above the gene structure, with the upstream base pair distance to the starting codon. Putative functions are indicated by color: carbohydrate
permease (blue), transcriptional regulators (red), glycoside hydrolases (green), Leloir pathway (yellow), and genes without a known relationship to carbo-
hydrate metabolism (white boxes). mucBP, mucus-binding domain protein; reg, putative transcriptional regulator; trans, transposase.
Fig. 4. Unrooted phylogenetic trees of (A) LacS and (B) LacA.
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scriptomics, proteomics, and functional genomics analyses will
provide a comprehensive platform for study of the molecular
interactions between probiotics and prebiotics.
Materials and Methods
Bacterial Strains and Growth Conditions. All bacterial strains and plasmids
used throughout this study are listed in Table 2. Lactobacillus broth cultures
were cultivated in MRS (Difco Laboratories) or SDM (49), supplemented with
0.5% (wt/vol) glucose (Sigma-Aldrich), lactose, lactitol (Danisco), or GOS
(94% GOS, DP 2–6; Danisco; Fig. S2) as carbon source, aerobically at 37 °C or
42 °C. Chloramphenicol (5 μg/mL) and erythromycin (2 μg/mL) were used
when necessary for selection. E. coli strains were cultivated in Brain Heart
Infusion medium (Difco) aerobically at 37 °C with aeration, and erythro-
mycin (150 μg/mL) and/or kanamycin (40 μg/mL) was added for selection.
Solid media were prepared by the addition of 1.5% (wt/vol) granulated agar
(Difco).
L. acidophilus NCFM Microarray Platform. Whole-genome oligonucleotide
microarrays were designed as described by Goh et al. (33) with four replicate
spots for each of the 1,824 predicted genes. Hybridization quality was
assessed by monitoring the Cy3/Cy5 ratio of labeled cDNA, prepared from
total RNA, after slide scan to observe a linear correlation between the two
ﬂuorophores. For DNA microarray transcriptome study, semisynthetic media
(25) used for cultivation of L. acidophilus NCFM were ﬁltered through a 0.22-
μm ﬁlter, and oxygen was removed by the Hungate method (50). L. acid-
ophilus NCFM cultures were propagated in parallel in semisynthetic media
with 1% (wt/vol) glucose or GOS as carbon source. Cultures were transferred
for four passages on each sugar before being harvested at the early loga-
rithmic phase (OD600= 0.35–0.5) by pelleting at 4 °C (3,000 × g, 15 min) and
ﬂash freezing the pellets for storage at −80 °C.
cDNA Preparation and Microarray Hybridization. Cells were mechanically dis-
rupted by beadbeating, and total RNA was isolated using TRIzol-chloroform
extraction (Invitrogen). Genomic DNA was removed with Turbo DNase
(Ambion), followedbyRNApuriﬁcationusing anRNeasyMini Kit (Qiagen) (33).
Reverse transcription of total RNA, ﬂuorescent labeling of cDNA, and
hybridizations were done using 20 μg of total RNA for each replicate, as
described by Goh et al. (33). Total RNA from each of the two carbohydrate
treatments was labeled with both Cy3 and Cy5 for two technical replicates to
each growth condition.
Microarray Data Acquisition and Analysis. Hybridized chips were scanned at
10-μm resolution per pixel using a ScanArray Express microarray scanner
(Packard BioScience) for 16-bit spot intensity quantiﬁcation. Fluorescent in-
tensities were quantiﬁed and background subtracted using the QuantArray
3.0 software package (Packard BioScience). Median values were calculated
for all ORF tetraplicate intensities and log2-transformed before being
imported into SAS JMP Genomics 4.0 (SAS Institute) for data analysis. The full
dataset was interquantile normalized and modeled using a mixed-model
ANOVA for analysis of the differential gene expression pattern and visual-
ization using heat maps and volcano plots.
Construction and Phenotypic Determination of the lacS Deletion Mutant. Ge-
nomic DNA of L. acidophilus NCFM was isolated by the method of Walker
and Klaenhammer (51) or by the Mo Bio Ultraclean microbial DNA isolation
kit (Mo Bio Laboratories). Plasmid DNA from E. coli was isolated using
a QIAprep Spin miniprep kit (Qiagen). Restriction enzymes (Roche Molecular
Biochemicals) were applied according to the instructions supplied by the
manufacturer. DNA ligation was done using T4 DNA ligase (New England
Biolabs) as directed by the manufacturer’s recommendations. All PCR pri-
mers (Table S2) were synthesized by Integrated DNA Technologies. PCR
reactions, preparation and transformation of competent L. acidophilus
NCFM and E. coli cells, analysis by agarose gel electrophoresis, and in-gel
puriﬁcation were done as described by Goh et al. (33).
The construction of an Δupp isogenic mutant with in-frame DNA excision
of 96% of the lacS (LBA1463) coding region was done according to Goh et al.
(33). In short, the upstream and downstream ﬂanking regions (approximate
length of 750 bp each) of the deletion target were PCR-ampliﬁed with the
1463A/1463B and 1463C/1463D primer pairs, respectively, and fused by
splicing by overlap extension PCR (SOE-PCR). The SOE-PCR product was
cleaved with EcoRI and BamHI before ligation into pTRK935 linearized with
compatible ends and transformed into NCK1831. The resulting recombinant
plasmid, pTRK1015, harbored in NCK2126, was transformed into NCK1910
harboring pTRK669, for chromosomal integration of pTRK1015 and fol-
lowing DNA excision to generate the ΔlacS genotype. Conﬁrmation of DNA
deletion was done by PCR and DNA sequencing using primer pair 1463UP
and 1463DN (Table S2).
Lactose and GOS utilization of the lacS gene deletion mutant was tested by
comparative growth to wild-type L. acidophilus NCFM and NCK1909 (upp
mutant and parent strain of the ΔlacSmutant). All strains were grown in SDM
supplemented with 1% (wt/vol) glucose before inoculation [1% (vol/vol)] of an
overnight culture into SDM supplemented with 0.5% (wt/vol) of the following
carbohydrates in separate batches: lactose, GOS, lactitol, galactose, sucrose,
and glucose. Growth was monitored by optical density using a Fluostar
spectrophotometer in triplicate wells of a 96-well plate (200 μL per well) and
covered with an airtight seal. All carbohydrates were at least 95% pure.
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Abstract (words: 248) 
Probiotic microorganisms, such as bifidobacteria, exert beneficial effects on the human host through their 
presence in the gastrointestinal tract where the proliferation dependent heavily on consumption of 
complex, mainly oligosaccharides, carbohydrates, termed prebiotics. Functional understanding of the 
oligosaccharide uptake systems coupled with dedicated glycoside hydrolases are currently lacking 
functional characterization to understand the molecular mechanisms and broadness of prebiotic 
utilization.  
The aim of the present work was to characterize the substrate recognition of putative dual raffinose 
oligosaccharide family and isomaltooligosaccharide specific ABC transporter from Bifidobacterium 
animalis subsp. lactis, by screening the ligand affinities of the recombinant solute binding protein and 
deduce a potential mechanism of binding by the thermodynamic finger-prints. 
Surface plasmon resonance analysis was used to measure steady-state binding of isomaltooligosaccharide 
and raffinose family oligosaccharides in the µM-range validating the proposed dual specificity of the 
transporter, however the affinities found represent a 100 fold decrease in affinity compared to previous 
reports. Isothermal titration calorimetry suggested this weaker affinity to be driven by increased entropic 
contributions as a result of an altered ligand binding cleft in dual substrate binding. This was supported by 
sequence analysis, which allowed prediction of structural changes of binding residues compared to a 
homolog oligosaccharide binding protein. Noticeably, comparative genomics of the identified locus 
confined the occurrence of homologous loci to primary bifidobacteria, streptococci and lactobacilli. 
In conclusion, the present work reports the detailed substrate affinities and thermodynamics of potential 
prebiotic uptake by an ABC transporter with novel dual substrate specificity within probiotic 
bifidobacteria. 
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Introduction 
Probiotic microorganisms (1) have in the recent decade become well-documented by clinical trials for 
their abilities to promote human health through prevention of bacterial associated diarrhea (2, 3), bowel 
disorders (4) ranging through treatments of newborn (5) to the elderly (6). The genus Bifidobacterium has 
been shown to harbor several species and strains with probiotics status (7). The probiotic character of 
bifidobacteria is reflected by their genetically encoded abilities to pass through the human gastrointestinal 
tract, by displaying high tolerance towards acid and bile, and in the colon to utilize complex nutrients in a 
competitive habitat (8). A key attribute of the probiotic nature of bifidobacteria is their ability to utilize 
complex dietary carbohydrate, which is mediated by a battery of carbohydrate uptake and degradation 
proteins (9–11). Carbohydrates that are selectively metabolized by probiotics have been defined as 
prebiotics (12) and have shown to increase the probiotic cell numbers and exert positive effects in human 
intervention studies (13–15). However, the molecular mechanisms of selective metabolism within 
bifidobacteria are in most cases not well understood beyond in silico predictions and a few selected 
studies highlighting the impact of glycoside hydrolases (16), whereas the function and role of glycoside 
transporters remain largely unknown. 
The majority of bifidobacteria do not possess hydrolytic pathways for polysaccharide utilization (17) as 
opposed to many other members of the GIT microbiome (18). The bifidobacteria thus have evolved 
specialized carbohydrate transport systems for uptake of available dietary oligosaccharides and cross-
feeding on the polysaccharide breakdown products (19). Recent studies support the importance of 
oligosaccharide uptake within bifidobacteria and propose primarily ATP binding cassette (ABC) 
transporters to be involved with uptake of oligosaccharide prebiotics (20–22). The data supporting the 
functional role so far are only linked to increased bifidobacteria counts in vivo (13, 23).  
ABC transporters are identified in organism from all domains of life and facilitate an ATP energized 
uptake (or export) of vitamins, carbohydrates, oligo-peptides, amino acids, ions and various organic 
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compounds (24). The broad range of uptake is reflected by diversity in modularity of the domains 
constituting the transporter (25). Gram-positive bacterial carbohydrate transporters are typically found as 
pentamers composed of an extracellular cell wall attached solute binding protein, two membrane-
spanning domains forming the permease and two nucleotide binding proteins coupling the hydrolysis of 
ATP to energize the transport (25). The substrate specificity of ABC transporters is determined by the 
solute binding protein (26) and so far characterization of solute binding proteins within bifidobacteria has 
been limited to a lacto-N-biose binding protein (27). Explanation of the specificities for plant derived 
oligosaccharides prebiotics is currently lacking. 
The potential prebiotic utilization of the probiotic B. animalis subsp. lactis Bl-04 (28) revealed a genomic 
locus encoding a single ABC transporter adjacent to glycoside hydrolases with putative specificities for 
the candidate prebiotic groups of raffinose family oligosaccharides (RFO) (29, 30) and isomalto-
oligosaccharides (IMO) (31, 32), respectively. These types of potential prebiotics have been shown to 
increase bifidobacteria counts in vivo (29, 31), hence potentially linking the ABC transporter driven 
utilization of these potential prebiotics to the probiotics nature of B. lactis Bl-04. 
We therefore hypothesized that the solute binding protein (Balac_1599, in the following referred to as B. 
lactis Bl-04 α-1,6-glycoside binding protein (Bl16GBP)) could display broad substrate specificity for 
RFO and IMO, and the transporter could be a potential link to substantiate the mechanism of selective 
prebiotic utilization within bifidobacteria. In this light, the aim of the present work was to characterize the 
substrate binding of the recombinant RFO/IMO solute binding protein and through thermodynamics 
finger-prints rationalize the mechanism of the intriguing dual specificity, possibly related to probiotic 
functions within bifidobacteria.  
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Results 
Identification and sequence analysis of a RFO/IMO utilization locus in B. lactis Bl-04 
Gene landscape analysis of B. lactis Bl-04 identified a genomic locus encoding an oligosaccharide 
specific ABC transporter (Balac_1597–1599), two putative glycoside hydrolase family (GH, 
www.cazy.org) 36 α-galactosidases (Balac_1596 and Balac_1601) and a putative GH13 oligo-α-1,6-
glucosidase (Balac_1593), with the three hydrolases predicted to be intracellular (33) and the locus under 
transcriptional regulation by a NagC type regulator (Balac_1600). Sequence analysis of the GH36 α-
galactosidase Balac_1601 revealed the presence of the [CSSGGGR]514–520 active site motif (Balac_1601 
numbering) thus assigning this enzyme into subfamily I of GH36 harboring α-galactosidases specific for 
raffinose (α-D-Galp-(1–6)- D-Glcp-(α1,β2)-D-Fruf) and RFO (34). This together with the 67% amino acid 
sequence identity with the previously characterized α-galactosidase from B. bifidum (35) supports the 
specificity of this enzyme toward this class of α-1,6-galactosides abundant in human diet. The alter α-
galactosidase Balac_1596 was assigned to subfamily II harboring dominantly plant raffinose synthases. 
The putative oligo-α-1,6-glucosidase showed 66–72% amino acid sequence identity to two α-1,6-
glucosidases from B. breve shown to catalyze the hydrolysis of isomaltose (α-D-Glcp-(1–6)-D-Glcp), 
isomaltotriose (α-D-Glcp-(1–6)-α-D-Glcp-(1–6)-D-Glcp) and panose (α-D-Glcp(1–6)-α-D-Glcp-(1–4)-D-
Glcp) (36). The sequence analysis thus suggested that this locus encodes the uptake of RFO and IMO via 
a single ABC transporter and their subsequent degradation by the mentioned glycoside hydrolases. 
 
Dual substrate affinity characterization of recombinant Bl16GBP 
To confirm the specificity of Bl16GBP, the recombinant protein was produced and purified to yield a 44 
kDa protein corresponding to the theoretical 43.7 kDa mature polypeptide comprising residues 46–437, 
N-terminally flanked by four residues [GSHM] introduced form the cloning vector following the cleavage 
of the N-terminal His-tag. The structural integrity of the recombinant protein was assessed using 
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differential scanning calorimetry (DSC) (Figure S1). The calorimetric trace of Bl16GBP showed a well 
defined single thermal transition with a Tm of 68.2 °C, thus confirming the structural integrity and the 
thermostability of the protein. Interestingly a modest increase in Tm (0.9 °C) was observed in the presence 
2 mM raffinose suggesting ligand mediated stabilization.  
Ligand preference of Bl16GBP was screened using surface plasmon resonance (SPR) with Bl16GBP 
immobilized to a CM5 chip to 3900 response units (RU) for measuring the steady state binding of 
carbohydrate binding to Bl16GBP (Figure S2). No binding to the tested monosaccharides (fructose, 
galactose and glucose) was observed in agreement with the reported divergence of mono- and 
oligosaccharide binding proteins (26). Furthermore, the solute binding protein was specific for IMO and 
RFO as no binding was detected the β-glycosides cellobiose (β-D-Glcp-(1–4)-D-Glcp), β-1,4-xylo-
oligosaccharides ([β- D-xylf-(1–4)]1–6-D-xylf), β-galactooligosaccharides ([β-D-Galp-(1–4)]1–5-D-Glcp), 
β-fructo-oligosaccharides ([β-D-Fruf-(1–2)]1–5-(β2,α1)-D-Glcp) or to α-1,4-glucooligosaccharides ([α-D-
Glcp-(1–6)]1–6-D-Glcp) was measured. The dissociation constants for the tested RFO and IMO substrates 
were determined from a one binding site model to the steady state response as a function of concentration 
(Table 1 and Figure 1A). The highest affinity was measured towards the trisaccharides panose and 
raffinose with KD values of 8.7 µM and 22.7 µM, respectively (Table 1). Notably, about a 100 fold 
reduction in affinity was measured for the disaccharides melibiose and isomaltose as compared to panose.  
Distinguishable differences in the affinity for longer oligosaccharides were observed between RFO and 
IMO with the affinity dropping 16 fold for stachyose ([α-D-Galp-(1–6)]2-D-Glcp-(α1,β2)-D-Fruf) as 
compared to raffinose and no measurable binding of verbascose ([α-D-Galp-(1–6)]3-D-Glcp-(α1,β2)-D-
Fruf), whereas the affinity for IMO with degree of polymerization (DP) 3–7 was very similar and only 
about 10–16 fold lower than for panose (Table 1). The binding affinity of the solute binding protein for 
raffinose was essentially unchanged in the pH range 5.5–8.0 (Table 2). 
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The binding affinities of panose and raffinose were also measured by isothermal titration calorimetry 
(ITC) (Figure 2), and the experimental binding stoichiometries determined were consistent with a 1:1 
binding model and enthalpically dominated binding of ligands was measured (Table 3) and the binding 
affinities were comparable. 
The temperature dependence of raffinose binding to Bl16GBP was measured by SPR and the raffinose 
dissociation (Figure 2B) was modeled to a van’t Hoff equation of the binding data to yield an estimated 
enthalpy (∆H) of -67 kJ/mol and entropy (T∆S) of -40 kJ/mol. Thus the substrate binding was found to be 
energetic favorable by enthalpic contributions and negative entropy confirming the above temperature 
increase of protein unfolding with substrate bound. 
 
Sequence comparison for structure-function insight in the Bl16GBP binding cleft  
Multiple sequence alignment of representative bifidobacteria homologs of Bl16GBP, together with a 
previously identified and structure determined lacto-N-biose (Gal-β-(1–3)-GlcNAc) specific solute 
binding protein, referred to as GL-BP, (PDB: 2Z8F) from B. longum (27), was done to deduce both 
conserved and different functional amino acids in proximity of the substrate binding cleft (Figure 4). 
Notably, from the global alignment a significant part of the conserved residues were related to secondary 
structural elements indicating an overall similar structural fold of Bl16GBP although a loop deletion of 
two amino acids GG289-290 (GL-BP numbering) was found and corresponded to a flexible hinge region 
(37), thus the deletion identified in Bl16GBP (and homologs) may result in a more rigid conformation as 
possibly reflected by the low difference in unfolding temperature increase in the presence of raffinose. 
The residues potentially lining the substrate binding cleft of Bl16GBP were compared to the 
corresponding 21 residues found within 4 Å of the bound lacto-N-tetraose (Gal-β-(1–3)-GlcNAc-β-(1–3)-
Gal-β-(1–4)-Glc) in GL-BP (residues highlighted in Figure 4). The corresponding 21 residues in 
Bl16GBP indicated how the side chains were overall less bulky thus displaying a structurally broader 
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binding cleft required for the dual specificity observed. Two tryptophans in the lacto-N-biose solute 
binding protein (W231 and W252) were found to be the main residues involved with aromatic stacking to 
the ligand and hence proposed to exhibit a commonly found motif for carbohydrate binding (38). In 
Bl16GBP only a single tryptophan were functionally conserved by a tyrosine substitution, whereas the 
other tryptophan was lacking and the corresponding residues was positioned in a putative variable loop 
region. These observations indicate a certain plasticity of the Bl16GBP binding cleft and the apparent 
wide binding cleft with the loss of aromatic stacking for substrate binding may explain the weaker 
binding in the µM range and the dual specificity of both RFO and IMO. 
 
Discussion 
The significance of ABC transporters in probiotics for uptake of prebiotic oligosaccharides has become 
evident through gene and protein identification (39, 40). To date however, characterization of protein 
structure-function relationships is limited for understanding the diversity of substrate specificities 
proposed for ABC transporters and their contribution to selective prebiotic utilization by probiotics.  
The present work identified a putative locus encoding an ABC transporter for potential prebiotic 
utilization in B. lactis Bl-04 and presents biophysical SPR and ITC characterization of the dual specificity 
solute binding protein conferring the initial step of uptake of the candidate type of prebiotic RFO and 
IMO. To support the selective mechanism of RFO and IMO utilization as a key attribute of prebiotics (12, 
41), we mapped the phylogenetic comparison of Bl16GBP homologs (Figure 4) together with putative 
raffinose solute binding proteins previously identified by transcriptional analysis in B. longum NCC2705 
{252 Parche 2007;}} and Streptococcus mutant UA159, which also was upregulated by isomaltose (42). 
The taxonomical distribution was confined to the Actinobacteria and Firmicutes phylae with the dominant 
species being Bifidobacterium or Streptococcus and Lactobacillus, respectively, leading to species 
prevailingly found in the gastrointestinal tract (Cellulomonas excluded albeit being a plant biomass 
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degrading organism) strengthening the potential selective utilization of RFO and IMO. Gene landscape 
analysis of the gene clusters encoding the above putative RFO/IMO solute binding proteins (Figure 5) 
revealed a consistent co-encoding of a putative oligosaccharide ABC transporter permease and the 
identified solute binding protein with a GH36 α-galactosidase. Notably, only gene clusters from 
Firmicutes encoded a GH13_18 sucrose phosphorylase, suggesting divergent catabolism of simpler 
carbohydrates within the two phylae. No distinct pattern was found for the occurrence of GH13 oligo-α-
1,6-glucosidases, although not encoded in the lactobacilli gene clusters, where an alternative pathway for 
utilization of IMO was proposed (Møller et al., J. Bacteriol. 2012, in press.; Andersen et al., in review at 
PLoS ONE). Interestingly, the B. animalis gene clusters encoded an additional GH36 α-galactosidase sub-
classified into GH36_II (34) with no predicted signal peptide indicating that the B. lactis Bl-04 gene may 
have a potential novel specificity for α-1,6-glycosides beyond the substrates binding to Bl16GBP.  
The SPR characterization of the dual substrate specificity Bl16GBP revealed strongest affinity for the 
trisaccharides panose and raffinose while binding of longer RFO was weaker and confined to melibiose 
and stachyose, as no binding of the longer verbascose was measured. This apparently restricted binding 
mode was not observed for the IMO, found to bind all the tested DP 2–7 IMO, indicating that the ligand 
binding cleft recognizes the non-reducing ends of either α-1,6-glucosides or α-1,6-galactosides where the 
terminal hexose-glycosyl defines the end-point of RFO binding. No binding of sucrose (α-D-Glcp-
(α1,β2)-D-Fruf) or isomaltulose (α-D-Glcp-α-(1–6)-D-Fruf) was observed, emphasizing that Bl16GBP 
recognizes the reducing end of an α-1,6 linked hexose as a key determinant of substrate binding. 
The higher µM range of binding affinities was in striking contrast to previous characterizations of 
oligosaccharide binding proteins were sub µM binding affinities were reported (Table 4), indicating that 
the dual substrate specificity may have evolved with the cost of reduced affinity. Sequence comparison to 
the structural determined lacto-N-biose solute binding protein identified key residues in the ligand binding 
cleft, where a key tryptophan was lacking among the corresponding Bl16GBP residues and with an 
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overall display of a seemingly open binding cleft assist to rationalize the decrease in affinity by increase 
plasticity of the Bl16GBP binding cleft. 
The enthalpic and entropic finger-prints of ligand binding compared to previously reported 
oligosaccharide solute binding proteins, confirms the ligand binding to be driven by enthalpy with a 
negative entropic contributing (Table 4). An overall, albeit weak, tendency of the entropic contribution 
being one third the enthalpic, which was largely unchanged, for trisaccharide binding, was also observed 
for solute binding proteins being mono-specific, however as for panose binding a larger entropy was 
measured. This implies the apparent lower affinity of Bl16GBP to be enforced by an increase in entropy 
indicating how the dual substrate specificity is affecting the mechanism of oligosaccharide binding. 
The identification of a putative RFO/IMO specific ABC transporter from the probiotic B. lactis Bl-04 has 
been further pursued by functional analysis. Screening of proposed carbohydrate ligands by SPR revealed 
novel dual substrate specificity by binding of RFO (DP2–4) and IMO (DP2–7) with binding affinities in 
the higher µM range markedly weaker than previous observations of oligosaccharide solute binding 
proteins in the sub µM range. The thermodynamics of ligand binding by ITC proposed the reduced 
affinity to be linked to greater entropic contributions. This was supported by sequence comparison to a 
structurally determined solute binding protein where corresponding identified key residues in the 
substrate binding cleft indicated plasticity of the Bl16GBP binding cleft. Comparative Gene landscape 
analysis revealed the substrate specific solute binding protein to be co-encoded with both GH36 and 
GH13 enzymes and taxonomical predominantly restricted to species known to harbor probiotic strains 
thus enforcing the selective utilization of RFO and ISO as a requirement for prebiotic use by the strains of 
bifidobacteria and lactobacilli.  
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Materials and methods 
 
Bioinformatics analysis 
Phylogenetic analysis was done using ClustalW (43) and visualized using Dendroscope (44). All 
homology searching was done using BLAST (45). 
 
Cloning of the Bl16GBP coding open reading frame 
B. animalis subsp. lactis Bl-04 genomic DNA was used as template for the PCR amplification of the 
Balac_1599 open reading frame (Genbank gene ID: 8009526) with the following primer pair:  
Forward: 5’ GAATTCCATATGGGCAGCGGGCAGGTCACGCTC (Nde1 restriction site in bold) 
Reverse: 5’ CGCGGATCCCTACTTGCGGAAGTCACGAGCC (BamHi restriction site in bold) 
The PCR amplicon (1201 basepairs), flanked by Nde1 and BamH1 restriction sites was constructed to 
include the natural stop-codon but excluding the signal peptide as predicted by SignalP (33), was ligated 
into the pET28a(+) vector (Novagen, Darmstadt, Germany) and transformed by heat shock into E. coli 
DH5α (Invitrogen, Carlsbad, CA, USA). Single colony clones were selected on LB agar plates with 50 
µg/ml kanamycin and colonies harboring the engineered pET28a(+) with the Bl16GBP insert were 
confirmed by restriction analysis and sequencing using the T7 primer pair (Eurofins MWG, Ebersberg, 
Germany). Verified plasmid was transformed in E. coli BL21(DE3) for protein expression. 
 
Production and purification of recombinant Bl16GBP 
Recombinant Bl16GBP was produced in a 5 L Biostat B bioreactor (B. Braun Biotech International, 
Melsungen, Germany) according to a fed-batch protocol developed for the production of other proteins 
175
12 
 
(34), with the following modifications: heterologous expression was induced at 37 ºC when OD600 
reached a value of 8 by the addition of isopropyl-β-D-thiogalactopyranoside (IPTG; Sigma-Aldrich, St. 
Louis, MO, USA) to a final concentration of 100 µM. The cells were harvested after 18 h of induction by 
centrifugation (10.000 g at 4 °C for 15 min) and stored at -20 °C.  
Cells were resuspended in Bugbuster (Novagen, Darmstadt, Germany) with Benzonase Nuclease 
treatment (Novagen) and incubated at 4 ºC for 1 hour, hereafter the suspension was centrifuged (43,000 g, 
90 min) and sterile filtered (0.22 µm) before loading to a 5 ml HisTrap HP column (GE Healthcare, 
Uppsala, Sweden) as described elsewhere (34). The affinity purification was followed by anion exchange 
chromatography using an 8 ml Mono Q 10/100 GL column (GE Healthcare) equilibrated in 20 mM 
phosphate buffer, pH 7.0 (buffer A) and installed on an ÄKTA Advant™ chromatograph (GE 
Healthcare). Protein was elution by an increasing gradient of buffer A with 500 mM NaCl added over 10 
column volumes. 
The purity of eluted protein was validated by SDS-PAGE and fractions containing pure protein were 
pooled and buffer exchanged into 20 mM phosphate, pH 7.0. The pET28(a)+ encoded N-terminal hexa-
his-tag was removed by incubation for 24 h at room temperature with thrombin, 1 U/100 µg Bl16GBP 
protein (Novagen). The reaction mixture was spun down and the supernatant was affinity purified as 
above with a one-step gradient over 5 column volumes where the flow-through contained the cleaved 
Bl16GBP, which was buffer exchanged into 20 mM phosphate, pH 7.0. 
The protein concentration was determined by measuring A280 using a molar extinction coefficient ε280nm = 
51750 M-1cm-1 determined experimentally by aid of amino acid analysis (46), comparable to the predicted 
value of ε280nm = 45380 M-1cm-1. 
 
Carbohydrate ligands 
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Fructose, galactose, glucose, sucrose, maltose, maltotriose, maltotetraose, maltopentaose, maltohexaose, 
maltoheptaose were all purchased from Sigma. XOS was obtained from Shandong Longlive Bio-
technology Co., Ltd, (China). Cellobiose was from Fluka AG (Switzerland). GOS and FOS were kindly 
supplied from DuPont Health and Nutrition as custom preparations.  
 
Differential scanning calorimetry  
Bl16GBP (0.5 mg/mL) was dialyzed against 1000 volumes of either 20 mM MES, pH 6.5 or in the same 
buffer including 2 mM raffinose to assess possible stabilization of protein in the ligand bound form, and 
degassed for 10 min at 20 °C. DSC analysis was performed using a VP-DSC calorimeter (MicroCal, 
Northampton, MA, USA) with a cell volume of 0.52061 mL at a scan rate of 1 °C·min-1. Baseline scans 
collected with buffer in the reference and sample cells were subtracted from sample scans. Origin v7.038 
software with a DSC add-on module was used for assigning Tm.  
 
Surface plasmon resonance 
Surface plasmin resonance (SPR) analysis was performed using a Biacore T100 (GE Healthcare) and 100 
µg/ml Bl16GBP in 10 mM sodiumacetate pH 4.5 was immobilized onto a CM5 chip (GE Healthcare) 
using a standard amine coupling protocol before aiming for an immobilization level of 4000 response 
units. Binding studies were carried out at 25 °C in a 20 mM phosphate pH 7.0, 150 mM sodium chloride, 
0.005% (v/v) P20 (GE Healthcare) running buffer unless otherwise stated and all solutions were filtered 
prior to analysis (0.22 µm). In the initial screening of binding activity, carbohydrate ligands were 
dissolved in the running buffer to a final concentration of 1 mM and injected over the chip surface at a 
flow of 30 µL/min with association times of 90 and 180 s, respectively.  
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Carbohydrate ligands, which displayed binding affinity towards the immobilized protein, were further 
analyzed (Table S1) using the above flow rate, contact and dissociation time. Binding of IMO ligands 
were tested at 10 concentrations (3.9–1000 µM), whereas melibiose and stachyose was tested at 10 
concentrations (3–1600 µM) and (8–4000 µM), respectively. Raffinose binding was measured at 13 
concentrations (0.24–1000 µM). Binding of verbascose was done using the same conditions as for 
stachyose but no saturation was observed. Binding affinities (KD) were fitted to a one-binding site model 
(Biacore Evaluation software, GE Healthcare) to binding levels measured for each carbohydrate in 
triplicates. 
The pH dependence of binding was measured using raffinose at four concentrations (4–250 µM) in 20 
mM sodium acetate pH 4.0–5.5) or 20 mM sodium citrate-phosphate (5.5–8.0) and a similar NaCl and 
surfactant concentration as above in both buffers. The temperature dependence of raffinose binding (13 
concentrations as in range above) to Bl16GBP was analyzed by measuring the KD at eight temperatures in 
the range 15–43 °C and the energetic of binding were determined using linear van’t Hoff analysis using 
the Biacore Evaluation software. 
Isothermal titration calorimetry  
The affinity of raffinose and panose to Bl16GBP was determined by isothermal titration calorimetry 
(iTC200, GE healthcare). Titrations were conducted in triplicates at 25°C by injection of 2 mM raffinose 
or panose into 108 µM Bl16GBP in 20 mM sodium citrate-phosphate pH 7.0. ITC heat trace profiles are 
shown in figure 2 for raffinose and panose. Injection of panose and raffinose into buffer was performed 
for measuring the heat of dilution which was subtracted in the data analysis. The ITC experiments include 
a pre-injection of 0.5 µL, which was discarded from the analysis, followed by 38·1µL injections into an 
ITC cell volume of 204 µL. The ITC heat trace was processed as described previously (47) and fitted to a 
single site binding model governed by the equilibrium association constant, KD, the molar enthalpy for 
binding,  ∆H, and the average number of binding sites on the protein n.   
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Figures: 
 
Figure 1: SPR quantified binding of raffinose to Bl16GBP. A: The relative response units as function of 
raffinose concentration (□) fitted to a 1:1 binding model shown with error bars. B: The temperature 
dependence of raffinose binding to Bl16GBP depicted by a van’t Hoff plot.  
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Figure 2: ITC study of the binding affinity of panose and raffinose to Bl16GBP. A: Representative ITC 
heat traces of 2mM panose and raffinose titrated into 108 µM Bl16GBP. B: Integrated corresponding heat 
of reaction to a single site binding model where the best fits are shown by solid lines. The experiments 
were performed at 25°C by 38 injection of 1 µL. 
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Figure 3: Multiple sequence alignment of putative functional homologs of Bl16GBP and the lacto-N-biose 
binding protein (GL-BP) from B. longum (PDB: 2Z8F). Conserved residues are highlighted in red and all 
residues within 4 Å of the bound ligand (lacto-N-tetraose) have been highlighted in green boxes in the in 
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GL-BP (2Z8F) sequence. Secondary structure extracted from the GL-BP structure has been represented 
using ESPript (http://espript.ibcp.fr/ESPript/ESPript) and the alignment was constructed using ClustalW 
(43). The Bl16GBP homologs are identified by their locus tags: Blon_2458, Bbr_1867, BL1521 and 
BAD_1574. 
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Figure 4: Phylogenetic map of putative RFO/IMO specific solute binding proteins representing 
taxonomical clusters harboring gene clusters for RFO/IMO utilization. All entries are shown by the full 
strain name and the corresponding solute binding protein locus tag in brackets. The tree has been rooted 
using a B. longum fructose solute binding protein (48). 
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Figure 5: Gene landscape analysis of representative gene clusters encoding RFO/IMO solute binding 
proteins. The gene clusters have been aligned according to their solute binding proteins. Gene functions 
are colored as glycoside hydrolases in red where GH36 melA refer to Balac_1601 homologs, GH36_II 
refers to Balac_1596 homologs, GH4 agal refers to α-galactosidase homolog, GH13 ag1 refers to 
Balac_1593 homologs and GH13_18 refers to subgroup 18 of GH13 encoding sucrose phosphorylases 
(49). Genes in green represents the components of ABC transporter by ABC SPB being the solute binding 
protein, ABC perm being the permeases and ABC ATP being the ATP binding kinases. Genes in grey 
refer to transcriptional regulators (reg), hypothetical proteins (hypo) and genes of the Leloir Pathway: 
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galactose kinase (galK) and galactose-1-phosphate uridylyltransferase (galT). Putative ORF less than 100 
amino acids were not shown. 
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Tables: 
Table 1: Substrate specificities of Bl16GBP measured by SPR. Dissociation constants (KD) were 
measured as triplicates and listed with the standard errors together with the modeled maximal binding and 
Chi2-estimate for the fitted one-binding site model. Isomaltooligosaccharides are denoted as IM where the 
number state the degree of polymerization. 
Raffinose-like carbohydrates  
Carbohydrate  KD (µM)  SE (µM) Rmax  Chi2  
Melibiose  729 72 24.21 0.219 
Raffinose  20.7 0.36 34.81 0.115 
Stachyose  327 11 37.2 0.268 
Verbascose  >4000  - 54.7 0.382 
Isomaltooligosaccharides  
Carbohydrate  KD (µM)  SE (µM) Rmax  Chi2  
IM2  1059 73.00 19.11 0.0578 
IM3  126.4 2.80 32.97 0.699 
Panose  8.7 0.15 34.39 0.11 
IM4  93.9 1.10 41.87 0.05 
IM5  102.7 1.30 50.96 0.0734 
IM6  103.9 1.10 56.38 0.0628 
IM7  142.5 0.96 68.53 0.0383 
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Table 2: The influence of pH upon binding of raffinose to Bl16GBP. 
pH KD (µM) Rmax SE (µM) 
4.5 62.2 14.4 2.30 
5.5 21.2 25 0.08 
6.0 19.7 25.1 0.07 
6.5 23.5 25.1 1.46 
7.0 20.2 22.5 2.40 
7.5 16.5 25.2 0.71 
8.0 17.9 24.98 0.73 
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Table 3: Dissociation constants and thermodynamics of panose and raffinose binding to Bl16GBP 
measured by ITC. 
 KD [µM] ∆G[kJ/mol] ∆H [kJ/mol] -T∆S[kJ/mol] n 
Panose 17.5 ± 0.3 -27.1 -63.7 ± 0.5 36.5 0.70 ± 0.01 
Raffinose 27 ± 2 -26.1 -46.3 ± 0.1 20.2 0.60 ± 0.02 
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Table 4: Comparison of thermodynamic finger-prints for trisaccharide binding by oligosaccharide solute 
binding proteins.  
Strain Ligand KD [µM] 
∆G 
[kcal/mol] 
∆H 
[kcal/mol] 
-T∆S 
[kcal/mol] Reference 
Bifidobacterium 
animalis subsp. 
lactis 
Raffinose 27.0 -6.49 -11.33 4.84 This study 
Panose 17.5 -6.23 -14.98 8.75 This study 
Streptococcus 
pneumonia Maltotriose 0.51 -7.65 -6.32 1.33 (50) 
Geobacillus 
stearothermophi
lus 
Arabinotriose 0.22 -9.2 -14.3 5.1 (51) 
Streptococcus 
pneumonia 
Blood group 
antigen A  
[GalNac-α(1,3)-
Fuc-α(1,2)-Gal] 
1.01 -8.21 -9.2 0.99 (52) 
Blood group 
antigen B 
[Gal-α(1,3)-Fuc-
α(1,2)-Gal] 
1.15 -8.26 -8.4 0.14 (52) 
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Supplementary material: 
 
Figure S1: Differential scanning calorimetry of Bl16GBP. Unbound Bl16GBP is shown in green and 
Bl16GBP in the presence of 2 mM raffinose is shown in red. 
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Figure S2: SPR binding curves raffinose binding to Bl16GBP at 25 °C. The sensorgram is shown with 
baseline stabilization (-60:0 s), measurement of response unit by raffinose concentrations (0.49–1000 
µM) (0:90 s) and raffinose wash-off with baseline stabilization (90–180 s). The increase in raffinose 
concentration is illustrated by the color gradient leading from green (0.49 µM) to red (1000 µM). 
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Table S1: Carbohydrates used for SPR and ITC measurements. All carbohydrates are listed with chemical 
structure, Manufacturer and purity. 
Carbohydrate Structure Manufacturer or 
supplier 
Purity (as given 
by Manufacturer 
or supplier) 
Melibiose  α-D-Galp-(1–6)-D-Glcp Sigma > 98% 
Raffinose family 
oligosaccharides 
[α-D-Galp-(1–6)]a-D-
Glcp-(α1,β2)-D-Fruf 
Sigma > 99% 
Panose α-D-Glcp(1–6)-α-D-Glcp-
(1–4)-D-Glcp 
Carbosynth Ltd. (UK) > 98% 
Isomaltooligo-
saccharides 
[α-D-Glcp-(1–6)]b-D-Glcp Kind gift from 
Professor Atsuo 
Kimura, Hokkaido 
University (Japan) 
- 
a Lists the three main types of raffinose family oligosaccharides. For a=1: Raffinose, for a=2: stachyose 
and for a=3: verbascose. 
b Lists the distribution of isomaltooligosaccharides through isomaltose (b=1) till isomaltoheptaose (b=6). 
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6.5 Ongoing collaborative work 
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This appendix outlines a small activity of the experimental work initiated as part of this Ph.D. 
project, which is not completed at the present time. This is a collaboration with Professor Hanne 
Frøkiær, Department of Basic Sciences and Environment, Faculty of Life Sciences, University of 
Copenhagen. 
 
Carbohydrate dependent immuno-modulation by Lactobacillus acidophilus NCFM 
stimulated with oligosaccharides 
Probiotic microorganisms interact with the host immune system by modulating the immune 
response when degraded by dendritic cells (1). The immune modulation is largely screened by 
the interleukins (IL) 10 and 12 produced by the dendritic cells as part of the innate immune 
system, where the ratio signals a pro-inflammatory response by increased IL-12 and anti-
inflammatory response by increased IL-10. The dendritic response to probiotic lactobacilli and 
bifidobacteria differ on the strain level (2) and functional studies have proposed lipoteichoic acid 
(3) and S-layer proteins (4) to affect the IL-profile and interactions with dendritic cells, 
respectively. 
From the current project, it was indicated how the different utilized glycosides affected the 
applied probiotics Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis 
Bl-04. Building on this, it was hypothesized that the changed catabolism could lead to metabolic 
changes of factors such as cell membrane lipid or cell wall glycoside compositions, which could 
potentially change the innate immune response. 
For the experimental design L. acidophilus NCFM was selected for dendritic stimulation based 
on prior knowledge of the bacteria and the induced immune response pathway through Toll-like 
receptors (5). 
L. acidophilus NCFM cultures (harvested in the stationary phase) were prepared in semi-defined 
media (6) supplemented with either glucose as a control carbohydrate, cellobiose (β-D-Glcp-(1–
4)-D-Glcp) as a β-glucoside representative), lactose (β-D-Galp-(1–4)-D-Glc) as a β-galactoside 
representative and raffinose (α-D-Galp-(1–6)-D-Glcp-(α1,β2)-D-Fruf) as a α-galactoside 
representative. 
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Dose-response experiments have been performed using murine dendritic cells measuring the IL-
10 and IL-12 productions, to determine the concentration of L. acidophilus NCFM applied based 
on OD600 measurements and confirmed by cell counts. Cultures have been grown at DTU and all 
dendritic and enterocyte experiments have been performed by technician Anni Mehlsen at 
Copenhagen University in our collaboration with Professor Hanne Frøkiær. 
Preliminary results showed a reduced IL-12 profile for L. acidophilus NCFM when grown on 
cellobiose and lactose. Currently these results are being further analyzed by realtime 
quantitative-PCR to deduce the intracellular pathway changes in dendritic cells that reflect the 
mechanism of IL-12 changes compared to earlier work (5). 
In conclusion, this on-going work will add to the understanding of factors underlying the 
immune response of probiotics upon the host and may further highlight the importance of 
prebiotic induced changes in carbohydrate metabolism of probiotic microorganisms.  
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6.6 Posters contributions 
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Transcriptional screening[1] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Functional genomics validation 
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Differential proteomics[2] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Protein structure-function relationship[3] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data integration and summary 
The combination of the above methods and obtained results lead to in-depth molecular 
understanding of prebiotic utilization by L. acidophilus NCFM through identification of 
key proteins and their characterization. 
This poster represents a methodological platform to generate data of commercial value 
and relate the results into a systems biological perspective through functional data and 
comparative sequence analysis.  
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CASE: Lactobacillus acidophilus NCFM is a documented probiotic able to utilize the prebiotics β-galacto-oligosaccharides and raffinose family oligosaccharides.  
    The specific pathways for potential prebiotics remains to be characterized to advance the understanding of selective metabolism of probiotics.  
AIM:  Identify single genes and their protein products involved with prebiotic utilization and characterize key proteins for prebiotic uptake and catabolism. 
METHODS:  Global transcriptional analysis, DIGE-proteomics, in silico pathway reconstruction, functional genomics, recombinant protein characterization.  
OUTPUT:  Mapping of transporters and full catabolic pathways and validation by gene deletion mutants. Key protein molecular architectural understanding. 
Domain N 
1-305 
Domain C 
640-732 
Domain A 
325-639 
Linker helix  
306-324 
The global transcriptome influenced by various potential 
prebiotic (top) was measured. 
 
A mixed model ANOVA was applied for data analysis of 
the global transcriptome, resulting in defined gene 
clusters putatively involved with carbohydrate uptake 
and catabolism being upregulated. 
 
Differential transcriptomics (left) of β-galacto-oligo-
saccharides (GOS) versus glucose identified a lactose 
permease of the glycoside-pentoside-hexuronide type 
and a GH2 and GH42 β-galactoside. 
 
By the same approach, raffinose and stachyose induced 
an ATP binding cassette (ABC) transporter and GH36 a 
α-galactosidase, a key hydrolytic enzyme as presented 
below. 
 
pH 4 7
97,000 
10,000
97,000 
10,000 
Da
Global gene expression of L. acidophilus NCFM grown on 12 carbohydrates 
GLYCOLYSIS 
RAFFINOSE 
STACHYOSE 
RAFFINOSE SUCROSE 
 + GALACTOSE 
GLUCOSE + 
FRUCTOSE 
1439 –1442 
1438 (GH36) 
1437 
(GH13_18) 
LACTITOL 
GOS 
1463 LACTITOL 
GLUCITOL 
 + GALACTOSE 
 GLUCOSE 
+  GALACTOSE 
1462 (GH42) 
1467–68 (GH2) 
GOS 
STACHYOSE 
LELOIR 
In silico pathway reconstruction from transcriptional and proteomics findings 
Gene 
locus Function 
No growth 
Phenotype Chemical structure 
LBA1438 α-galactosidase Melibiose 
Raffinose 
Stachyose 
α-D-Galp-(1–6)-D-Glcp 
α-D-Galp-(1–6)-D-Glcp-(α1,β2)-D-Fruf 
[α-D-Galp-(1–6)]2- D-Glcp-(α1,β2)-D-Fruf 
LBA1442 Solute binding 
protein of ABC 
transporter 
Melibiose 
Raffinose 
Stachyose 
- 
- 
- 
LBA1463 GPH permease Lactose 
Lactitol 
GOS 
β-D-Galp-(1–4)-D-Glc 
β-D-Galp-(1–4)-D-Glc-ol 
[β-D-Galp-(1–4)]1-5-D-Glcp 
By pathway analysis, key genes of interest were 
selected for gene deletion, with the resulting mutant 
phenotypes in the table below. 
 
This validated the omics-based findings and revealed 
a broad substrate uptake profile of the GOS 
transporter, being the first identified Lactobacillus 
GOS transporter. Gene deletion within the raffinose 
pathway showed how a single gene can impact a 
ABC transporter (left) 
Phenotypic characterization of key metabolic genes 
GOS transcriptome 
Galactose: 
Wt ( ), Δ1438(∆) and 
Δ1442( )  
Raffinose: 
Wt ( ) 
Δ1438(∆) 
Raffinose: 
Wt ( ) 
Δ1442( )  
Initially, we established the reference proteome 
of L. acidophilus NCFM with 625 proteins 
identified, yielding knowledge of the main 
intracellular processes and formed the basis for 
differential in gel electrophoresis (DIGE) 
proteomics. 
 
 L. acidophilus NCFM were grown on the 
prebiotic lactitol and harvested in the late log 
phase. DIGE-proteomics (left)  identified 62 
proteins to be differentially expressed. The total 
intracellular path-way for lactitol catabolism were 
identified (below) 
Lactitol grown cells 
Glucose grown cells 
Internal standard 
lactitol + glucose 
DIGE-principle: 
Labeled DIG proteome (top) 
Reference lactitol map (below) 
The key α-galactosidase (LBA1438, LaMelA36A) 
was produced recombinant. The native enzymes 
was found as a tetramer and the structure was 
determined (right, only one monomer shown).  
 
The active site topology revealed a tight pocket 
maintained through the tetramer interactions 
supporting the substrate specify found through 
gene deletion of LBA1438. 
 
Sequence comparison within the glycoside 
hydrolase family (GH) 36, based on the 
LaMelA36A structure, differentiated the family 
based on structural motifs relating to putative 
specificities (below). 
 
 
 
Structure and domain 
organization of LaMelA36A 
Sequence clustering in GH36. Protein oligomerization  change the active site accessibility. 
Abstract  
Probiotics microbes depend on their ability to survive in the gastrointestinal tract, adhere to mucosal surfaces, and 
metabolize available energy sources from non-digestible dietary compounds. We identified genetic loci in 
Lactobacillus acidophilus NCFM responsible for utilization of complex carbohydrates that may function as prebiotic 
substrates, in vivo. Whole genome oligonucleotide microarrays were used to survey the global transcriptome during 
logarithmic growth of L. acidophilus NCFM in the presence of 11 different carbohydrates (glucose, raffinose, 
cellobiose, panose, stachyose, isomaltose, gentiobiose, lactitol, β-glucan oligomers, polydextrose®, isomaltulose). The 
data were analyzed in JMP Genomics, using a mixed-model ANOVA. Specific transporters of the ATP-binding cassette 
(ABC), phosphotransferase system (PTS) and galactoside-pentose hexuronide (GPH) families were identified for the 
uptake of stachyose, cellobiose and lactitol, respectively. The identified genes were functionally validated by targeted 
gene deletion within an in silico reconstructed stachyose operon. We identified a series of genes that are responsible 
for the uptake and catabolism of a variety of potential prebiotic di- and oligo-saccharides in L. acidophilus NCFM. 
 
Experimental starting point 
Lactobacillus acidophilus NCFM is a proven probiotic bacterium commercially used in dietary supplements 
and fermented dairy products.  Extensive Work has been done to understand the underlying molecular 
mechanisms of the probiotic effects, among others: bile tolerance, adherence to mucosal surfaces, 
mammalian host interactions and prebiotic utilization for pathogen exclusion. 
 The genome of L. acidophilus NCFM [1] encodes a significant part of transport systems and enzymatic 
machinery to process a wide array of complex carbohydrates, as summarized in table 1 and figure 1.  
Yet the specific metabolic pathways for potential prebiotics remains to be identified and characterized. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This study goes in depth with identification of genetic loci involved with prebiotic metabolism. 
11 potential prebiotic carbohydrates (shown in table 2 with predicted glycoside hydrolase for intracellular 
breakdown) were selected for measuring the total transcriptome in response to each carbohydrate. Genes of 
interest were assessed by targeted gene deletions to confirm their role in carbohydrate metabolism.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In silico operon reconstruction 
Gene clusters involved with carbohydrate metabolism were reconstructed from the identified up-regulated 
genes. This pictures the structure of genetic loci for potential prebiotic utilization in the Lactobacilli genus. 
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Global transcriptome analysis 
Total RNA were isolated, reverse transcribed and labeled with Cyanine3 and Cyanine5, two technical 
replicates for each condition. Hybridized probe intensities were background corrected and normalized before 
ANOVA modeling using JMP genomics 4.1. The global expression pattern was visualized by hierarchical 
clustering (figure 3) for the 11 growth conditions. Overall low variance between each condition was 
observed, correlating with regulation of few genetic loci in response to specific carbohydrate metabolism. 
 
 
 
 
 
 
 
 
 
 
 
Carbohydrate metabolism 
Significant, differentially expressed genes were identified (P < 10-2.75) and visualized by volcano plots (figure 
3). Selected up-regulated genes involved with carbohydrate metabolism are shown as an expression heat 
map in figure 4 and listed with gene annotation and fold up-regulation in table 3. Several operon-like sets of 
genes were discovered, all including both a membrane transporter and at least one glycoside hydrolase.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These findings show how L. acidophilus NCFM processes potential prebiotics, by a diverse set of transport 
systems and glycoside hydrolases. 
 
Functional genomics 
The functionality of the stachyose induced operon was validated using the upp gene deletion system [2], as 
illustrated in figure 6. The GH36 α-galactosidase (LBA1438) and substrate recognizing, solute binding protein 
of the ABC transporter (LBA1442) were deleted. Phenotypes were assessed by the introduced growth 
limitations, figure 7. Both LBA1438 and LBA1442 were found to be essential for metabolism of raffinose 
and melibiose. It is also highly likely that the other raffinose family oligosaccharides are catabolyzed via this 
pathway. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study summary 
Identification of specific metabolic pathways allows future pre/pro-biotic health  
claims to  both organism and carbohydrates for novel food and medical products  
• Differential gene expression show specific regulatory patterns in response to carbohydrate 
stimulations 
• Potential prebiotics in L. acidophilus NCFM are metabolized by a range of glycoside hydrolases, ABC 
transporters, PTS systems and a GPH permease 
• Genes LBA1438 and LBA1442 are essential for hydrolysis and transport, respectively, of raffinose 
and melibiose in L. acidophilus NCFM 
•  
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Lactobacillus acidophilus NCFM 
Genome size 1.99 Mb 
GC content 34,70% 
ORFS 1,864 
Carbohydrate metabolism 
ABC transporters 3 
PEP-PTS systems 20 
GPH permeases 2 
Glycoside hydrolases 37 
… of which are extracallular 2 
Table 1: Summary of genes annotated with 
carbohydrate metabolism 
Figure 1: Predicted carbohydrate transport and 
intracellular metabolism by L. acidophilus NCFM  
Carbohydrate Structure Predicted degrading enzymes 
Glucose Glc Glycolytic pathway 
Raffinose Gal- α1,6-Glc- α1,2-Fru α-galactosidase + sucrose phosphorylase 
Gentiobiose Glc-β1,6-Glc 6-phospho-β-glucosidases 
Panose Glc-α1,6-Glc-α1,4-Glc α-1,6-glucosidases, maltose phosphorylase 
Isomaltose Glc-α1,6-Glc α-1,6-glucosidases 
Stachyose Gal-α1,6-Gal-α1,6-Glc-α1,2-Fru α-galactosidase + sucrose phosphorylase 
Cellobiose Glc- β1,4-Glc phospho-β-glucosidases 
Polydextrose All glucose linkages Various α-glucosidases 
β-glucan …Glc-β1,3-Glc (β1,4)… β-glucanase + β-glucosidase 
Isomaltulose Glc-α1,6-Fru α-1,6-glucosidases 
Lactitol Sugar alcohol β-galactosidase or phospho-β-galactosidase  
β-glucoside operon 
Stachyose operon  
Locus tag Putative function 
LBA1443 Regulator 
LBA1442 Solute binding, ABC 
LBA1441 Permease, ABC 
LBA1440 Permease, ABC 
LBA1439 Kinase, ABC 
LBA1438 α-galactosidase, GH36 
LBA1437 
Sucrose phos-
phorylase, GH13_18 
msmE2 msmF2 msmG2 msmK2 melA gtfA2 msmR2 
Lactose operon 
Locus tag Putative function 
LBA1460 Surface protein 
LBA1461 Regulator 
LBA1462 β-galactosidase GH42 
LBA1463 GPH permease 
LBA1464 Transposase 
LBA1465 Regulator 
LBA1467 
β-galactosidase, large 
subunit GH2 
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Figure 2: Reconstruction of putative prebiotic genetic operons based on DNA microarray data.   
Regulatory genes are shown in red, Transporter complexes in blue and glycoside hydrolases in green 
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Figure 3: Rrepresentation of the hierarchical clustering of the global gene expression of L. acidophilus NCFM 
by carbohydrate. Red coloring indicates up regulation and blue coloring indicates down regulation of genes 
Locus 
tag Carbohydrate Annotation Fold induction 
724 Cellobiose Regulator 4,9 
725 Cellobiose PTS system 
IIC component 23,3 
726 Cellobiose 6-P-β-glucosidase 12,1 
1437 Stachyose Sucrose phosphorylase 4,7 
1438 Stachyose α-galactosidase 15,1 
1439 Stachyose ABC transporter 
ATP-binding protein 18,1 
1440 Stachyose ABC transporter 
permease 3,2 
1441 Stachyose ABC transporter 
permease 7,6 
1442 Stachyose ABC transporter 
Solute-binding protein 53,1 
1460 Lactitol mucus binding protein 8,5 
1461 Lactitol Transcriptional regulator 16,0 
1462 Lactitol β-D-galactosidase 42,0 
1463 Lactitol GPH permease 22,7 
1465 Lactitol Regulator 2,2 
1467 Lactitol β-D-galactosidase 
Large subunit 22,4 
1469 Lactitol UDP-galactose 4-epimerase 6,7 
Figure 3: Volcano plot of the differential gene 
expression by carbohydrate stimulation. Up-
regulated genes by stachyose, are circled at A while 
genes up-regulated by lactitol are circled at B 
 
 
Table 3: Identified genes involved with carbohydrate 
metabolism for cellobiose, stachyose and lactitol. 
Figure 4: Expression heat map of genes related 
to metabolism of potential prebiotics. 
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Figure 6: Overview mechanism of the upp gene 
replacement system. 
Figure 7:  ΔLBA1438 (top) and ΔLBA1442 
(below) grown on 1 % (w/v) raffinose in semi 
defined media compared to upp-wildtype. 
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Table 2: Carbohydrates used in this study together with structural glycoside composition, O-linkages and 
the enzymes predicted to facilitate intracellular hydrolysis 
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